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ABSTRACT 
 
Chagas disease is an important problem of public health in the Americas, is caused by the intracellular 
parasite Trypanosoma cruzi.  It is a complex disease with great variety of reservoirs and vectors, 
different ways transmission and parasite high genetic variability. For this reason the immunopathology 
is still not completely understood and there is no efficient treatment. Due to its high genetic variability 
T. cruzi has been classified into six different Discrete Typing Units. Studies evaluating the 
immunopathology in Chagas disease have been performed using single T. cruzi strains, thus, the role of 
the genetic variability of the parasite has not been taken in account. On the other hand, studies using a 
unique parasite strain and different mouse genetic backgrounds showed numerous inconsistences. For 
this reason it is important to evaluate the role of parasite genetic variability and the mouse genetic 
background, to better understand the immunopathology of Chagas disease.  
Previous studies in the laboratory demonstrated the importance of Toll-Like receptor 2 (TLR2) and 
Signaling Lymphocytic Activation Molecule Family 1 receptor (SLAMF1), during the infection with T. 
cruzi in vivo and in vitro using the Y parasite strain. The aim of this project was to evaluate the 
immunopathology of Chagas Disease using different reference strains of T. cruzi in vivo and in vitro, in 
mice with different mouse genetic background and deficient in the expression of TLR2 and SLAMF1 
receptors.  
We found that macrophages from C57BL/6 mice were more resistant to in vitro infection with all T. 
cruzi strains evaluated compared to BALB/c, being the rate of infection variable depending on the 
strain. TLR2 was crucial during the interaction phase of macrophages and all the different strains 
potentiating parasite internalization. In contrast, SLAMF1 played an important role as a microbial 
sensor by suppressing NAPDH oxidase 2 (NOX2) expression and Reactive Oxygen Species (ROS) 
production for all the T. cruzi strains evaluated, except for VFRA cl1.  
In vivo results with BALB/c and Slamf1-/- mice infected with Dm28c, Y and VFRA cl1 strains, where in 
agreement with in vitro results. Thus, Slamf1 -/- mice infected Dm28c and Y were more resistant to 
infection compared with infected BALB/c mice, but more susceptible when infected with VFRA cl1 
strain.  Infections with the Y strain denoted the inverse correlation between the presence of Myeloid-
derived Suppressor Cells (MDSCs) in the heart (denoted by expression of Arg-1, iNOS and COX-2 MDSCs 
markers) and mice survival, which was 30% and 100% in BALB/c and Slamf1 -/- mice, respectively. 
Dm28c and VFRA cl1 parasite strains caused lower levels of MDSCs in heart, but higher immune 
response in spleen and liver, indicating a more efficient control of the infection that impedes infected 
MD“Cs ƌeaĐhiŶg the heaƌt that as a ͞TƌojaŶ hoƌse͟, deliǀeƌ the paƌasites, ĐausiŶg ĐaƌdiaĐ daŵage aŶd 
the death of the mice. 
Finally,  we showed for the first time that immune-responsive gene 1 (Irg1) levels were high in mice 
hearts during T. cruzi infection. In vitro studies using epimastigotes showed a high IC50 for itaconic acid, 
a ŵetaďolite pƌoduĐed ďǇ Iƌgϭ that iŶhiďits pathogeŶ͛s isoĐitƌate lǇase, thus, the last ĐoŶstitutes a Ŷeǁ 
drug target for Chagas disease treatment.   
 
 
  
7 
 
RESUMEN 
La enfermedad de Chagas es importante problema de salud pública en Latino América, esta 
enfermedad es causada por el parasito intracelular Trypanosoma cruzi. La enfermedad de Chagas es 
una compleja enfermedad que involucra gran variedad de reservorios y vectores, tiene diferentes vías 
de transmisión además de que el parasito posee una alta variabilidad genética. Por estas razones la 
imunopatología aún no se ha esclarecido por completo.  Recientemente, T. cruzi  ha sido  clasificado en 
seis diferentes unidades de tipificación  debido a su alta variabilidad genética. Hasta el momento, la 
mayoría de los estudios imunopatológicos se han desarrollado únicamente empleado una cepa de 
parasito, ha sí que el papel de la variabilidad genética de T. cruzi  no ha sido considerando hasta el 
momento. Por otro lado, estudios usando una única cepa en diferentes fondos genéticos de ratón 
muestran resultados contradictorios. Por esta razón es importante evaluar el papel de la variabilidad 
genética del parasito así como la variabilidad genética del hospedador para entender de una mejor 
manera la enfermedad de Chagas. 
Estudios anteriores en el laboratorio han demostrado la importancia de los receptores Toll-like 2 (TLR2) 
y Signaling Lymphocytic Activation Molecule Family 1 receptor (SLAMF1), durante la infección con T. 
cruzi in vivo e in vitro utilizando la cepa Y. El propósito de este trabajo fue evaluar la imunopatología de 
la enfermedad de Chagas utilizando diferentes cepas de referencia de T. cruzi in vivo  e in vitro,  en 
ratones con diferente fondo genético y con deficiencia en la expresión de los receptores TLR2 y 
SLAMF1.    
Hemos encontrado que los macrófagos de ratones C57BL/6 son más resistentes a la infección in vitro 
con todas cepas de T. cruzi  evaluadas comparado con los BALB/c, siendo la tasa de infección variable 
dependiente de la cepa. TLR2 tuvo un papel crucial durante la fase de interacción en macrófagos 
potenciando la internalización de todas las cepas del parasito. En contraste, se observó que SLAMF1 
juega un papel importante como sensor microbiano por la suprimiendo la expresión de la NADPH 
oxidasa 2 (NOX 2) y la producción del Reactive Oxygen Species (ROS) para todas las cepas excepto 
papara la VFRA cl 1. 
Los resultados in vivo en ratones BALB/c y Slamf1-/- infectados con las cepas Dm28c, Y e VFRA cl1 
confirmaron los resultados obtenidos en el in vitro. Los ratones Slamf1-/- infectados con Dm28c e Y 
fueron más resistentes a la infección comparados con los ratones BALB/c, pero más susceptibles 
cuando fueron infectados con la cepa VFRA cl1. La infecciones con la cepa Y mostraron una correlación 
inversa entre la presencia de Myeloid-derived Suppressor Cells (MDSCs) en el corazón (explicado por la 
expresión de Arg-1, iNOS y COX-2, marcadores de MDSCs) y la supervivencia en ratones, donde un 30% 
y 100% en BALB/c y  Slamf1-/- sobrevivieron respectivamente. Las infecciones con Dm28c y VFRA cl1 
causaron niveles más bajos de MDSCs en el corazón, pero una respuesta inmune más fuerte en bazo e 
hígado, indicando un control más eficiente impidiendo a las MDSCs alcanzar al corazón como un 
͞Đaďallo de TƌoǇa͟ , lleǀaŶdo a los parásitos, causando daño cardiaco y finalmente la muerte a los 
ratones. 
Finalmente, hemos observado por primera vez que los niveles más altos del gene immune-responsive 
gene 1 (Irg1) en el corazón durante la infección de T. cruzi. El estudio In vitro utilizando epimastigotes 
mostraron un alto IC50 para el ácido itaconico, un metabolito producido por el IRG1 que inhibe la 
isocitrato liasa de los patógenos, por lo tanto esto contribuiría como una nueva diana de tratamiento 
en la enfermedad de Chagas. 
  
 
 
 
 
 
 
 
 
  
INTRODUCTION 
  
 
11 
 
1 INTRODUCTION 
1.1 CHAGAS DISEASE  
 
Chagas disease or American trypanosomiasis is considered by the World Health Organization 
(World Health Organization, 2015)  as a major problem in health and the fourth cause of death in 
Latin America. This parasitic disease caused by the protozoan Trypanosoma cruzi, was discovered 
in 1909 by the Brazilian physician Carlos Chagas (1879-1934), but the first evidence in human 
tissues of the Atacama mommies date to nearly 9 thousand years ago (Guhl et al., 1999). 
Chagas disease affects about 7 million individuals and 110 million are in risk of contracting the 
infection, given the vectors wide geographic distribution in the American continent (Rassi Jr. et al., 
2012). Every year 10-14 thousand people die for this disease. However, many aspects of the 
pathogenesis of Chagas Disease remain unknown and the treatments still are non-effective. 
 
Figure 1. Map of the world distribution of Chagas disease. Image taken from (Rassi Jr et al., 2010). 
The main mechanism of transmission to humans is vectorial, by the infected feces of the blood 
sucking reduviidae bugs of the Triatominae subfamily. Transmission can also occur via blood 
transfusion, orally (contaminated food), by congenital transmission or laboratory accidents (Prata, 
2001). The increment of cases in non-endemic countries is associated with the large number of 
Latin American immigrants, for this reason is considered an emergent problem in North America, 
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Europe and Japan (Parker and Sethi, 2011; Pérez-Ayala et al., 2011). United States of America is 
the first non-endemic country with 300 thousand people infected (mostly from Mexico), followed 
by Spain with 47-67 thousand people (Rassi Jr et al., 2010) (Figure 1). 
Chagas disease is a very complex disease in almost all aspects. Among those, it can be transmitted 
to humans and more than 150 species of domestic and wild animals by more than 130 species of 
the blood-sucking reduviidae bugs. The most important vector species are Triatoma infestant in 
the sub-amazonia endemic regions (Southern South America), Rhodnius prolixus mainly in 
northern South America (Colombia and Venezuela) and Triatoma dimidiata also in the northern 
South America but also in Central America and Mexico. 
1.2 TRANSMISSION CYCLE 
 
Figure 2. Trypanosoma cruzi morphology.  Amastigote: replicative form in the vertebrate host. 
Trypomastigote: infective form non-replicative in vertebrates and invertebrates. Epimastigote: replicative 
form in triatomines. 
T. cruzi is an intracellular protozoan that belongs to the order of kinetoplastidae order and 
Trypanosomatidae family. Is characterized by the presence of a flagellum that originates from the 
single mitochondrion in which is situated the kinetoplast, a specialized DNA-containing organelle. 
In its life cycle the parasite alternates between the bug vector and the vertebrate host.  The life 
cycle stages are: trypomastigote, amastigote and epimastigote. These forms can be distinguished 
by the position of the kinetoplast relative to the nucleus and by the presence or absence of a free 
flagellum (Figure 2). 
The epimastigote is the replicative flagellate form and is found in the hindgut of the triatomines. 
The trypomastigote is the flagellate and infective non-replicative form in the vector (metacyclic 
trypomastigotes) and the mammalian host (blood trypomastigote). The amastigote is the 
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aflagellate form and is localized intracellularly into the parasitophorous vacuoles of host cells 
where it multiplies inside the cell by binary fission (Brener, 1971). 
 
Figure 3. Life cycle of Trypanosoma cruzi, the causative parasite of Chagas disease. 1-5. Steps in vertebrate 
host. 5-8. Steps in invertebrate host (Triatomine). 
Image taken from (http://www.cdc.gov/parasites/chagas/biology.html) 
T. cruzi presents a complex life cycle with different stages in the insect vector and the mammalian 
host. Figure 3 shows a brief summary of the infection cycle of Chagas Disease. 1. Infected 
triatomine bug takes blood meal and defecate, metacyclic trypomastigotes are in the bug feces. 
These metacyclic trypomastigotes can enter by the bite wound or mucosal membrane 
(Conjunctiva).  2. Metacyclic trypomastigote travel to the blood stream and can penetrate a wide 
variety of mammalian cells at the bite wound site. Inside the cells the trypomastigotes transform 
into amastigotes. 3. Amastigotes multiply by binary fission in the host cell cytoplasm for ~ 5-6 
times until they occupy most of the cell volume 4. In this stage intracellular amastigotes transform 
into trypomastigotes, following by the rupture of the host cell plasma membrane releasing the 
trypomastigotes into the blood stream and where they are able to infect new cells or new tissues. 
5. The triatomine bug takes infected blood meal (metacyclic trypomastigote). 6. Trypomastigotes 
transform to epimastigotes from the proboscides to the midgut of the triatomines. 7. In the 
midgut the epismatigote multiplies. 8. The epimastigote transforms again into trypomastigote, 
from the midgut to the hindgut. Finally, the cycle is completed when a new bug bite a new host 
(Brener, 1972; Costales and Rowland, 2007). 
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1.3 GENETIC VARIABILITY OF T. CRUZI 
 
Trypanosoma cruzi is a very heterogeneous species presenting a high genetic variability. This 
genetic variability has been demonstrated using biological, biochemical and molecular technics, 
that allow their classification into at least six Discrete Typing Units (DTUs), named from TcI to TcVI 
( Zingales et al., 2009; Zingales et al., 2012). These DTUs are thought to be associated with the 
geographical distribution, the transmission cycle (domestic and sylvatic) and the clinical 
manifestation (Figure 4) with both homogeneous (TcI-TcII) groups and heterogeneous groups 
(TcIII–TcVI) that are considered hybrids due to ancestral recombination events (Westenberger et 
al., 2006). The different DTUs are circulating among mammalian host and insect vector across 
Latin America. Recently a new genotype has been found, designated as TcBat due to its association 
with bats in Brazil, Panama and Colombia (Marcili et al., 2009; Pinto Dias, 2013; Ramírez et al., 
2013). 
 
Figure 4. Distribution of the DTUs in South America. Image taken from (Zingales et al., 2012) 
The cardiac and megavisceral forms of Chagas disease in South America are associated with the 
DTUs TcI, TcII, TcV and TcVI. TcI is the most prevalent strain in countries at the north of the 
Amazon river basin (Colombia and Venezuela) where is associated with cardiomyopathy, whereas 
TcII–TcVI are the most prevalent in the southern cone countries; TcII is the principal agent of 
Chagas disease in the American Southern Cone and the vector is Triatoma infestans. For TcV y TcVI, 
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derived from the hybridization between TcII and TcIII/TcIV, the transmission cycle is mainly 
domestic (Zafra et al., 2008; B. Zingales et al., 2009). These DTUs are associated also with 
megavisceral syndromes. TcV is associated with congenital cases in Argentina (Burgos et al., 2007; 
Diosque et al., 2003). However, this distribution is not absolute, since all of them can be found 
across the continent.  For the case of North America, only cardiac cases have been reported 
almost associated with the TcI and occasionally with the TcIV. 
TcIII and TcIV are mostly associated with a sylvatic cycle and information about their geographical 
distribution is scarce. TcIII has not been associated in human cases and is found in domestic dogs 
and in peridomestics triatomines in Brazil. TcIV is associated with oral cases in the Amazon basin 
and Venezuela (Coura et al., 2002; Marcili et al., 2009). 
1.4 CLINICAL PHASES  
 
Chagas disease presents three clinical phases: acute, indeterminate and chronic phase. 
The acute phase lasts between 4-8 weeks, 90% of the patients in acute phase are asymptomatic. 
For this reason is very difficult to diagnose these patients and treat them. The other 10% present 
symptoms 1-2 weeks after exposure as fever, fatigue, body aches, headache, rash, loss of appetite, 
diarrhea and vomiting. The most recognized sing of acute phase is the Romaña's sign, which 
includes swelling of the eyelids on the side of the face near the bite wound or where the bug feces 
were deposited or accidentally rubbed into the eye. The acute phase is also characterized by a 
high parasitemia. 5-10% of the patients in acute phase present myocarditis. The mortality in this 
phase is around 1% as a result of severe myocarditis or meningoencephalitis. The treatment at this 
point will usually cure the patient, but because the difficult diagnosis many cases are not detected 
and thus not treated (Rassi Jr. et al., 2012). 
About 90% of the acute phase cases resolve spontaneously, even without the treatment. 60-70% 
of the patients never develop clinical manifestations; these patients have the Indeterminate or 
asymptomatic form. This phase is characterized by the presence of antibodies against T. cruzi in 
serum, low or undetectable parasitemia, and normal electrocardiogram and chest radiological 
examinations. 
The remaining 30-40% of the Chagas Disease patients progress to the chronic phase. However, the 
clinical manifestations usually appear 10-30 year after the initial infection, involving the heart, 
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esophagus, colon or a combination, and are denominated: cardiomyopathy, megavisceral 
syndromes and cardiodigestive forms, respectively (Marin-Neto and Rassi, 2009). The 
cardiomyopathy is the most serious manifestation in Chagas disease, about the 20-30% of the 
chronic patients developed this clinical manifestation. The megavisceral syndromes are seen 
almost exclusively at the south of the Amazon basin (Argentina, Brazil, Chile and Bolivia), 
approximately 10-15% develop megaesophagus or megacolon or a combination. Finally, 2% 
developed cardiomyopathy and megavisceral syndromes. 
1.5 IMMUNE RESPONSE 
 
After the invasion of T. cruzi across the endothelium, an activation of different innate immune 
system defense mechanisms start associated with specialized cells that recognize the parasite, 
especially involving macrophages. The infected macrophages secret Interleukin 12 (IL-12) that 
activate the Natural Killers to produce pro-inflammatory interleukin Interferon Ȗ (IFN-Ȗ), which is 
crucial for further activation of macrophages. The high levels of IFN-Ȗ promote the liberation of 
Nitric Oxide (NO), important for parasite killing (Machado et al., 2008; Munoz-Fernandez et al., 
1992; Silva et al., 1998). The lack of control in the production of IFN-Ȗ by the natural killer is in part 
responsible for tissue damage in the chronic phase (Cunha-Neto et al., 2005). On the other hand, 
T. cruzi also triggers immunosuppression of T lymphocytes and macrophages. This 
immunosuppression could be mediated by anti-inflammatory cytokines as IL-4, IL-10 and 
Transforming growth factor beta (TGF-ȕ) to avoid excessive response by the pro-inflammatory 
cytokines in acute phase (Sanjabi et al., 2009). 
T. cruzi infected cells produce NO in response of IFN-Ȗ. NO regulates the cardiac muscle and 
endothelium physiology but produced in excess cause damage in the myocardium and leads to 
alterations in cardiac functions. In mice infected with the Y strain of T. cruzi, it has been found an 
infiltration of myeloid cells which express Inducible Nitric Oxide Synthase (iNOS) and Arginase-1 
(Arg-1), implicated in the suppression in the proliferation of T cells (Cuervo et al., 2008). 
Cyclooxygenase 2 (COX-2) is also expressed by MDSCs and is responsible of prostaglandin-
mediated cardiac inflammatory infiltration (Guerrero et al., 2015). Also, the immunosuppression 
implicates AgC10 parasite antigen which negatively regulates the activation of T cells and 
macrophages (Kierszenbaum et al., 1999). 
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After recognition of the parasite, the antigen presenting cell (APC) migrates to nearby lymph 
nodes, to present the antigens to the T lymphocytes (Gutierrez et al., 2009). Antigen presentation 
is mediated by the interaction between the TCR (T cells receptors) and major histocompatibility 
complex I (MCH-I) in CD8+ lymphocytes or MCH-II in CD4+ lymphocytes. Once activated this 
complex promotes the recruitment of others inflammatory cells as B cells and neutrophils. Two 
main different adaptive immune responses may take place, namely Th1 and Th2. 
In the acute phase the immune response is mainly Th1. The activation of T cells involves the Th1 
with a production of IFN-Ȗ, IL-12 and the Tumor Necrosis Factor (TNF) (Abrahamsohn and 
Coffman, 1995). The activation is related to the anti-parasite inflammatory process as well as 
leukocyte infiltration of different parasite target tissues. These responses activate also the natural 
killer, which helps with its cytotoxic activity and the capacity to produce IFN-Ȗ. IFN-Ȗ activate 
macrophages M1 with high iNOS levels, inhibiting the replication of the parasites through the 
production of NO and cyclooxygenase 2 (COX-2) involved in the production of prostaglandins. NO 
reaction with the oxygen free radicals causing the destruction of the parasite (Arantes et al., 
2004). On the other hand, NO participate in the production of chemokines by the cardiomyocytes 
(Machado et al., 2008). Also, the CD8+ cytotoxic T lymphocytes are responsible for the elimination 
of infected cells trough the perforin/granzyme system, for the activation of macrophages and to 
promotion of Th1 response (Gavrilescu and Denkers, 2003). The increment of COX-1 and COX-2 
has been demonstrated in mice heart tissues infected with T. cruzi during the acute phase 
(Guerrero et al., 2015). 
The Th2 response involves the production of IL-4, IL-5, IL-10, IL-13 and the TGF-ȕ by B cells, 
mastocytes and macrophages (Gutierrez et al., 2009). The secretion of IL-10 plays an important 
immunoregulatory role in the infection by T. cruzi. It has been demonstrated that this cytokine can 
balance the pro-inflammatory response conducted by the TNF (Dutra et al., 2014). Some authors 
suggest that the Th2 also contributes to the activation of M2 macrophages. M2 activation 
promotes the survival of the parasite into the host cells (Martinez and Gordon, 2014). M2 
macrophages in the heart inflammatory infiltration present high levels of Arg-1 and the myeloid-
derived suppressor cells (MDSCs), which express iNOS and Arg-1, are involved in the suppressing T 
cell proliferation. IL-4 helps IL-10 in the negative regulation of TNF production in the spleen 
(Cuervo et al., 2008). 
18 
 
T. cruzi has two important characteristics: the ability to invade multiple cell types and the capacity 
to evade the cytotoxic systems intracellular, escaping from the parasitophorous vacuole to the 
cytoplasm to multiply.  Also, the parasite alters a great number of signaling pathways as well 
antigenic presentation (Tarleton et al., 1996). 
1.6 TRYPANOSOMA CRUZI HOST CELL INTERACTION 
 
The invasion of T. cruzi in the host cells involves recognition of many molecules in the surface of 
the parasite and the host cells (Figure 5). The genetic variability and the different forms of the 
parasite play an important role in the adhesion, expressing different molecules in the surface.   
Parasite Molecules: PAMPs 
Mucins are the major glycoproteins in the surface of the parasite. Their sugar residues interact 
with the mammals cells and also can act as ligands (De Souza et al., 2010). In macrophages Gp90 is 
anti-phagocytic being necessary for the parasite internalization.  They are only presented in the 
mammal stages of T. cruzi (De Souza et al., 2010). 
Transialidases including Tc85 constitute a glycoprotein super family composed by gp85, gp82 and 
TSA-1. The members of this group are expressed on the parasite surface and their amount varies 
depending on the stages.  Tc85 family is able to bind with different host receptor molecules, like 
the host cell cytokeratin 18, fibronectin and laminin (Giordano et al., 1999).  Tc85 is an 85kDa 
glycoprotein that has been identified as a ligand for fibronectin in different cells (Monocytes, 
neutrophils and fibroblast). Is abundant in trypomastigotes (De Souza et al., 2010). Gp82 and 
gp35/50, proteins are expressed in the metacyclic trypomastigotes and are highly immunogenic 
(Teixeira and Yoshida, 1986). Gp82 is only presented in metacyclic trypomastigotes and is highly 
expressed in the G strain compared with the CL Brener. Gp35/50 is abundant in the surface, is 
resistant to protease digestion and protects the metacyclic trypomastigotes from destruction in 
the oral route. Gp83 is a ligand used by T. cruzi to attach and enter into the cells, present in all 
DTUs and only expressed in trypomastigotes. 
Some T.cruzi proteases have been implicated in the host infection like Cruzipain, Oligopeptidase B 
and Tc80. Cruzipain is a lysosomal cysteine proteinase. It is located in the endosomal-lysosomal 
(reservosome) system of epimastigote and is expressed in the surface of epimastigotes and the 
transition form of amastigote-trypomastigote. It is secreted in the flagellar pocket and cleaves 
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kininogen to generate short lived kinins which stimulate IP3- mediated Ca2+ release.  
Oligopeptidase B is secreted by trypomastigotes and induces indirectly Ca+ mobilization during T. 
cruzi invasion. Tc80 is an oligopeptidase, important for the parasite transit through the 
extracellular matrix. 
 
Figure 5. Model of molecules involved in parasite host-interactions. Image taken from (Piacenza et al. 
2013). 
The entry of T. cruzi involves a great amount of molecules in the surface of the host cell and these 
molecules can vary depending on the cells involved. Integrins are involved in the invasion process. 
This receptor mediates the attachment between two cells or cell and extracellular matrix. 
Cytokeratine 18 is the most abundant structural proteins of epithelial cells, organized as 
heterodimers and form a network of 10–12 nm wide intermediate filaments. Galectins, a family of 
galactose binding lectins can bind with T.cruzi (Pineda et al., 2015). Galectin-3 mediates the 
attachment and entry in dendritic cells and in smooth muscle cells. Fibronectin and laminin can 
activate the PI-3Kinase signaling pathway. Transforming growth factor beta (TGF-β) receptor 
facilitates T. cruzi entry in epithelial cells. Tyrosine kinase (Trk) is present in neuronal, glial and 
dendritic cells. Trk A leads T. cruzi invasion through tran-sialidase bindings in the trypomastigotes.  
TrK C helps the host-T. cruzi equilibrium in the nervous system, promoting the survival of neuronal 
and glial cells after the infection. 
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The Pattern-recognition receptors (PRRs) are the first line of immune defense against pathogens 
(Piacenza et al., 2012). The PRRs are expressed in the cell surface and are responsible of the 
recognition of the parasite. These molecules are more present in the surface myeloid of antigen-
presenting cells, as macrophages and dendritic cells. Among those, the best studied are Toll Like 
Receptors (TLRs) T. cruzi is recognized by some TLRs; TLR-2, TLR-4 and TLR-9.  TLR-2 induces 
phagocytosis of trypomastigotes by the activation of Ras-related protein 5 (Rab5) (Maganto-Garcia 
et al., 2008). Signaling Lymphocytic Activation Receptor F1 (SLAMF1) or CD150, present inly on 
the surface of hematopoietic cells, is required for T. cruzi replication in the macrophages and 
dendritic cells (Calderón et al., 2012). 
1.7 T. CRUZI INVASION 
Host-parasite interaction involves a great deal of parasite molecules and host receptors. Three 
mechanisms of T. cruzi entry into the host cells have been identified (Figure 6). 
 
Figure 6. Model of T. cruzi invasion. Different mechanism in the entry of T. cruzi: A. Lysosome dependent, B. 
Actin dependent and C. Lysosome independent.  Image modified from (Piacenza et al. 2013). 
The lysosome dependent pathway involves lysosome and Ca2+ dependent fusion of lysosome with 
vacuole to form the parasitophorous vacuole, which begins when the host plasma membrane and 
the parasite enter in contact (Figure 6 A). The actin dependent pathway is a mechanism of invasion 
in professional phagocytic cells.  In this phagocytic process, trypomastigotes penetrate into the 
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host cells through an expansion of the plasma membrane and can either localized in early 
endosomes or lysosomes culminating the formation of the parasitophorous vacuole (Figure 6 B), 
and finally in the lysosome independent pathway, the initial entry into the plasma membrane 
takes place by an invagination that recruits Phosphatidylinositol (3,4,5)-trisphosphate (PIP3). The 
internalization of the parasite involves an early endosome mediated by Early endosome antigen 1 
(EEA1) and Rab5 to finally fusion in a lysosome (Figure 6 C) (Caradonna and Burleigh, 2011; 
Maganto-Garcia et al., 2008).  
To establish the infection in phagocytic cells as macrophages, T. cruzi must endure in an oxidant 
environment. To survive this environment the parasite uses antioxidant enzymes, like peroxidases, 
to protect it against the macrophage-released reactive oxygen and nitrogen species (Piacenza et 
al., 2012). Trypomastigotes trigger in macrophages the activation of Nicotinamide Adenine 
Dinucleotide Phosphate (NADPH) oxidase. As a result there is a continued production of super 
radical anions (O·̄2). Proinflammatory cytokines (IFN-Ȗ and TNF), also triggered by the infection of 
the parasite stimulate infected macrophages to produce large amounts of (∙NO) via iNOS, which 
oxidizes the L-arginine and transfer electrons to NADPH. The ∙NO affects the parasite survival into 
the macrophages (Munoz-Fernandez et al., 1992; Piacenza et al., 2012). 
Once T. cruzi is in the lysosomal compartment in the host cell, the disruption of the 
parasitophorous vacuole takes place, an important step for the intracellular infection. To initiate 
this disruption, trypomastigotes and amastigotes secrete a hemolysin, named TC-TOX which 
increases the acidification (pH 5.5) into the parasitophorous vacuole for the lysis of it. In addition, 
the surface neuraminidase/transialidase in the trypomastigotes facilitates the process.  After the 
disruption of the parasitophorous vacuole, the trypomastigotes located, now in the cytoplasm of 
the host cells, transform into amastigotes and after several replications and transformations 
amastigote-trypomastigote, the motile forms of the parasite cause the rupture of the host 
membrane and the bloodstream infective trypomastigote can infect neighboring cells or 
disseminate the infection through in bloodstream (Cardoso et al., 2016; Li et al., 2016). 
Myeloid cells are not only a major infection-susceptible cells but also play an important role in the 
dissemination of the parasite in new tissues acting as a ͞Trojan horse͟ (Calderón et al., 2012). This 
hypothesis is also supported by to the lack of parasites in blood in mice infected with some strains 
of T. cruzi but presenting focal and spatiotemporally dynamic amastigote nests in tissues (Lewis et 
al., 2014; Messenger et al., 2015). 
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1.8 TOLL LIKE RECEPTOR 
Toll like receptors (TLRs) are a protein family which plays an important role in innate immunity 
response in front different pathogens. It is a large family with at least 13 members, denominated 
from TLR-1 to TLR-13. TLR1 to TLR9 are conserved between mouse and humans.  TLR-10 is 
expressed only in humans and TLR-11 to 13 only in mouse (Akira and Takeda, 2004). 
 
Figure 7. Cellular localization of Toll Like Receptor. Imagen modified from (Charles A. Janeway Jr, Paul 
travers, 2011) 
TLR-1, TLR-2 and TLR-4 are expressed in the surface of the cells. In contrast, TLR-3, TLR-7, TLR-8 
and TLR-9 are anchored to endosomal plasma membrane. There are several signal transduction 
pathways triggered by TLR engagement, but most of them use MyD88 as an adapter molecule 
(Takeda and Akira, 2005). Table 1 shows the details on TLR cellular localization, TLRs 
microorganisms ligands and origin including T. cruzi, that stimulates TLR2 by mucins and their 
related glycoinositophospholipid (GIPL) anchors (Campos et al., 2001) (Campos et al. 2001). 
TLRs activation by T. cruzi leads to the production of pro-inflammatory cytokines and chemokines 
necessary for the recruitment of phagocytic cells into the affected area or tissues. In Chagas 
disease this receptors have a crucial role, increasing the susceptibility in the MyD88-deficient mice 
have an increased susceptibility to infection associated with a decreased production of IL-12 and 
IFN-Ȗ. Tlr4-/- infected mice present higher parasitemia an in consequence lower production of the 
pro-inflammatory cytokines (IFN-Ȗ and TNF), and NO compared with the WT mice (C57BL/6) 
(Oliveira et al., 2010). 
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T. cruzi also promotes host cell activation via TLR9 and TLR7 stimulating the cytokine production 
from macrophages and dendritic cells, respectively.  In vivo experiments with Tlr9-/- and Tlr7-/- , 
showed that knockout mice were more susceptible to the infection with the parasite 
(Bartholomeu et al., 2008; Caetano et al., 2011). 
Table 1. TLRs. Table modified from (Akira and Takeda, 2004). * TLRs only expressed in mice. 
 
1.8.1 TLR-2 
Glycosylphosphatidylinositol (GPI) anchors of T. cruzi from mucin like glycoproteins (tGPI-mucin) 
plays an important role triggering activation in macrophages (Campos et al. 2001). The structure of 
Receptor Localization Ligand Origin Ligand
Triacyl l ipopeptides Bacteria and mycobacteria
Soluble Factors Neisseria meningitidis
Lipoprotein/lipopetides Various pathogens
Peptidoglycan Gram-positive bacteria
Lipoteichoic acid Gram-positive bacteria
Lipoarabinomannan Mycobateria
Phenol-soluble modulin Staphylococcus epidermis
Glycoinositolphopholipids Trypanosoma cruzi
Glycolipids Treponema maltophilum
Porins Neisseria
Atypical l ipopolysaccharide Leptospira interrogans
Atypical l ipopolysaccharide Porphyromonas gingivalis
Zymosan Fungi
Heat-shock protein 70° Host
TLR-3 Endolysosome Double-stranded RNA Viruses
Lipopolysaccharide Gram-negative bacteria
Taxol Respiratory syncytial virus
Fusion Protein Mouse mammary-tumor virus
Evelope protein Chlamydia pneumoniae
Heat-shock protein 60° Host
Heat-shock protein 70° Host
Type III repeat extra domain A of fibronectin Host
Oligosaccharides of hyaluronic acid Host
Polysaccharide fragments of heparan sulphate Host
Fibrinogen Host
TLR-5 Plasma membrane Flagelin Bacteria
Diacyl l ipopeptides Mycoplasma
Lipoteichoic acid Gram-positive bacteria
Zymosan Fungi
Imidazoquinoline Synthetic compounds
Loxoribine Synthetic compounds
Bropirimine Synthetic compounds
Single-stranded RNA Viruses
Imidazoquinoline Synthetic compounds
Single-stranded RNA Viruses
TLR-9 Endolysosome CpG-conyaining DNA Bacteria and viruses
TLR-10 Endolysosome Not Determined Not Determined
TLR-11* Plasma membrane Not Determined Uropathogenic bacteria
TLR-12* Endolysosome Profil in Toxoplasma gondii
TLR-13* Endolysosome 23S ribosomal RNA Bacteria
Plasma membrane
Plasma membrane
Plasma membrane
Endolysosome
Endolysosome
Endolysosome
TLR-1
TLR-2
TLR-4
TLR-6
TLR-7
TLR-8
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these GIPLs is variable, for example in the strains Y, G and Tulahuén contain ceramide, while CL 
Brener strain contain a mixture of dihydroceramide and alkylacylglycerol species, and also vary in 
epimastigotes and trypomastigotes in the same strain. These GIPLs variability determines their 
recognition by TLR2 (alkylacylglycerol) or TLR4 (dihydroceramide), that is important to determine 
the activation of the immune response in the host (Ropert et al., 2002). 
The TLR-2 activation by the tGPI-mucin initiates IL-12, TNF and NO production, that protect the 
host during the early stage of the infection (Campos et al., 2001). The interaction of T. cruzi with 
TLR-2 induces a Rab5 endosome dependent mechanism necessary for the invasion of the parasite 
in macrophages (Maganto-Garcia et al., 2008). 
1.9 SLAM RECEPTOR FAMILY 
 
The signaling lymphocytic activation receptor or SLAM is a family of cell surface receptors. These 
receptors are type I transmembrane glycoproteins, which are expressed on most hematopoietic 
cells as B cells, T cells, macrophages, dendritic cells and natural killers.. 
 
Figure 8. SLAM family of cell surface receptors. Modified from (C. S. Ma and Deenick, 2011). 
The SLAM family has 9 members, encoded by SLAMF1-SLAMF9 in mouse and named: 
SLAMF1(CD150), SLAMF2 (CD48), SLAMF3 (LY9), SLAMF4 (CD244 or 2B4), SLAMF5 (CD84), SLAMF6 
(CD352 or NTB-A), SLAMF7 (CD319 or CRACC), SLAMF8 (CD353 or BLAME) and SLAMFF9 (CD84-H1) 
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(Sintes and Engel 2010). The consensus structure of SLAM family consists of an extracellular 
membrane distal IgV-like domain linked to an IgC2-like proximal domain, a transmembrane region, 
and an intracellular domain that contains signaling tyrosine-based switch motifs in many cases 
(Figure 8). Seven of the nine members are self-ligand receptors, and SLAMF2 and SLAMF4 interact 
with each other (Van Driel et al., 2016). 
Six of the SLAMF receptors contain one or more copies of a unique intracellular immune receptor 
that contains tyrosine-based switch motif, which serves as docking site for adapter molecules and 
enzymes bearing Src homology 2 (SH2) domains. The adapter molecules SLAM-associated protein 
(SAP), EWS/FLI activated transcript-2 (EAT-2) and EAT-2-related transducer (ERT) all have high 
affinity for this unique motif (C. S. Ma and Deenick, 2011). 
Table 2. SLAMF. Table modified from (Van Driel et al., 2016) 
 
1.9.1 SLAMF1 (CD150)  
 
SLAMF1 is expressed in the surface of T cells, B cells, macrophages and dendritic cells. In the 
adaptive and innate response SLAMF1 has four principal functions (Figure 9). 
 
Receptor Expression
Deficiency: 
Resistant
Deficiency: 
Susceptible
SLAMF 
ligand
Microbial Ligand
SLAMF3
T,B,iCD8, NKT, 
mono, MΦ, HSC MCMV Slamf3
SLAMF5
Pan-lymphocyte, 
plat, mast, eo
Slamf5
SLAMF7 T, B, mono, DC, NK Slamf7
SLAMF8
iCD8, mono, DC, 
MΦ, Neu, endo, 
FRC
Slamf8
SLAMF9 mono, DC Unknown
Slamf2LCMV, γHV-ϲϴ
SLAMF1 T. cruzi Gram- , L. majo r Slamf1
SLAMF2 S. aureus FimH+
T, T cels; B, B cells; act, activated; MΦ, macrophage; DC, dendritic cell; plat, platelet; HSC,
hematopoietic stem cell; mono, monocyte; NKT, natural kil lerT cell; eo, eosinophil; mast, mast cell;
endo, endothelial cell; FRC, fibroblastic reticular cell; LCMV, lymphocytic choriomeningitis virus; Omp, 
outer membrane porin; FimH, bacterial lectine; MCMV murine, murine gamma-herpes virus
ĐǇtoŵegaloǀiƌus; γHV-68, murine gamma-herpes virus 68.
Measles virus, 
E.coli  (OmpC/F+), 
S. typhimurium
E.coli,                  
C. rodentium 
Act T, act B, mono, 
MΦ, DC, plat, HSC
Pan-Lymphocyte
NK, NKT, T, CD8, 
DC, mast, mono, eo
NK, NKT, T, B, MΦ, 
pDC
E. coli (FimH+)
Slamf4 
CD2
SLAMF4
SLAMF6 S. typhimurium
L. mexicana, 
C. rodentium 
Slamf6
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SLAMF1 is a co-signaling cell-surface receptor. Costimulatory signals derived from SLAM–SLAM 
engagements lead to an increase in IL-4 secretion in an SAP-dependent manner following TCR 
activation of CD4+ T cells (Figure 9 A). SLAM/SAP-mediated signaling is responsible for the 
development of NKT cells resulting from the SLAM–SLAM interactions between DP thymocytes 
(Figure 9 B). SLAMF1 is the measles receptor for activated T cells and dendritic cells (Figure 9 C). In 
addition is a sensor of Gram-negative bacteria; SLAM internalizes into the macrophage phagosome, 
where it governs key processes for bacterial removal. The interaction SLAMF1 with Ompc/F+ from 
E.coli results in a more effective phagocytosis in macrophages, regulating positivity the formation 
and activation of NADPH oxidase (NOX2) complex (Figure 9 D) (Sintes and Engel, 2011) . 
 
Figure 9. Role of SLAMF1 receptor. A. Self-ligand receptor B. Lineage commitment C. Measles virus receptor 
D. Bacterial Sensor. Image modified from (Sintes and Engel, 2011). 
Also, SLAMF1 is able to act as co receptor with TLR4 in the response to LPS necessary to eliminate 
Leishmania major, increasing the production on NO and the macrophage microbicide activity (Van 
Driel et al., 2016). 
SLAMF1 is also required for the replication of T. cruzi in macrophages and dendritic cells. Thus, it 
has been reported that Slamf1-/- mice are much less susceptible to the infection with the strain Y 
compared with control BALB/c mice. Likely, SLAMF1 deficiency alerts macrophage entry and those 
cells ŵaǇ fuŶĐtioŶ as ͞TƌojaŶ hoƌse͟ disseminating the parasite throughout the body (Calderón et 
al., 2012). 
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1.10 MOUSE GENETIC BACKGROUND 
 
One of the problems with the studies using mouse models, not only in Chagas disease is the 
pathogen resistance associated with the mouse genetic background. In the case of the intracellular 
parasite Leishmania it is clear that the mouse genetic background influences the infection 
outcome where C57BL/6 mice will not die of visceral leishmaniasis whereas BALB/c will do 
(Loeuillet et al., 2016). In the case of Chagas disease is very important understand the association 
T. cruzi-mouse strains because may have an effect protective or pathogenic.  
In this regard, there are several apparent opposing results related to the importance of immune 
response in experimental mice infection. Those differences may be due to the use of mouse 
models with different genetic background, the different strains of T. cruzi used but also the 
amount of parasite injected in the mice. Thus, infections in BALB/c and C57BL/6 mice with 2000 
parasites of the strain Y showed high parasitemias that co-related with low survival where the 
most susceptible mice were the BALB/c and Swiss and the least are C57BL/6. A higher heart 
parasite load was found in BALB/c mice compared with C57BL/6. Furthermore, an efficient 
clearance of heart parasite load observed in C57BL/6 at 17 days post-infection (d.p.i.) but not in 
BALB/c, indicating that C57BL/6 mice are able to control the parasite replication in the heart and 
for this reason have a better chance to survive to the disease, in agreement with higher 
inflammation levels in C57BL/6 than BALB/c mice (Cuervo et al., 2008; Sanoja et al., 2013). In 
contrast, C57BL/6 and BALB/c mice infected with the Tulahuén strain of T. cruzi revealed an acute 
disease accompanied by thymocyte depletion, with C57BL/6 mice showing progressive and lethal 
disease and BALB/c mice exhibiting partial recovery (Carrera-Silva et al., 2008; Roggero et al., 
2002). 
1.11  IMMUNOPATHOLOGY OF CHAGAS DISEASE  
 
Chagas disease presents a complex immunopathology and the mechanism is still unclear. Figure 10 
summarizes the key immunopathogenic molecules expressed in myeloid cells studied in our work. 
Macrophages are the first responders in the infection with T. cruzi, where parasite surface 
molecules are recognized by TLRs and other receptors as SLAMF1, implicated in NADPH oxidase 2 
(NOX2) activation (Dhiman and Garg, 2014). NOX2 is a multi-subunit complex that utilizes NADPH 
as an electron donor to reduce O2 to superoxide (O2·−) and Reactive Oxygen Species (ROS) 
pƌoduĐtioŶ ƌefeƌƌed to as ͞ƌespiƌatoƌǇ ďuƌst͟ that seƌǀes as the first line of host defense against 
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microbes, killing them by oxidative damage of DNA, proteins and lipids (Machado et al., 2012). In 
phagocytes, NOX2 consists of the membrane-bound catalytic sub-units p22phox and gp91phox, 
forming the flavocytochrome b558 and the cytoplasmic regulatory sub-unities P40 phox, P47 phox, 
P67 phox and the small Rho GTPase. In vivo experiments using p47phox-/- mice demonstrated that the 
NOX2 deficiency increased the parasite load, tissue pathogenesis and mortality and suggested to 
play an important role in the control of T.cruzi (Dhiman and Garg, 2014). 
COX-2 is a key enzyme in prostaglandin production and is induced by several factors, including 
infection by T. cruzi. The role of COX-2 in mice infected with T. cruzi is contradictory, some authors 
described that COX inhibitors cause an increase in mortality and parasitemia (Mukherjee et al., 
2011). On the other hand, other studies associate COX-2 pharmacological inhibition with 
decreased parasitemia (Hideko Tatakihara et al., 2008). Previous studies in our laboratory 
demonstrated an important role of COX-2 in the myocarditis produced by the infection by T.cruzi, 
where COX-2 is associated with leukocyte infiltration in the heart, in particular higher presence of 
MDSCs expressing  COX-2 but also for Arg-1 and iNOS, although no significant changes in parasite 
burden were observed (Guerrero et al., 2015).  
In macrophages Arg-1 is a M2 marker, induce TGF-β aŶd ĐǇtokiŶes suĐh as IL-4, IL-10 and IL-13. 
Arg-1 catalyzes the hydrolysis of L-arginine to ornithine and urea, which is required for polyamine 
synthesis, essential for the growth of cells and T. cruzi.  Arg-1 is expressed most abundantly in the 
liver but is not exclusive for this organ. During the infection by T. cruzi has been demonstrated that 
its expression increases mouse susceptibility (Cuervo et al., 2008; Gonzalez, 2014). 
Recently, the Immune-response gene 1 (Irg-1) has been described as a novel M1 macrophage  
marker (Michelucci et al., 2013). Irg-1 is an enzyme that produces itaconic acid or 
methylenesuccinic acid, that inhibits isocitrate lyase, the key enzyme of the glyoxylate shunt, a 
pathway necessary for microorganism to survive on limited carbon conditions (Tallam et al., 2016). 
The antimicrobial activity of itaconic acid has been demonstrated for Mycobacterium tuberculosis 
and Salmonella enterica, where the growth of M. tuberculosis in vitro was completely inhibited at 
25–50 mM, whereas for S. enterica 50-100 mM (Michelucci et al., 2013). In the case of Chagas 
disease, previous metabolomics study using BALB/c mice infected with Y strain presented high 
levels of Irg1  gene (Gironès et al., 2014). 
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Figure 10. Model of immune regulatory genes in Chagas Disease. Upon T. cruzi infection, activated 
macrophages triggering the expression of iNOS and COX-2. The NO synthesized by iNOS is involved in killing 
of the intracellular parasite.  
 
 
 
 
 
 
 
 
 
  
OBJECTIVES 
  
33 
 
 
2 OBJECTIVES 
The general objective of this study was to investigate the role of T. cruzi and mouse genetic 
variability in the course of infection using a macrophage model in vitro and the experimental mice 
infection in vivo. For this we proposed the following specific objectives: 
1. To identify the relationship between of T. cruzi and mouse genetic variability with parasite 
load in macrophages in vitro. 
2. To determine the role of Tlr2 and Slamf1 in T. cruzi infection and its relationship with 
parasite load in macrophages in vitro. 
3. To evaluate the relationship between Slamf1 and T. cruzi susceptibility in the experimental 
mouse model in vivo. 
4. To determine the parasiticidal activity of Itaconic acid in epimastigote cultures. 
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3 METHODS AND MATERIALS 
3.1 MATERIALS  
3.1.1 Parasites 
All T. cruzi strains except the Y strain were obtained from Dr. M. Miles (London School of Hygiene 
and Tropical Medicine, London, UK) through the European program ChagasEpiNet (Table 3). Y strain 
was obtained from Harvard Medical School, Boston, Massachusetts, USA. This strain was isolated 
originally from human patient in Brazil (Zingales et al., 2009). 
Table 3. T. cruzi strains 
DTU Ref. Strain Origin Host/vector 
TcI Dm28c Carabobo, Venezuela Didelphis marsupialis 
TcI Sylvio X10 cl1 Para, Brazil Homo sapiens 
TcI C8 La Paz, Bolivia Triatoma infestans 
TcII Y São Paulo, Brazil Homo sapiens 
TcII Esmeraldo cl3 Bahia, Brazil Homo sapiens 
TcII Tul8 cl1 Tupiza, Bolivia Triatoma infestans 
TcIII M6421 cl6 Belem, Brazil Homo sapiens 
TcIII CM17 Meta, Colombia Dasypus sp. 
TcIV 10R26 Santa cruz, Bolivia Aotus sp 
TcV Bug2148 cl1 Rio Grande so Sul, Brazil Triatoma infestans 
TcV Sc43 cl1 Santa Cruz, Bolivia Triatoma infestans 
TcVI VFRA cl1 Francia, Chile Triatoma infestans 
TcVI Cl brener Rio Grande so Sul, Brazil Triatoma infestans 
TcVI Tulahuén cl2 Tulahuén, Chile Homo sapiens 
TcVI Tulahuén Tulahuén, Chile Homo sapiens 
3.1.2 Mice 
Female mice Slamf1-/- (Obtained from Dr. Cox Terhost, USA), Tlr2-/- (Obtained from Dr. Shizuo Akira) 
and BALB/c and C57BL/6 mice (Obtained from Charles River Laboratories), mice where maintained 
under pathogen-free conditions at Centro de Biologia Molecular Severo Ochoa (CSIC-UAM) animal 
facility. 
3.1.3 Ethic Statement 
This study was carried out in strict accordance with the European Commission legislation for the 
protection of animal used purposes (2010/63/EU). The protocol for the treatment of the animals 
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ǁas appƌoǀed ďǇ the ͞Coŵite de EtiĐa de IŶǀestigaĐioŶ de la Comunidad de Madƌid͟, “paiŶ (permits 
PROEX 21/14 and PROEX 148/15). Animals had unlimited access to food and water. They were 
euthanized in a CO2 chamber and all efforts were made to minimize their suffering. 
3.2 METHODS  
3.2.1 Parasite culture 
 In vitro T. cruzi trypomastigotes Dm28c, Y, M6421 cl6, 10R26, Bug2148 cl1 and VFRA cl1 
were cultured in Vero cells (ATCC number CCI-81) in RPMI with 5% FBS (RPMI complete 
medium containing 5% FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin 
and 0.1 mM non-essential amino acids) at 37°C in the biosafety level 3 cell cultured 
laboratory at Centro de Biologia Molecular Severo Ochoa (CSIC-UAM). 2-3 days after co-
culture, the T. cruzi trypomastigotes released into the supernatants of the infected Vero 
cells were collected, pelleted by centrifugation (720 g, 10 min., and room temperature), 1 ml 
of fresh complete RPMI was restored and new plates with Vero were cells infected with 500 
μl of T. cruzi trypomastigotes.  
 Blood T. cruzi trypomastigotes from Y strain were maintained by weekly intraperitoneal 
inoculation in BALB/c mice.  
 Blood T. cruzi trypomastigotes from the other strains Dm28c, Y, M6421 cl6, 10R26, 
Bug2148 cl1 and VFRA cl1 strain were maintained by intraperitoneal inoculation in BALB/c 
mice. These mice were immunosuppressed following the protocol of Calabrese et al., were 
at 5 d.p.i. the mice were injected intraperitoneally with a single dose of cyclophosphamide 
(Sigma) (200 mg/kg of body weight) (Calabrese et al., 1996). 
 Epimastigotes 15 different strains of T.cruzi classified by DTU from TcI to TcVI.  TcI (Dm28c, 
Sylvio X10 cl1 and C8), TcII (Y, esmeraldo cl3 and Tul8 cl1), TcIII (CM17 and M6421 cl6), TcVI 
(10R26), TcV (Bug2148 cl1 and SC43 cl1) and TcVI (Cl Brener, VFRA cl1, Tulahuén cl2 and 
Tulahuén) were cultured in flask of 25ml with 5ml of LIT medium (35 g of Liver Infusion,5 g 
of Tryptose, 4 g of NaCl, 0.4 g of KCl,  8 g of (Na2HPO4) 12H2O,  2 g of Glucose, 4 ml of Hemin 
in a liter of double-distilled water) supplement with 10% FBS at 28°C, in the biosafety level 3 
cell cultured laboratory at Centro de Biologia Molecular Severo Ochoa (CSIC-UAM). 2/3 days 
after check the parasites in the microscopy and add 5ml of LIT medium.  
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3.2.2 Thioglycollate-elicited peritoneal macrophages 
 
Female mice Slamf1-/- , Tlr2-/- , BALB/c and BL6/c57 mice between 8-12 weeks old were injected 
intraperitoneally with 10% thioglycollate (Gibco, Grand Island, NY) (1 ml per mouse). After 4 days, 
mice were euthanized by CO2 inhalation. Peritoneal cell were collected with 10 ml of cold PBS. 
Peritoneal cells were pelleted by centrifugation (260 g, 10 min, 4°C) and seeded in 6-well plates (106 
cells/well) in RPMI medium supplement with 5% FBS overnight at 37°C. Non-adherent cells were 
removed by gently washing three times with warm PBS. At this time, more than 90% cells 
correspond to macrophages. 
3.2.3 In vitro infection 
Peritoneal macrophages were co-cultured with metacyclic trypomastigotes of the T. cruzi strains 
Dm28c, Y, M6421 cl6, 10R26, Bug2148 cl1 and VFRA cl1 in a rate of 5parasites:1cell; and analyzed at 
1h (Interaction), 6h (Internalization) and 24h (Intracellular proliferation). Afterwards, the cells were 
washed with PBS three times to remove unbound parasite.  
3.2.4 In vivo infection 
Experiments were performed in the biosafety laboratory 3 in the animal facility at Centro de Biologia 
Molecular Severo Ochoa (CSIC-UAM), employing groups of 5 mice BALB/c and Slamf1-/-. They were 
infected intraperitoneally with 2000 parasites/mice with the strains Dm28c, Y and VFRA cl1. The 
mice were sacrificed at 14 and 21 d.p.i. , with the respective control non-infected, by CO2 inhalation. 
Samples of heart, spleen and liver were analyzed by Western Blot for protein expression and 
quantitatiǀe ƌeal tiŵe PC‘ ;foƌ paƌasite ƋuaŶtifiĐatioŶ aŶd host͛s ŵ‘NA geŶe eǆpƌessioŶͿ. 
3.2.5 DNA extraction 
Parasite DNA was isolated with the High Pure Template preparation kit (Roche) from different 
samples: 
 Infected macrophages with the different T. cruzi strains Dm28c, Y, M6421 cl6,  10R26, 
Bug2148 cl1 and VFRA cl1 at 1 h, 6 h, 24 h and their respective no infected controls. 
Macrophages were scrapped from the p-6 cell with 200 μl of Binding buffer and transfer to 
1.5 ml tubes (Eppendorf). 
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 25-35 mg of infected tissues (Heart, spleen and liver) from BALB/c and Slamf1-/- mice and 
the respective controls. 200 μl of tissue lysis buffer, 40 μl of proteinase K and the tissue 
were mixed and incubated overnight at 55°C. 
For all samples 200 μl of Binding buffer and 40μl Proteinase K (except for the tissues) were added 
and incubated for 10 min at 70°C. After that 100 μl of isopropanol was added, mixed and applied in 
the filter tube were centrifuged for 1 min at 8000 g. 500 μl of Inhibitor Removal Buffer was added to 
the filter tube and centrifuged for 1 min at 8000 g. Two washes with 500 μl of Wash buffer was 
performed with a centrifugation for 1 min at 8000 g. Extra centrifuge for 10 second to remove the 
excess of liquid was performed and finally 50 μl of elution buffer was added followed by a 
centrifugation for 1 min at 8000g. The purified DNA obtained was quantified in the Nano drop 
(Thermo Scientific) and kept at -70°C.  
3.2.6 Parasite load 
For T. cruzi detection, qPCR reactions were conducted with 20ng of the DNA from blood and 
macrophages and 100 ng tissues. T. cruzi  DNA detection was performed following Piron et al., 
2007(Piron et al. 2007).  The parasite load were performed by triplicate amplifying the intergenic 
region of the non-transcribed mini-exon gene using primer Cruzi 1 (5`ASTCGGCTGATCGTTTTCGA3`) 
Cruzi 2 (5`AATTCCTCCAAGCAGCGGATA3`) and the genomic mouse TNF primers TNF-antisense 
(5`CAGCAAGCATCTATGCACTTAGACCCC3`) TNF Sense (5`TCCCTCTCATCAGTTCTATGGCCCA3` on an 
ABI PRISM 7900 HT instrument (Applied Biosystem). The quantity of T. cruzi mouse DNA in the 
samples was calculated from the comparative threshold cycle (CT) values obtained from T. cruzi 
primers and normalized with the respect mouse TNF primer. The regression equation resulting from 
plotting the CT values obtained from standard curve from 1000 pg to 0.001 pg of parasite DNA, and 
then used to extrapolate the quantity of parasite DNA in the samples.  Results were expressed as pg 
of T. cruzi DNA per ng of total DNA.  
3.2.7 RNA extraction 
RNA extraction was performed with TRIzol reagent (Invitrogen) following their protocol. We used 
different samples: 
 Infected macrophages with the different T. cruzi strains Dm28c, Y, M6421 cl6, 10R26, 
Bug2148 cl1 and VFRA cl1 at 1h, 6h, 24 h and their respective no infected controls. 
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Macrophages were scrapped from the p-6 cell with 500 μl of TRIzol reagent and transfer to 
1.5 ml tubes (Eppendorf). 
 25-35 mg of infected tissues (Heart, spleen and liver) from BALB/c and Slamf1-/- mice and the 
respective controls. The tissues were homogenized with a PT1300D (Kinematica Polytron, 
Fisher Scientific) in 1 ml of TRIzol reagent. 
To the homogenized samples (macrophages and tissues) 200 μl of chloroform were added and 
mixed vigorously. The samples were centrifuged for 15 min at 12000 g, 4°C. The aqueous upper 
phase was removed into a new tube and 500 μl was added to precipitated the RNA, an incubation of 
20 min was performed a -20°C. Then, the samples were centrifuged for 15 min at 12000 g, 4°C. The 
pellet was washed with 1 ml of 75% ethanol and centrifuged for 5 min at 7500 g, 4°C. The 75% 
ethanol was discarded and finally after an air dry the pellet was resuspended in 30 μl of DEPC water. 
The purified RNA obtained was quantified in the Nano drop (Thermo Scientific) and kept at -70°C.  
3.2.8 Quantitative real time PCR (qPCR) and Reverse –transcription qPCR (RT-qPCR) 
Total RNA were extracted by TRIzol reagent from:  
 Infected macrophages with the different T. cruzi strains Dm28c, Y, M6421 cl6, 10R26, 
Bug2148 cl1 and VFRA cl1  at 1h, 6h, 24 h and their respective no infected controls.  
 25-35 mg of infected tissues (Heart, spleen and liver) from BALB/c and Slamf1-/- mice and the 
respective controls.  
For quantitative RT-PCR analysis, reverse transcription of total RNA was performed using the High 
Capacity cDNA Archive Kit (Applied Biosystems) and the amplification of different enzymes and 
cytokines genes was performed using gene specific oligonucleotide (Table 4) in triplicate reactions 
with GoTaq® qPCR Master Mix (Promega) on an ABI PRISM 7900 HT instrument (Applied Biosystem, 
Life Sciences). The relative quantity of each gene expression was calculated by the by the 
comparative threshold cycle (CT) method following the protocol instructions. All quantifications 
were normalized to the ribosomal 18S gene to account for the variability in the initial concentration 
of RNA and in the conversion efficiency of the reverse transcription (∆CT). Finally, all data from 
samples taken from infected macrophages or infected mice were normalized with the respect to the 
values obtained from non-infected macrophages or non-infected mice (∆∆CT). The relative quantity 
(RQ) was calculated as, RQ=2-∆∆Ct.  
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Table 4. qPCR Primers. 
Primer Name Gene Sequence (5`-3`) 
18s Right 18s CCATCCAATCGGTAGTAGCG  
18s Left 18s AACCCGTTGAACCCCATT 
Arg-1 Right Arg1 TTTTTCCAGCAGACCAGCTT 
Arg-1 Left Arg1 AGAGATTATCGGAGCGCCTT  
Cybb Right p47phox TGCAGTGCTATCATCCAAGC 
Cybb Left p47phox CTTTCTCAGGGGTTCCAGTG 
Il-10 Right Il10 TGTCAAATTCATTCATGGCCT  
Il-10 Left Il10 ATCGATTTCTCCCCTGTGAA 
Il-1b Right Il1b GGTCAAAGGTTTGGAAGCAG  
Il-1b Left Il1b TGTGAAATGCCACCTTTTGA 
Il-6 Right Il6 ACCAGAGGAAATTTTCAATAGGC  
Il-6 Left Il6 TGATGCACTTGCAGAAAACA 
Irg-1 Right Irg1 CGTGTCGAAGCTTGGCGGGT  
Irg-1 Left Irg1 CCTGTGCCTCGCTGCTCGAC 
Slamf1 Right Slamf1 TTATTGCCGTGAAAACCAGC 
Slamf1 Left Slamf1 TCAACCTATCATCGCAAGCA 
TNF Right Tnf AGGGTCTGGGCCATAGAACT  
TNF Left Tnf CCACCACGCTCTTCTGTCTAC 
TLR2 Right Tlr2 GCTGGAGGACTCCTAGGCT 
TLR2 Left Tlr2 GTCAGAAGGAAACAGTCCGC 
 
Genes evaluated in all infected samples were divided in enzymes (3 genes) and cytokine (4 genes):  
Enzymes: 
 NADPH Oxidase-2 (NOX2): NADPH oxidase is a multisubunit enzyme comprising membrane 
and cytosolic components, which actively communicate during the host responses to a wide 
variety of stimuli (Panday et al. 2015). NOX2 mediate ROS production which have an 
important role in the elimination of invading microorganisms in macrophages and 
neutrophils.  In Gram- bacteria SLAMF1 receptor regulates positively the production of 
NOX2 (C. S. Ma and Deenick, 2011). 
 Arginase-1 (Arg1): is expressed most abundantly, but not exclusively, in the liver. Catalyzes 
the hydrolysis of L-arginine to ornithine and urea. In macrophages is a M2 marker, induce 
TGF-β aŶd ĐǇtokiŶes suĐh as IL-4, IL-10 and IL-13 (Cuervo et al., 2008). During the infection 
by T. cruzi has been demonstrated that increases susceptibility.  
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 Immune-response gene 1 (Irg1): is highly expressed in mammalian macrophages, coding for 
an enzyme producing itaconic acid, which have an antimicrobial effect in macrophages, 
inhibiting isocitrate lyase, the key enzyme of the glyoxylate shunt (Michelucci et al., 2013).  
Cytokines: 
 Pro-inflammatory: Interleukin 1b (Il1b), Interleukin 6 (Il6) and Tumor Necrosis Factor (Tnf). 
 Anti-inflammatory: Interleukin 10 (Il10). 
3.2.9 Protein extraction and western blotting 
Different samples for the protein extraction were used: 
 25-35 mg of infected tissues (Heart, spleen and liver) from BALB/c and Slamf1-/- mice and the 
respective controls. The tissues were homogenized with a PT1300D (Kinematica Polytron, 
Fisher Scientific) in 1 ml of RIPA (50mM Tris-HCl (pH 8), 50 mM NaCl, 1 mM EDTA, Complete 
Mini Protease inhibitor Cocktail tablets (Roche), 0.1% SDS, 1% Triton-X100, 0.5% sodium 
deoxycholate in distilled water). 
The samples were lysed in RIPA for 30 min at 4ºC and supernatants were collected after 
centrifugation. Protein concentration was determined by the bicinchonic acid method (BCA, Pierce) 
using Bovine Serum Albumin for standard curve. 30 μg of heart, 30 μg of liver or 40 μg of spleen 
protein extracts were separated by SDS-PAGE (10-15% Poliacrylamide) and subjected to Western 
Blot with appropriate antibodies (Table 5) overnight. Nitrocellulose membrane Hybond-ECL 
(Amersham Bioscience) was also incubated with secondary antibody coupled to peroxidase and 
revealed by Clarity Westen ECL Substrate (Bio-Rad) and protein detected by IŵageQuaŶt™ LA“ ϰϬϬϬ 
mini (GE). 
Table 5. Western blot Antibodies 
Antigen Reference Provided Dilution Positive control 
iNOS sc-650 Santa Cruz Biotecnology 1:1000 Raw cells +LPS 
Arg-1 sc-18354 Santa Cruz Biotecnology 1:1000 Raw cells +LPS 
Actin sc-1616 Santa Cruz Biotecnology 1:1000 Raw cells +LPS 
COX-2 BD-610203 BD Bioscience 1:1000 Raw cells +LPS 
NOX2 sc-130543 Santa Cruz Biotecnology 1:1000 Raw cells +LPS 
YAP1 14074 Cell Signalling 1:1000  
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3.2.10 Reactive Oxygen Species Assay               
Peritoneal macrophages BALB/c and Slamf1-/-were co-cultured with metacyclic trypomastigotes of 
the T. cruzi strains Dm28c, Y, M6421 cl6, 10R26, Bug2148 cl1 and VFRA cl1 in a rate of 
5parasites:1cell; at 6 h.p.i. Afterwards, the cells were washed with PBS 1X three times to remove 
unbound parasite. The macrophages were seed with RPMI without Red phenol. Following the 
CELLROX green reagent (Life Technologies) protocol, Macrophages were scrapped from the 6-well 
plate cell with 1 ml of RPMI without red phenol reagent and transferred to cytometry tubes. 2 μl of 
CellROX Green ReageŶt ǁeƌe added to the saŵples foƌ a fiŶal ĐoŶĐeŶtƌatioŶ of ϮϱϬ μM aŶd 
incubated for 30 min at 37°C.  The medium was discarded and the samples were collected, pelleted 
by centrifugation (720 g, 10 min. 37°C) and washed three times with PBS 1X following by 
centrifugation (720 g, 10 min. 37°C). The samples were fixed with paraformaldehyde 1% in PBS 20 
min at 4°C protected from light. Finally, the samples were analyzed by flow cytometry in the 
FACSCanto II (BD Biosciences) and the data was analyzed with the program FlowJo (TriStar, Ashland, 
OR, USA).                                                                                                                                                                                                          
3.2.11 Construction of the networks 
We used data of the expression levels of the 9 genes (3 enzymes, 4 cytokines and 2 receptors) and 
the parasite load (T. cruzi) of macrophage and organ samples using qRT-PCR values to calculate the 
“peaƌŵaŶ͛s correlation ρ(rho) between the 10 parameters with the GraphPad Prism version 5.0 for 
Windows (GraphPad Software, San Diego California USA). The statistically significant correlation 
data was introduced in text format into the Cytoscape program (http://www.cytoscape.org), a 
software platform for network visualization and analyses. The correlation data is detailed in the in 
the Appendix (Tables S2 to S16). The networks picture each strain of T. cruzi as a central node: 
Dm28c (Blue ellipse), Y (Red ellipse), M6421 cl6 (Green ellipse), 10R26 (Orange ellipse), Bug2148 cl1 
(Purple ellipse) and VFRA (Pink ellipse). Pairs of data (secondary nodes) with significant correlation 
(Figure SX) are indicated in boxes connected to the nodes by lines (edges). For positive correlations, 
when data increase (+ +) or decrease (- -), continuous or dashed red lines were drawn, respectively. 
For negative correlations, when the first data in the pair increases and the second decreases (+ -) a 
continuous green line was drawn, and when the first data decreases and the second increases (- +) a 
dashed green line was drawn. Secondary nodes in the periphery of the central nodes indicate the 
associations of a particular strain and the association between principal nodes indicates common 
associations between different parasite strains. 
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3.2.12 Itaconic acid levels 
 
Itaconic acid levels were determined in mouse heart tissues extracts from non-infected and 21 d.p.i. 
by Metabolon Inc. Heart tissue was defrosted at room temperature and cut approximately 80 mg. 
The sample was heat-inactivated at 50°C for 30 min. Follow by that 1600 μl of methanol solvent A 
(containing standard resuspended in 80% HPLC grade Methanol; Sigma Aldrich) were added to the 
heart. After incubation for 24 h at room temperature, samples were stored at -80°C until shipment 
in dry ice. The extracted samples were split into equal parts for analysis on the gas chromatography 
(GC)/mass spectrometry (MS) and liquid chromatography (LC)/MS platforms. Values were 
normalized in terms of raw area counts (OrigScale). For a single day run, this is equivalent to the raw 
data. Each biochemical in OrigScale is rescaled to set the median equal to 1 and expressed as 
imputed normalized counts for each biochemical (ScaledImpData) (Gironès et al., 2014). 
3.2.13 Inhibition Assay of Itaconate 
 
Epimastigote TcI (Dm28c, Sylvio X10 cl1 and C8), TcII (Y, Esmeraldo cl3 and Tul8 cl1), TcIII (CM17 and 
M6421 cl6), TcVI (10R26), TcV (Bug2148 cl1 and SC43 cl1) and TcVI (Cl Brener, VFRA cl1, Tulahuén 
cl2 and Tulahuén) were cultivate in 96-well plates (106 parasite/well) in LIT medium supplement with 
10% FBS at 28°C. We analyzed 7 different treatment conditions (0, 0.3, 1, 3, 10, 30, 100 mM of 
Itaconate) and control cultures were maintained without drug, for 4 days at 28°C. Each one of the 15 
T.cruzi strains and treatment concentration was evaluated by triplicate. After 4 days of treatment 
parasite inhibition were determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide assay (MTT assay), where the parasites were collected by centrifugation (720 g, 10 min, 
28°C), the supernatant were removed and the pellet was resuspended in ϱϬ μl of 5 mg/ml of MTT 
and incubated by 3 hours. Afterward, the pellet were collected by centrifugation (720 g, 10 min, 
28°C) and resuspended in 100 μl of MTT solvent (1:1 Isopropanol : DMSO) and the absorbance read 
at 590 nm. The half maximal inhibitory concentration (IC50) were calculated to evaluate the 
treatment with the GraphPad Prism version 5.0 for Windows (GraphPad Software, San Diego 
California USA).  
3.2.14 Statistical Analysis 
For in vivo experiments data reported is mean ± Standard deviation (SD) from groups of five mice 
(n=5). Results shown from in vitro experiments are representative of at least two experiments.   
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Significance was evaluated by student´s two-tailed t-test (95% confidence interval) with the 
GraphPad Prism version 5.0 for Windows (GraphPad Software, San Diego California USA).  
Discriminant Analysis of Principal Components (DAPC) was performed, to assess the association 
between the gene expressions of enzymes, cytokines and the parasite load in BALB/c and Slamf1-/- 
macrophages or organs infected with the different strains of T. cruzi with the Statistical Package for 
the Social Sciences 17, SPSS.  
 
 
 
  
RESULTS 
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4 RESULTS 
4.1 MOUSE GENETIC BACKGROUND 
 
The mouse genetic background is beginning to be considered an important factor in biomedical 
research since it determines disease outcome.  Susceptibility and resistance to parasite infections in 
mice are determined by unknown genetic determinants, but there are two strains considered to be 
the extremes BALB/c and C57BL/6. In the case of Chagas disease BALB/c genetic background has 
been reported as susceptible while C57BL/6 has been reported as resistant to in vivo infection with 
the strain Y (Cuervo et al., 2008). However, other strains as Tulahuén behaved differently (Carrera-
Silva et al., 2008). In this study we used 6 different reference strains of T. cruzi, classified from TcI to 
TcVI, with the aim to understand the role of the genetic variability of the parasite in BALB/c and 
C57BL/6 peritoneal macrophage model. We evaluated the three phases of the infection: The 
interaction (1 h.p.i.), the internalization (6 h.p.i) and the intracellular proliferation (24 h.p.i.). those 
times were selected based on previous evidence (Maganto-Garcia et al., 2008; Zhao et al., 2013).  
4.1.1 Kinetics of BALB/c and C57BL/6 Peritoneal Macrophage Infection with Different Strains of T. 
cruzi. 
 
First, we evaluated the level of infection between BALB/c and C57BL/6 peritoneal macrophages 
infected with the T. cruzi strains, measuring the parasite load in the three phases. Figure 11 shows 
the kinetics of the parasite load in peritoneal macrophages. 
All the parasite strains showed higher intracellular proliferation (24 h.p.i.) in BALB/c macrophages 
than C57BL/6 macrophages, in agreement with previous in vivo results with the Y strain (Cuervo et 
al., 2008; Sanoja et al., 2013). Despite this, no significant differences were observed in the 
interaction (1 h.p.i.) among both mouse strains. Dm28c showed significantly higher replication than 
the rest in BALB/c but the opposite in C57BL/6 macrophages. 
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Figure 11. Parasite load in infected macrophages. Kinetic analysis of parasite load of BALB/c and C57BL6 
peritoneal macrophages at 1 h, 6 h and 24 h after infection with parasite strains of different DTUs, parasite 
load was quantified by qPCR. Mean and Standard error of the mean ± (SEM) of two independent experiments 
are represented. The asterisks indicate the statistical significance, t-student (*p<0.05, **p<0.005 and 
***p<0.001), between BALB/c and C57BL/6 macrophages. 
 
4.1.2 Expression of Immunoregulatory Genes in C57BL/6 and BALB/c Macrophages Infected with 
Different Strains of T. cruzi. 
 
Next, we studied the macrophage activation by analyzing the kinetics of gene expression of a panel 
of relevant molecules. We measured the gene expression of 3 enzymes (Nox2, Arg1 and Irg1) 
defining macrophage M1, M2 and inflammation status, 3 pro-inflammatory cytokines (Il1b, Il6 and 
Tnf) and the anti-inflammatory cytokine Il10. In addition, we also quantified gene expression of 
Slamf1 and Tlr2 receptors, known to be important for infectivity, as well as the parasite load.  Table 
6  summarizes the results in BALB/c and C57BL/6 macrophages infected with different parasite 
strains. We observed high variability in gene expression and parasite load depending on the strain. 
In general, we found an enhanced enzyme and cytokine gene expression in C57BL/6 macrophages 
infected with all the strains of T. cruzi compared with the infection of same strains in BALB/c 
macrophages. Thus the high C57BL/6 macrophage activation together with low parasite load 
indicated a more efficient control of infection in this strain of mice. Contrarily, BALB/c macrophages 
only presented higher expression of Tnf, Slamf1 and Tlr2 and higher parasite load compared with 
the C57BL/6 macrophages, indicating a less efficient control of parasite infection. 
51 
 
Table 6. Summary of expression of immunoregulatory genes and parasite load in BALB/c and C57BL/6 
peritoneal macrophages infected with different strains of T. cruzi. Gene expression was determined by RT-
qPCR and RQ value were obtained after normalizing value from infected respect to no-infected macrophages. 
For each gene and parasite load a color code was given from high (Red) to low (Green). The real values 
obtained and the statistically significant differences between mouse strains are shown in Figure S  3 (Enzymes), 
Figure S  4 (Cytokines) and Figure S  5 (Receptors).  Parasite load (T.cruzi) corresponds to values from Figure 11.  
 
Despite this general tendency, we observed differences in gene expression and parasite load 
depending on the infecting T.cruzi strain. To further analyze the data, we performed Discriminant 
Analysis of Principal Components (DAPC) with the gene expression and parasite load data, to find 
associations between activation state of the macrophages, mice and T. cruzi strains.  The analysis 
was performed with the gene expression of the 3 enzymes, 4 cytokines and the parasite load in the 
three different phases of the in vitro infection evaluated. 
Figure 12. Discriminant Analysis of Principal Components (DAPC). These scatterplots show the first two 
principal components of the DAPC of gene expression and parasite load data according to the three different 
phases of macrophage infection with the different T. cruzi strains. A. Interaction at 1 h.p.i. B. Internalization at 
6 h.p.i. C. Intracellular proliferation at 24 h.p.i. The diagrams show clustering of BALB/c peritoneal 
macrophages infected with the different strains of T. cruzi (Black dashed line) and C57BL/6 (Gray dashed line). 
The discriminant analysis of principal components at 1 h.p.i. (Figure 12 A), was able to discriminate 
76.7%, where 52% and 24.7% are explained in first (x-axis) and second (y-axis) principal components, 
respectively. Three different clusters were found, the first was the infection in C57BL/6 
macrophages with the strains M6421 cl6, Bug2148 cl1 and VFRA cl1; the second was the infection 
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with 10R26 in C57BL/6 macrophages and in the third one the rest of the infections including Dm28c 
and Y in C57BL/6 macrophages and all the strains in BALB/c macrophages.  
Table 7. Discriminant frequencies in the interaction phase in BALB/c and C57BL/6 peritoneal macrophages 
infected with different strains of T. cruzi  
 
Table 7 shows that the theoretical groups predicted by the DAPC analysis matched in a high percent 
with the real groups. We found that all the infections with the different strains of T. cruzi 
discriminated between BALB/c and C57BL/6 mouse genetic background, except infection in C57BL/6 
with the Y that was grouped as a BALB/c infection. 
Table 8. Discriminant frequencies in the internalization phase in BALB/c and C57BL/6 peritoneal 
macrophages infected with different strains of T. cruzi 
 
DAPC analysis at 6 h.p.i. discriminated 78.9 % this phase, which 61.5% and 17.4 % are explained in 
first (x-axis) and second (y-axis) principal components, respectively.  Two different clusters were 
found, one for all infected in C57BL/6 and the other all infection in BALB/c and the non-infected 
controls BALB/c and C57BL/6 (Figure 12 B). The percent of the discrimination shown in Table 8 
demonstrated that in this phase with the components evaluated, the infections in C57BL/6 
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macrophages with the different strains of T. cruzi were able to discriminate each group in a 100%. In 
contrast, the infection in BALB/c macrophages with the T. cruzi strains could discriminate one in 
100%, four in 83% and the last one 67%. 
The DAPC analysis at 24 h.p.i was only able to discriminate 88.2% our model, which 71.7% and 
16.5% are explained in first (x-axis) and second (y-axis) principal components, respectively. At this 
time, more heterogeneity was found as should be expected as longer time passed. Thus, only 
BALB/c macrophages infected with Dm28c and M6421 cl6 and 10R26 in C57BL/6 macrophages were 
discriminated (Figure 12 C). The percent of the discrimination is shown in Table 9 and again we 
found a clear discrimination between the infections in BALB/c and C57BL/6 macrophages with all 
strains and better discrimination in the C57BL/6 infections. 
Thus, mouse gene expression and parasite load data DAPC was able to correctly discriminate 
between groups in a high percent indicating a high heterogeneity in the activation of macrophages 
depending on mouse and parasite strains, being this effect more evident as the intracellular 
infection progress.  
However, the mouse genetic background seems more important than the parasite strain in the 
process of macrophage activation and it is influence in parasite load at different times, especially at 
1 h.p.i. and 6 h.p.i. At 24 h.p.i. only 3 combination of mouse and parasite load grouped separated 
from the rest.  
Table 9. Discriminant frequencies in the intracellular proliferation phase in BALB/c and C57BL/6 peritoneal 
macrophages infected with different strains of T. cruzi. 
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4.1.3 Correlation Networks  
 
Finally, correlation analysis were performed for determine the direction and strength of a 
relationship between our variables.  
 
Figure 13. Networks of the macrophage activation during the interaction phase with the different strains of 
T. cruzi. A. BALB/c macrophages. B. C57BL/6 macrophages.  Networks were generated and represented as 
indicated in the Methods section. 
We included gene expression of the immunoregulatory genes, as well as the receptor expression 
(Slamf1 and Tlr2) and the parasite load in the analysis.  As in the summary of the genes we found 
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different patterns of positive or negative correlations (during interaction in Table S 2, internalization 
in Table S 3 and intracellular proliferation in Table S 4) depending not only on the mouse genetic 
background of the infected macrophages but also between the different strains of T. cruzi. In order 
to easily visualize the correlation we used the Cytoscape software to draw correlation network. 
We used the different strains of T.cruzi as central nodes. During the interaction in BALB/c 
macrophages the resulting network was composed of 24 secondary nodes and 49 edges (Figure 13 
A) and C57BL/6 was composed of 25 secondary nodes and 42 edges (Figure 13 B), with 6 as the 
maximum degree of connectivity of a node and 1 as the minimum.  
We found an aggrupation between the Dm28c, Y and VFRA cl1 strains by positive correlations during 
the interaction of BALB/c macrophages. In contrast, for C57BL/6 many of the correlations for Dm28c 
were negative, therefore changing the shape of the network and drawing it apart, indicating that 
this strain has a different behavior in macrophages depending on the mouse genetic background. In 
the case of the Y strain in C57BL/6 the loss and appearance of new correlations in of correlations 
compared to BALB/c separated it from Dm28c and VFRA cl1. In the case of 10R26 and Bug2148 cl1 
infections in BALB/c macrophages there were few negative correlations, while in C57BL/6 
macrophages Dm28c, 10R26 and M6421 cl6 present more negative than positive correlation. The 
increment of negative correlation in C57BL/6 mouse genetic background associated with the low 
parasite load, which could indicate a substantial interaction and early signal transduction after 
binding of T.cruzi to macrophages. Interestingly, a positive correlation between the parasite load 
and Tlr2 was found in the infection in C57BL/6 macrophages with the strain Dm28c, Y and VFRA cl1; 
and positive correlation between the parasite load and Slamf1 with the strains M6421 cl6 and 
Bug218 cl6 with the same of mouse macrophages, in agreement with gene expression show in Table 
S 2, Table 6 and parasite load (Figure 11). Interestingly, in BALB/c macrophages high expression of 
Tlr2 and Slamf1 correlated with low parasite load of Bug2148_cl1. However, in C57BL/6 high 
expression of Tlr2 correlated with high parasite load of Y and Dm28c, and Slamf1 with M6421_cl1 
and Bug2148_cl1. 
The resulting networks during the internalization phase in BALB/c macrophages was composed of 18 
secondary nodes and 28 edges (Figure 14 A) and C57BL/6 was composed of 8 secondary nodes and 
14 edges (Figure 14 B), with 6 as the maximum degree of connectivity of a node and 1 as the 
minimum. In both cases a reduction compared with interaction phase was found in secondary nodes 
and edges. In C57BL/6 internalization no significant positive or negative correlations associated with 
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the strain VFRA cl1 were found. In BALB/c and C57BL/6 macrophages infected with the 10R26 there 
were less correlations during the internalization compared to the interaction, this and the increment 
in the parasite load indicated the lack of control of the infection during this phase. In both cases the 
strain showing more association with the others strains was Dm28c, in BALB/c with Y, M6421 cl6 
Bug2148 cl1 and VFRA cl1 and in C57BL/6 with M6421 cl6, 10R26 and Bug2148 cl1. Association in 
C57BL/6 macrophages was found between the down regulation of both, parasite load and gene 
expression of Slamf1 and Tlr2 receptors. 
 
Figure 14. Networks of the macrophage activation during the internalization phase with the different strains 
of T. cruzi. A. BALB/c macrophages. B. C57BL/6 macrophages. Networks were generated and represented as 
indicated in the Methods section. 
In the phase of intracellular proliferation the resulting network for BALB/c macrophages was 
composed of 14 secondary nodes and 20 edges (Figure 15 A) and for C57BL/6 macrophages it was 
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composed of 15 secondary nodes and 20 edges (Figure 15 B), with 6 as the maximum degree of 
connectivity of a node and 1 as the minimum. No significant correlations were found in the 
intracellular proliferation of Dm28c in BALB/c macrophages and the internalization of VFRA cl1 in 
C57BL6 macrophages, were in both cases high parasite load was found respect to other parasite 
strain (Figure 11 ), likes because the high level of infection with Dm28c reduced the macrophage 
control of infection or even at this phase the macrophage killed and released new parasites. Again, 
higher numbers of positive correlations where found in all infections in BALB/c macrophages 
compared to C57BL/6 macrophages. 
 
Figure 15. Networks of the macrophage activation during the intracellular proliferation phase with the 
different strains of T. cruzi. A. BALB/c macrophages. B. C57BL/6 macrophages.  Networks were generated and 
represented as indicated in the Methods section. 
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4.2 TLR2 IN MACROPHAGES 
 
TLR receptors play an important role in the entry of diverse pathogens, previous studies using the Y 
strain demonstrated that TLR2 is required for the entry of T. cruzi and in the previous section we 
show that TLR2 expression positively correlates with the parasite load especially during the 
interaction at 1 h, for many parasite strains. On the other hand, the variability of the structure of the 
GIPLs in the parasite, which is different depending on the parasite strain, determines the recognition 
by TLR2 or TLR4 (Campos et al., 2001).  For this reason we study the role of TLR2 in macrophage 
activation and the pathogen recognition with different T. cruzi strains. 
4.2.1 Kinetics of C57BL/6 and Tlr2-/- Peritoneal Macrophage Infection with Different Strains of T.cruzi. 
 
To determine the role of TLR2 receptor, we analyzed the kinetic of parasite load inside Tlr2-/- 
peritoneal macrophages to evaluate their susceptibility. The Tlr2-/- mouse strain used has a C57BL/6 
background, for this reason we compared the rate of infection between Tlr2-/- and C57BL/6 
peritoneal macrophages infected with the T. cruzi strains.  
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Figure 16. Kinetic of parasite load in C57BL/6 and Tlr2-/- peritoneal macrophages. Kinetic analysis of parasite 
load of C57BL6 and Tlr2-/- peritoneal macrophages at 1 h, 6 h and 24 h after infection with parasite strains of 
different DTUs, parasite load was quantified by qPCR. Mean and Standard error of the mean ± (SEM) two 
independent experiments are represented.  The asterisks indicate the statistical significance, t-student 
(*p<0.05, **p<0.005 and ***p<0.001), between Tlr2-/- and C57BL/6 macrophages.  
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Figure 16 shows parasite loads in peritoneal macrophages at different times. We found that Tlr2-/- 
macrophages presented lower parasite load compared with C57BL/6 macrophages. These were 
significant at 1 h.p.i. for M6421 cl6, at 6 h.p.i. for Dm28c and VFRA cl 1 and at 24 h.p.i. for Dm28c 
and 10R26. However, in other conditions parasite load was also lower in Tlr2-/- macrophages in 
comparison with C57BL/6, indicating the importance of Tlr2 for T. cruzi entry at all times points.   
4.2.2 Role of TLR2 Receptor in the Phases of Peritoneal Macrophages Infected with Different Strains 
of T. cruzi 
 
To evaluate the effect of TLR2 receptor efficiency in the different phases, we first normalized 
parasite load of Tlr2-/-peritoneal infected macrophages in different phases by dividing Tlr2-/- parasite 
load by C57BL/6 parasite load. Secondly, we took the value of parasite load at 1 h.p.i,  Figure 17  A 
shows normalized parasite load at 1 h.p.i. Parasite load in the internalization phase at 6 h.p.i. was 
normalized respect normalized levels at interaction phase (Figure 17 B). Finally, intracellular 
proliferation at 24 h.p.i. was normalized respect normalized levels at internalization phase (Figure 17 
C). We found that Tlr2 receptor is required for the interaction, internalization and the intracellular 
proliferation for all strains, except for the internalization of Y. 
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Figure 17. Effect of TLR2 deficiency on parasite load of peritoneal macrophages respect C57BL/6. Dashed 
lines correspond to normalized C57BL/6 parasite load (equal to 1 for all parasite strains). Gray boxes 
correspond to normalized values of Tlr2-/- macrophages at each stage of infection. A. Interaction at 1 h.p.i. B. 
Internalization at 6 h.p.i. C. Replication at 24 h.p.i. 
4.2.3 Expression of Immunoregulatory Genes in C57BL/6 and Tlr2-/- Macrophages Infected with 
Different Strains of T. cruzi. 
 
Table 10 summarizes the gene expression of the 3 enzymes, 4 cytokines, 2 receptors and the 
parasite load of Tlr2-/- and C57BL/6 macrophages infected with the different strains of T. cruzi 
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(Figure S  6, Figure S  7 and Figure S  8). A stronger activation was found in C57BL/6 than Tlr2-/- 
macrophages, as it would be expected if T. cruzi binds to TLR2. However, there was high parasite 
load in Tlr2-/- macrophages infected with VFRA cl1 compared with the rest of parasite strains, which 
was similar to the values that we found in the C57BL/6 macrophage infections, at 24 h.p.i 
nonetheless this is not resulting in higher activation of macrophages with that strain.   
Table 10. Summary of expression of immunoregulatory genes and parasite load in C57BL/6 and Tlr2-/- 
peritoneal macrophages infected with different strains of T. cruzi. Gene expression was determined by RT-
qPCR and RQ value were obtained after normalizing value from infected respect to no-infected macrophages. 
Results are shown in Figure S  5 (Enzymes), Figure S  6 (Cytokines) and Figure S  7(Receptors). Parasite load 
(T.cruzi) correspond to value from Figure 16. For each gene and parasite load a color code was given from high 
(Red) to low (Green). 
 
The discriminant analysis of principal components was performed with the gene expression of the 3 
enzymes, 4 cytokines and the parasite load in the three different phases evaluated (Figure 18) to 
further determine the role of Tlr2 in the activation of macrophages infected with different strains of 
T. cruzi. 
 
Figure 18. Discriminant Analysis of Principal Components (DAPC). These scatterplots show the first two 
principal components of the DAPC of gene expression and parasite load data according to the three different 
phases of the macrophage infection with the different T. cruzi strains. A. Interaction at 1h B. Internalization at 
6h C. Intracellular proliferation at 24h. The diagrams show clusters of C57BL/6 peritoneal macrophages 
infected with the different strains of T. cruzi (Black dashed line) and Tlr2 -/-(Gray dashed line).   
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The DAPC analysis was able to discriminate 84% in our model, in which 58.4% and 25.6% are 
explained in first (x-axis) and second (y-axis) principal components, respectively. We observed that 
the data allowed discrimination of M6421 cl 6 to VFRA cl 1 infecting parasite strains in C57BL/6 
macrophages but not for Dm28c and Y that grouped together (Figure 18 A, Black dashed line boxes 
from 1 to 6). More importantly, Tlr2-/- infected macrophages and non-infected controls grouped 
together (Figure 18 A, gray dashed line boxes), likely indicating the low positive binding and poor 
activation of Tlr2-/- macrophages by all T.cruzi strains. 
Table 11. Discriminant frequencies in the interaction in Tlr2-/- and C57BL/6 peritoneal macrophages infected 
with different strains of T. cruzi.  
 
The percent of the discrimination is shown in Table 11, a 100% of discrimination was found for all 
the infections with different T. cruzi strains in C57BL/6 macrophages. The discrimination for Tlr2-/- 
was worse than in the infections in C57BL/6 macrophages with values of only a 33% in some cases, 
these low frequencies are likely associated with the lower parasite load found.  
Table 12. Gene expression and parasite load discriminant frequencies in the internalization Tlr2-/- and 
C57BL/6 peritoneal macrophages infected with different strains of T. cruzi. 
 
 
The DAPC analysis at 6 h.p.i. was able to discriminate 86.6% in our model, which 74.12% and 12% 
are explained in first (x-axis) and second (y-axis) principal components, respectively. We found 3 
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clusters: one for infection in Tlr2 -/- with al strains of T. cruzi together with NI, another for the 
infection of C57BL/6 macrophages with all the strains of T. cruzi except M6421 cl6 and the last one 
with the infection in C57BL/6 macrophages with M6421 cl6.  
Table 12, shows again a clear discrimination in the infection in the C57BL/6 macrophages but even 
worst discrimination compared with the interaction in the all cases of the infection in the Tlr2 -/- 
macrophages. 
Table 13. Gene expression and parasite load discriminant frequencies in the internalization Tlr2-/- and 
C57BL/6 peritoneal macrophages infected with different strains of T. cruzi. 
 
The DAPC analysis at 24 h.p.i. was able to discriminate 77.2% in our model, which 50.9% and 26.3% 
are explained in first (x-axis) and second (y-axis) principal components, respectively. We found 4 
clusters: one for infection in Tlr2 -/- with al strains of T. cruzi and NI, another for the infection of 
C57BL/6 macrophages with all the strains of T. cruzi except Dm28c and VFRA cl1 and the others two 
with the infections in C57BL/6 macrophages with Dm28c and VFRA cl1. The percent of the 
discrimination is on Table 13. 
 
4.2.4 Correlation Networks 
 
We performed network correlation analysis, including gene expression of the immunoregulatory 
genes, as well as the receptor expression (Slamf1 and Tlr2) and the parasite load.  As in the summary 
of the genes we found different patterns of positive or negative correlations depending of the 
macrophage infection with the different strains of T. cruzi using Cytoscape. Specific changes, 
appearance and disappearance in the correlations between the C57BL/6 and Tlr2-/- on each infection 
phase evaluated will indicate the role of TLR2 receptor in the infection with the different strains of T. 
cruzi. Correlations are shown in the appendix section 8 (Interaction in Table S 5, Internalization in 
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Table S 6 and Intracellular replication in Table S 7). We used the different strains of T. cruzi as central 
nodes. 
During the interaction C57BL/6 resulting network was composed of 25 secondary nodes and 42 
edges (Figure 19 A) and Tlr2-/-  was composed of 19 secondary nodes and 32 edges (Figure 19 B), 
with 6 as the maximum degree of connectivity of a node and 1 as the minimum.  
 
Figure 19. Networks of the macrophage activation during the interaction phase with the different strains of 
T.cruzi. A. C57BL/6 macrophages. B. Tlr2-/- macrophages.  Networks were generated and represented as 
indicated in the Methods section. 
We found an aggrupation based in the correlation of the infected macrophage with the different 
strains in Tlr2-/- between Y strain as a central node and all other strains showing as the common 
strain in this phase. Interestingly, a huge change from positive correlation to negative was found in 
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C57BL/6 to Tlr2-/- infected with the Y strain, respectively. In Tlr2-/- macrophages there is no 
correlation with the parasite load, except for the Bug2148 cl1 and M6421 cl6 in which there is a 
positive correlation between parasite load and Slamf1 gene expression. As mentioned for C57BL/6 
macrophages we found positive and negative correlation between many genes, but for TLR2 
deficiency seems to reverse this tendency depending on the infecting strain.  Besides, the overall 
number of negative correlations was lower than for C57BL/6 indicating a certain dysregulation in 
Tlr2-/- macrophages. 
 
Figure 20. Networks of the macrophage activation during the internalization phase with the different strains 
of T.cruzi. A. C57BL/6 macrophages. B. Tlr2-/- macrophages. Networks were generated and represented as 
indicated in the Methods section.   
The resulting networks during the internalization in C57BL/6 macrophages were composed of 8 
secondary nodes and 14 edges (Figure 20 A) and Tlr2-/-was composed of 16 secondary node and 26 
edges (Figure 20 B), with 6 as the maximum degree of connectivity of a node and 1 as the minimum. 
While in C57BL/6 the central axis in the network is Dm28c with negative correlations, in the Tlr2-/- it 
changed as in the interaction phase to the Y strain, but in this case with only positive correlations.  
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The strain VFRA cl1 which did not present correlations in C57BL/6 macrophages, did present them in 
Tlr2-/-, with a negative correlation associated with the Slamf1 suggesting as increment in the parasite 
load at this phase where the SLAMF1 receptor is down-regulated and the parasite can be better 
internalized in the absence of this receptor (Figure 23). 
At 6 h.p.i there are few correlations in C57BL/6 infected macrophages, but in Tlr2-/- macrophages we 
observed both positive and negative gene expression correlations, which could indicate even more 
regulated macrophage activation after infection. The negative correlations observed for C57BL/6 
macrophages infected with Dm28c and Bug2148 cl1 between the Slamf1 and the parasite load are 
lost in the absence of Tlr2 indicating a possible relation between the two receptors with this strain. 
 
Figure 21. Networks of the macrophage activation during the intracellular phase proliferation with the 
different strains of T.cruzi. A. C57BL/6 macrophages. B. Tlr2-/- macrophages.  Networks were generated and 
represented as indicated in the Methods section. 
In the intracellular proliferation phase C57BL/6 resulting network was composed of 15 secondary 
nodes and 20 edges (Figure 21 A) and Tlr2-/- was composed of 15 secondary node and 20 edges 
(Figure 21 B), with 6 as the maximum degree of connectivity of a node and 1 as the minimum. In 
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Tlr2-/- macrophages infected with the VFRA cl1 appear as separate group and only with one negative 
correlation, probably because is the only strain which at this phase has similar parasite load as in 
C57BL/6 macrophages. Tlr2-/- macrophages infected with the strain Y, M6421 cl6 and 10R26 present 
more significant correlations associated with the gene expression of Tnf, Cybb, Il1b and Il10. In Tlr2-/- 
infected with Y a positive correlation between the receptors (Slamf1-Tlr2) and the negative 
correlation between the parasite load and Slamf1, indicate a down-regulation of this receptor by 
TLR2. 
4.3 SLAMF1 IN MACROPHAGES 
 
SLAMF1 receptor has been considered as a molecule detrimental for the host in some infection 
because it helps the entry of pathogens as measles virus, Leishmania major and also in the case of T. 
cruzi.  In vitro infections with the Y strain in Slamf1-/- dendritic cells and macrophages demonstrated 
to be more resistant than the wild type cells (BALB/c) (Calderón et al., 2012).  We addressed the role 
of SLAMF1 receptor in the infection with the different strains of T. cruzi, using first the macrophage 
model. In this case we used as controls BALB/c peritoneal macrophages because the SLAMF1 
deficiency is in this mouse genetic background. 
4.3.1 Kinetics of BALB/c and Slamf1-/- Peritoneal Macrophage Infection with Different Strains of T. 
cruzi.  
 
We first determined the parasite load of infection in Slamf1-/- and BALB/c peritoneal macrophages. 
We compared the rate of infection between Slamf1-/- and BALB/c peritoneal macrophages infected 
with the T. cruzi strains, measuring the parasite load in the three phases, as described before.  
 
Figure 22 shows the kinetic of the parasite load in peritoneal macrophages. In general, we found 
that Slamf1-/- macrophages presented lower parasite load than BALB/c macrophages for all the 
strains, except for VFRA cl1, that showed the opposite  values and higher parasite load. In addition, 
we found higher parasite load in both strains compared with C57BL/6 mice (Figure 11).  
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Figure 22.  Kinetics of parasite load in Slamf1-/- and BALB/c - peritoneal macrophages. Kinetic analysis of 
parasite load of BALB/c and Slamf1-/- peritoneal macrophages at 1 h, 6 h and 24 h after infection with parasite 
strains of different DTUs. Parasite load was quantified by qPCR. Mean and Standard error of the mean ± (SEM) 
in two independent experiments are represented.  The asterisks indicate the statistical significance, t-student 
(*p<0.05, **p<0.005 and ***p<0.001), between BALB/c and Slamf1-/- macrophages. 
 
4.3.2 Role of SLAMF1 Receptor in the different Phases of Macrophage Infection with Different 
Strains of T. cruzi. 
 
To further evaluate the effect of SLAMF1 receptor in T. cruzi strain infectivity, we first normalized 
parasite load of Slamf1-/- infected peritoneal macrophages in different phases by dividing Slamf1-/- 
parasite load by BALB/c parasite load. Figure 21 A shows normalized parasite load at 1 h.p.i. Parasite 
load during the internalization phase at 6 h.p.i. was normalized respect normalized level at the 
interaction phase (Figure 21 B). Finally, intracellular proliferation at 24 h.p.i. was normalized respect 
the internalization phase normalized level (Figure 21 C). We found that Slamf1 receptor is required 
for the interaction and internalization. Thus Slamf1 facilitates Dm28c, Y, 10R26 and Bug2148 cl1 
strains entry, but might be blocking it in the case of M6421 cl6 and VFRA cl1 strains. The intracellular 
proliferation was lower for all strains in Slamf1-/- macrophages compared to BALB/c, except for VFRA 
cl1, suggesting an inhibitory role of Slamf1 in all phases of the infection with those strains.  
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Figure 23. Effect of SLAMF1 deficiency on parasite load of peritoneal macrophages respect BALB/c. Dashed 
lines correspond to normalized BALB/c parasite load (equal to 1 for all parasite strains). Gray boxes correspond 
to normalized values of Slamf1-/- macrophages at each stage of infection. A. Interaction at 1 h.p.i. B. 
Internalization at 6 h.p.i. C. Replication at 24 h.p.i. 
 
4.3.3 Expression of Immunoregulatory Genes in BALB/c and Slamf1-/- Macrophages Infected with 
Different Strains of T. cruzi.  
 
Table 14 is a summary of the gene expression of the 3 enzymes, 4 cytokines, 2 receptor and the 
parasite load of Slamf1-/- and BALB/c macrophages infected with the different strains of T. cruzi. We 
could not find a defined pattern in this case.  
Table 14. Summary of expression of immunoregulatory genes and parasite load in BALB/c and Slamf1-/- 
peritoneal macrophages infected with different strains of T. cruzi. Gene expression was determined by RT-
qPCR and RQ value were obtained after normalizing value from infected respect to no-infected macrophages. 
Results are shown in Figure S  9 (Enzymes), Figure S  10 (Cytokines) and Figure S  11 (Receptors). Parasite load 
(T.cruzi) correspond to value from Figure 22. For each gene and parasite load a color code was given from high 
(Red) to low (Green). 
 
We performed a discriminant analysis of principal components to further determine the role of 
SLAMF1 in the activation of macrophages infected with different strains of T. cruzi.  The analysis was 
performed with the panel of gene expression of the 3 enzymes, 4 cytokines and the parasite load in 
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the model of infection in peritoneal macrophages with T. cruzi in the three different phases 
evaluated. 
 
Figure 24. Discriminant Analysis of Principal Components (DAPC). These scatterplots show the first two 
principal components of the DAPC of gene expression and parasite load data according to the three different 
phases of the macrophage infection with the different T. cruzi strains. A. Interaction at 1h B. Internalization at 
6h C. Intracellular proliferation at 24h. The diagrams show clusters of BALB/c peritoneal macrophages infected 
with the different strains of T. cruzi (Black dashed line) and Slamf1 -/-(Gray dashed line).  
 
In this study BALB/c and Slamf1-/- macrophages presented lower discrimination between groups 
than in C57BL6 and Tlr2-/-(Figure 18). The DAPC at 1 h.p.i. analysis was able to discriminate 85.3% in 
our model, which 77.5% and 7.8% are explained in first (x-axis) and second (y-axis) principal 
components, respectively. We found 3 clusters: one for infection in Slamf1-/- with al strains of T. 
cruzi and NI, another for the BALB/c infection with Dm28c and another one for the infection of 
BALB/c macrophages with the rest strains (Figure 24 A). The percent of the discrimination is on 
Table 15. This likely reflects the influence of SLAMF1 in the attachment of the parasites of different 
strains as well as the higher interaction of DM28c with BALB/c already mentioned. 
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Table 15. Discriminant frequencies in the interaction in Slamf1-/- and BALB/c peritoneal macrophages 
infected with different strains of T. cruzi. 
 
The DAPC analysis at 6 h.p.i. was able to discriminate 87.5% in our model, which 66% and 21.6% are 
explained in first (x-axis) and second (y-axis) principal components, respectively (Figure 24 B). We 
found 3 clusters, one for the infection of Slamf1-/- macrophages with 10R26, another for the BALB/c 
macrophages infected with Dm28c and 10R26 and finally the last one for the other infected and 
non-infected. The percent of the discrimination is shown in Table 16. 
Table 16. Discriminant frequencies in the internalization in Slamf1-/- and BALB/c peritoneal macrophages 
infected with different strains of T. cruzi. 
 
The DAPC analysis at 24 h.p.i. was able to discriminate 95% in our model, which 83.9% and 11.1% 
are explained in first (x-axis) and second (y-axis) principal components, respectively (Figure 24 C). 
Three different clusters were found, one for the BALB/c macrophages infected with Dm28c, other 
for the infection of Slamf1-/- macrophages with VFRA and one for the rest of the infected and non-
infected. The percent of the discrimination is shown in Table 17. 
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Table 17. Discriminant frequencies in the intracellular proliferation in Slamf1-/- and BALB/c peritoneal 
macrophages infected with different strains of T. cruzi. 
 
4.3.4 Correlation Networks 
 
We performed a network correlation analysis, where we included gene expression of the 
immunoregulatory genes, as well as the receptor expression (Slamf1 and Tlr2) and the parasite load. 
As in the summary of gene expression we found different patterns of positive or negative 
correlations depending of the macrophage infection with the different strains of T. cruzi using 
Cytoscape. Changes, appearance and disappearance in the correlations between BALB/c and Slamf1-
/- on each phase evaluated indicate the role of SLAMF1 receptor in the infection with the different 
strains of T. cruzi are detailed in the appendix section 8 (Interaction in Table S 8, Internalization in 
Table S 9 and Intracellular proliferation in Table S 10). 
As mentioned before, using the different strains of T.cruzi as central nodes, during the interaction 
phase BALB/c the resulting network was composed of 24 secondary nodes and 49 edges (Figure 25 
A). On the other hand, Slamf1-/- was composed of 27 secondary nodes and 50 edges (Figure 25 B), 
with 6 as the maximum degree of connectivity of a node and 1 as the minimum. At 1 h.p.i BALB/c 
macrophage network showed an aggrupation between the Dm28c, Y and VFRA cl1, while in Slamf1-/- 
macrophages the cluster was between the strains Y, M6421 cl6 and 10R26. The strain VFRA cl1 in 
the network of Slamf1-/- was apart from the other strains, likely associated to the very different 
pattern of this strain where the deficiency of SLAMF1 incremented the parasite load in 
macrophages. The negative correlation in the Slamf1-/- infected with the strain Y could be associated 
with the resistant profile in the in vivo experiments, efficiently activating macrophages for the 
control of the infection. 
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Figure 25. Networks of the macrophage activation during the interaction phase with the different strains of 
T.cruzi. A. BALB/c macrophages. B. Slamf1-/- macrophages. Networks were generated and represented as 
indicated in the Methods section.  
The resulting networks during the internalization in BALB/c macrophages was composed of 18 
secondary nodes and 28 edges (Figure 26 A) whereas Slamf1-/- was composed of 16 secondary nodes 
and 22 edges (Figure 26 B), with 6 as the maximum degree of connectivity of a node and 1 as the 
minimum. Interestingly, the pattern of the node was very different depending of SLAMF1 deficiency. 
Thus, Slamf1-/- macrophages infected with the strain Y present many more edges than the rest. On 
the other hand, the strain 10R26 is separated in the network. Interestingly, at this phase was when 
this strain presented higher amount of ROS, as can be observed in Figure 29. 
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Figure 26. Networks of the macrophage activation during the internalization phase with the different strains 
of T.cruzi. A. BALB/c macrophages. B. Slamf1-/- macrophages.  Networks were generated and represented as 
indicated in the Methods section.  
Finally, in the intracellular proliferation BALB/c resulting network was composed of 14 secondary 
nodes and 20 edges (Figure 27 A) whereas Slamf1-/- was again different and composed of 14 
secondary node and 18 edges (Figure 27 B), with 6 as the maximum degree of connectivity of a node 
and 1 as the minimum.  The network in Slamf1-/- shows the Dm28c and M6421 cl6 separated from 
the other strains, and few common correlations between the strains, indicating a highly variable 
effort of SLAMF1 deficiency in T. cruzi intracellular proliferation depending on the infecting strain, as 
also indicated in Table 14. 
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Figure 27. Networks of the macrophage activation during the intracellular proliferation phase with the 
different strains of T.cruzi. A. BALB/c macrophages. B. Slamf1-/- macrophages.  Networks were generated and 
represented as indicated in the Methods section.  
4.3.5 SLAMF1 regulates NOX and ROS 
 
SLAMF1 induces production of PI3P, which positively regulates the activity of the NOX2 enzyme and 
phagolysosomal maturation. Higher mounts of ROS and NOX2 could explain why the Slamf1-/- 
macrophages are less susceptible to the infection by T. cruzi. So, next we analyzed NOX2 expression 
at 6 h.p.i., taken as the end-point of internalization, and compared it with ROS production. 
As already shown, NOX2 gene expression was higher in Slamf1-/-macrophages with all strains of T. 
cruzi except for VFRA cl1 which present the opposite results (Figure 28). Next, we evaluated the 
amounts of ROS in the cells by a cytofluorometry assay (Figure 29). 
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Figure 28. Gene expression of NOX2 in Slamf1-/- and BALB/c peritoneal macrophages infected of different 
parasite strains at 6 h.p.i. Standard error of the mean ± (SEM) are represented.  The asterisks indicate the 
statistical significance, t-student (*p<0.05 and **p<0.005), between BALB/c and Slamf1-/- macrophages. 
In agreement with NOX2 gene expression, we found the lowest ROS production in the Slamf1-/- 
macrophages infected with VFRA cl1, suggesting an association between parasite load, and the 
production of ROS and NOX2 gene expression. Higher production of ROS and NOX2 gene expression 
is associated with lower parasite loads, which indicates that ROS and NOX2 production help to the 
elimination of the parasite in macrophages. 
 
Figure 29. Reactive Oxygen Species in Slamf1-/- and BALB/c peritoneal macrophages infected of different 
parasite strains at 6 h.p.i. The diagrams show Non-infected BALB/c macrophages (Red line), Non-infected 
Slamf1-/-(Blue line), BALB/c infected with the different strains of T. cruzi (Green line) and Slamf1-/-(Purple line). 
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4.4 IN VIVO INFECTION 
 
BALB/c and Slamf1-/- mice were infected with three of the six different strains of T. cruzi that showed 
the most divergent effects in vitro in infecting macrophages, detailed below.  
The Dm28c strain had been previously described not causing parasitemia in infected BALB/c and 
C57BL/6 mice (de Melo Medeiros et al., 2010), but  it caused the highest parasite load in BALB/c 
peritoneal macrophages in our in vitro experiments. 
The Y strain that caused a peak of parasitemia between the 7-11 d.p.i and multiple experiments in 
BALB/c mice infected that demonstrated it is highly lethal in this model where just 30-40% of the 
mice survive the first 21 d.p.i. with high (2000 parasite/mouse) and low (50 parasite/mouse) 
inoculums of T. cruzi (Sanoja et al., 2013) . In addition, previous studies in our lab demonstrated that 
Slamf1-/- mice infected with this strain are resistant to the infection (Calderón et al., 2012). 
The VFRA cl1 strain presents a late peak of parasitemia compared with the Y and had been 
demonstrated to produce a mild infection, where all the BALB/c mice survive to the infection but 
presenting cardiac pathology (Rodriguez et al., 2014). Also, in vitro VFRA cl 1 presented higher 
parasite load in the absence of SLAMF1 at all infection phases (1, 6 and 24 h.p.i.), suggesting that the 
receptor is somehow detrimental for parasite infection. 
4.4.1 Parasitemias.  
 
As previously described, 30% of BALB/c mice succumbed to infection with the Y strain, while Slamf1-
/- mice showed 100% survival. Infection with Dm28c and VFRA cl1 strains did not cause mortality in 
BALB/c neither Slamf1-/- mice (data not shown). BALB/c and Slamf1-/- infected with the Y strain 
presented a first peak of parasitemia at 9 d.p.i, but the parasitemia was lower in the Slamf1-/- (Figure 
30A). We did not find any detectable parasitemia of Dm28c in BALB/c and neither in Slamf1-/- mice. 
Finally, the BALB/c and Slamf1-/- infected with the VFRA cl1 strain  presented similar amounts of 
parasites in blood and a late peak of parasitemia at 14-16 d.p.i compared with the infection with the 
Y strain (Figure 30 B). 
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Figure 30. Time course of T. cruzi infection in Slamf1-/- mice and BALB/c. A. Survival was monitored from 0 to 
21 d.p.i. Only the Y strain caused the death of BALB/c mice. B. Parasitemia was monitored every 2 or 3 days  
from 0 to 21 d.p.i.; Mean parasitemias of 5 mice per group infected with Dm28c, Y and VFRA cl1 strains is 
shown.  
 
4.4.2 SPLEEN 
 
Next, we analyzed the effect of T. cruzi infection in several of the most important organs spleen, 
heart and liver to better understand the outcome of the infection.  T. cruzi infection promotes 
splenomegaly in mice and humans. Splenocytes are important cells involved in the host immune 
response since splenectomy prior to infection increases susceptibility to infection, as ascertained by 
the numbers of circulating parasites (de Meis et al., 2009). In addition, splenomegaly is related to 
increased formation of granulocytes (Goni et al., 2002) and MDSCs (Gonzalez, 2014), with 
suppressor activities and also able to produce NO to fight the infection.   
4.4.2.1 Splenomegaly and Parasite Load  
 
In order to evaluate the splenomegaly we weigh sacrificed mice (g) and spleens (mg) and calculated 
the spleen weight/body weight ratio at 14 and 21 d.p.i. We found significantly higher splenomegaly 
indexes in BALB/c and Slamf1-/- mice infected with all the strains evaluated at 14 d.p.i. compared 
with their respective non-infected controls (NI) (Figure 31 A). Interestingly, in BALB/c mice 
splenomegaly was significantly higher than in Slamf1-/- mice infected with all strains, except for the 
infection with Y at 21 d.p.i. (Figure 31 A and B). Spleen parasite load was lower, for Dm28c and Y 
although did not reach significant difference in Slamf1-/- spleen than in BALB/c infected spleens, 
strains and both times of infection (Figure 31 C and D). In contrast, in VFRA cl1 infection parasite 
levels in spleen were either identical or slightly higher, but again did not reach statistical 
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significance. Interestingly, we found an overall Spearman correlation of 0.6572 with a significance of 
P< 0.0001 between the splenomegaly and parasite load. 
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Figure 31. Splenomegaly and parasite load in spleen of BALB/c and Slamf1-/- mice infected with the different 
strains. A. Splenomegaly at 14 d.p.i. B. Splenomegaly at 21 d.p.i. C. Parasite load at 14 d.p.i. D. Parasite load at 
21 d.p.i. Means and Standard errors of the means ± (SEM) of 5 mice per group are represented. The asterisks 
indicate the statistical significance, t-student (*p<0.05, **p<0.005 and ***p<0.001), when comparing BALB/c 
and Slamf1-/- infected mice. 
 
4.4.2.2 Spleen Gene expression 
 
We next analyzed the same immunoregulatory enzymes and cytokines genes evaluated in the 
macrophage model. Table 18 summarizes the gene expression of Irg1, Cybb, Il1b, Il6, Il10 and Tnf.   
Table 18 shows the great diversity in the gene expression in the infected BALB/c mice. Thus, in 
spleens from Dm28c infected mice gene expression was higher at 14 d.p.i., being infection reduced 
at 21 d.p.i. In contrast, in Y and VFRA cl1 infections gene expression increased at 14 d.p.i. that was 
maintained at 21 d.p.i. For VFRA cl1 in BALB/c mice at 14 d.p.i., there was higher levels Irg1, Il6 and 
Il10 than in infections with the other parasite strains. However, Slamf1-/-mice showed increased 
expression of Irg1, Cybb, Il6 and Tnf respect to BALB/c mice infected with Dm28c, and also, but 
lower, with the Y strain. 
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Table 18. Summary of expression by of immunoregulatory genes and parasite load in spleen of BALB/c and 
Slamf1-/- mice infected with different strains of T. cruzi. Gene expression was determined by RT-qPCR and RQ 
value were obtained after normalizing value from infected respect to no-infected spleens. Results are shown in 
Figure S  12 (Enzymes) and Figure S  13(Cytokines).  Parasite loads (T. cruzi) correspond to values from Figure 
31. For each gene and parasite load a color code was given from high (Red) to low (Green). 
 
The analysis of discriminant of principal components was performed with the gene expression of the 
2 enzymes, 4 cytokines and the parasite load at 14 and 21 d.p.i. The DAPC analysis of spleen at 14 
d.p.i. was able to discriminate 99.7% in our model, which 81.7% and 17.9% are explained in first (x-
axis) and second (y-axis) principal components, respectively. We found at 14 d.p.i. that infections 
with Dm28c in BALB/c and Slamf1-/- mice are more separated in the DAPC from the other infections 
(Y and VFRA cl1) and the non-infected controls. This is because of the earlier peak of the gene 
expression observed with this strain. 
 
Figure 32. Discriminant Analysis of Principal Components (DAPC). These scatterplots show the first two 
principal components of the DAPC of data according to the spleens infected with the different T. cruzi strains. 
A. 14d.p.i. B. 21 d.p.i. The diagrams show clusters of with the different strains of T. cruzi Dm28c (Blue dashed 
line) and Y (Red dashed line).   
Table 19 shows 100% discrimination in all the cases except for BALB/c infected with VFRA cl1 strain. 
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Table 19. Discriminant frequencies in spleens of Slamf1-/- and BALB/c mice infected with different strains of 
T. cruzi at 14 d.p.i. 
 
The DAPC analysis of spleen at 21 d.p.i. was able to discriminate 99.8% in our model, in which 97.1% 
and 2.7% are explained in first (x-axis) and second (y-axis) principal components, respectively. We 
found that infections with Y in BALB/c and Slamf1-/- mice are more separated in the DAPC compared 
with the other infections and the controls associated with the very high gene expression observed 
with this strain at this time point. The percent of discrimination in Table 20, shows again 100% 
discrimination in all cases except for BALB/c spleens infected with VFRA cl1. 
Table 20. Discriminant frequencies in spleens of Slamf1-/- and BALB/c mice infected with different strains of 
T. cruzi at 21 d.p.i. 
 
4.4.2.3 Spleen Correlation Networks 
 
We identified different networks with the correlations between gene expression of the 
immunoregulatory genes and the parasite load in the analysis of the BALB/c and Slamf1-/-spleens at 
14 and 21dp.i. Using the Cytoscape software, we visualized the correlations between the strains 
shown in the appendix section 8 (Table S 11 and Table S 12) and compared the obtained networks 
between the BALB/c and the Slamf1-/-. Appearance and disappearance of the correlations between 
BALB/c and Slamf1-/- spleen at the different days of sacrifice indicate the differential role of SLAMF1 
receptor in the infection with the different strains of T. cruzi. Statistical significance of the 
correlations are shown in the appendix section 8 (Table S 13 and Table S 14). 
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Figure 33. Networks of the spleen of BALB/c and Slamf1-/-mice. A. BALB/c spleen at 14 d.p.i. B. Slamf1-/ spleen 
at 14 d.p.i. Networks were generated and represented as indicated in the Methods section. 
Using the different strains of T. cruzi as central nodes, in the spleens of BALB/c mice infected with 
the different strains the resulting network was composed of 15 secondary nodes and 20 edges 
(Figure 33 A) whereas Slamf1-/- infection network was composed of 15 secondary nodes and 41 
edges (Figure 33 B), with 3 as the maximum degree of connectivity of a node and 1 as the minimum.  
We found more correlations in BALB/c spleen of mice infected with the VFRA cl1 strain than with 
Dm28c and Y, and several of those correlations were exclusive of VFRA cl1 strain. Interestingly, the 
interactions shared between the strains always contain the Irg1 gene, Y strain contains only negative 
correlations while Dm28c had only positive correlation indicating a different immune response in 
the spleen for each strain. In contrast, almost all correlations in the Slamf1-/- were shared between 
all the strains evaluated, and only the correlation between Il1b-Il10 was exclusive for the infection 
with VFRA cl1 where and two other correlations were shared for only two of the strains evaluated. 
This could be indicative of the importance of SLAMF1 receptor in generating variability in BALB/c 
mice immune response upon infection with different strains. As in BALB/c network Dm28c 
presented only positive correlations while the strains Y and VFRA cl1 presented positive and 
negative correlations.  
At 21 d.p.i the network was composed of 15 secondary nodes and 30 edges (Figure 34 A) and 
Slamf1-/- was composed of 15 secondary nodes and 42 edges (Figure 34 B), with 3 as the maximum 
degree of connectivity of a node and 1 as the minimum. 
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Figure 34. Networks of the spleen of BALB/c and Slamf1-/-mice. A. BALB/c spleen at 21 d.p.i. B. Slamf1-/ spleen 
at 21 d.p.i. Networks were generated and represented as indicated in the Methods section. 
We found at 21 d.p.i. more correlations between Y and VFRA cl1 than at 14 d.p.i, in which several 
correlations that were exclusive of VFRA cl1 shows are now common with the strain Y. Only one 
correlation was VFRA cl1 strain exclusive, moreover, was the only strain at this day with negative 
correlations. The infection with the Dm28c shared just one positive correlation with the other 
strains. However, in Slamf1-/- spleens the correlations were common in almost all cases among the 
three different strains and only three correlations were shared by two strains (Dm28c and Y). In 
contrast, the Y strains presented some negative correlations in comparison with the infection with 
BALB/c infection where the correlations were only positive. 
4.4.2.4 Spleen Protein expression 
 
The proteins COX-2, NOX2, iNOS and Arg-1 play an important role in parasite elimination after the 
infection. We evaluated the expression of these proteins in the samples of BALB/c and Slamf1-/- T. 
cruzi spleens infected with the Dm28c, Y and VFRA cl1 at 14 and 21 d.p.i. and the NI controls (Figure 
35).  
Surprisingly, iNOS protein in the spleen was not detected in any case. Only BALB/c mice infected 
with Y expressed Arg-1 at 14 d.p.i. indicating that Slamf1-/- receptor is implicated on the detection of 
this enzyme in the spleen. COX-2 levels were higher at 14 d.p.i. being higher in the mice infected 
with Y than the others 2 strains and more expressed in Slamf1-/- mice. NOX2 was induced at 14 d.p.i. 
in all conditions being higher in Slamf1-/- spleens of mice infected with VFRA cl1. At 21 higher 
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expression of NOX2 was observed in all conditions except for BALB/c and Slamf1-/- mice infected 
with the Y strain, in which slights decreased compared to 14 d.p.i. 
 
Figure 35. Protein Expression level in Spleen of BALB/c and Slamf1-/- mice infected with Different Strains of T. 
cruzi. Expression levels of iNOS, Arg-1, COX-2 and NOX2 at 14 and 21 d.p.i. and their respective controls. 
Ponceau staining is shown as a loading control. 
4.4.3 HEART 
 
4.4.3.1 Heart Hypertrophy and Parasite Load  
 
The heart is one of the most important organs affected by T. cruzi infection in humans. We 
evaluated the hypertrophy in the heart, by weighting the heart of the sacrificed animals (mg) at 14 
and 21 d.p.i. and dividing it by the body weight (g) to calculate the heart weight/body weight ratio 
(Figure 36 A and B).  
 
We observed a higher hypertrophy, although not significant, in Y and VFRA cl1 infected BALB/c mice. 
In contrast, we observed significant increment of heart weight/body weight ratio in Slamf1-/- mice 
infected with Dm28c and VFRA cl1 at 14 d.p.i. and with Y and VFRA at 21 d.p.i. compared to NI 
infected Slamf1-/-. Regarding parasite load, the Y strain was the most infective, followed by VFRA cl1 
and finally Dm28c (Figure 36 A and B). Slamf1-/- mice showed lower parasite load than the wild type 
in the cases of Dm28c and Y, but not for VFRA cl1 where the parasite load was higher in the 
knockout than the wild type. This result is in concordance with what we found in vitro, where 
Slamf1-/- deficient macrophages showed less parasite load than BALB/c in Dm28c and Y but not in 
VFRA cl1. In addition we found that heart hypertrophy seems to be associated with the actual 
parasite load, where the higher parasite load resulted in an overall higher heart weight/body weight 
ratio with a Spearman correlation of 0.6793 and a significance of p<0.001. 
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Figure 36. Heart hypertrophy and parasite load in BALB/c and Slamf1-/- mice infected with the different 
strains of T. cruzi at 14 and 21 d.p.i. A. Hypertrophy at 14 d.p.i B. Hypertrophy at 21 d.p.i. C. Parasite load at 
14 d.p.i. and D. Parasite load at 21d.p.i. Means and Standard errors of the means ± (SEM) of 5 mice per group 
are represented. The asterisks indicate the statistical significance, t-student (*p<0.05, **p<0.005 and 
***p<0.001), when comparing the infected BALB/c and Slamf1-/- mice. 
4.4.3.2 Heart Gene Expression 
 
Table 21 presents a summary of the gene expression of the enzyme and cytokines evaluated. We 
found a peak of activation at 14 d.pi. in BALB/c and Slamf1-/- mice infected with the Y indicating that 
this strain would cause, more cardiac damage compared to the Dm28c and VFRA cl1. This activation 
is also associated with the higher hypertrophy and higher parasite loads found in the hearts of the 
mice infected with this strain. 
Table 21. Summary of expression of immunoregulatory genes and parasite load in heart of BALB/c and 
Slamf1-/- mice infected with different strains of T. cruzi. Gene expression was determined by RT-qPCR and RQ 
value were obtained after normalizing value from infected respect to no-infected hearts. Results are shown in 
Figure S  14 (Enzymes) and Figure S  15 (cytokines). Parasite load (T.cruzi) corresponds to value from Figure 35. 
For each gene and parasite load a color code was given from high (Red) to low (Green). 
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The analysis of discriminant of principal components was performed with the gene expression of the 
3 enzymes, 4 cytokines and the parasite load at 14 and 21 d.p.i. 
 
Figure 37. Discriminant Analisis of Principal Components (DAPC). These scatterplots show the first two 
principal components of the DAPC of data according to the hearts infected with the different T. cruzi strains. 
A. 14 d.p.i. B. 21 d.p.i. The diagrams show clusters of with the different strains of T. cruzi Dm28c (Blue dashed 
line), Y (Red dashed line) and VFRA (Green dashed line). 
The DAPC analysis in Heart at 14 d.p.i. was able to discriminate 99.2% in our model, which 54.2% 
and 45% are explained in first (x-axis) and second (y-axis) principal components, respectively. We 
found at 14 d.p.i. that infections with Y in BALB/c and Slamf1-/- mice are more separated in the DAPC 
compared with the other infections and the controls, that is because  of the high gene expression 
and the higher parasitemia found in the heart with the Y strain. Table 22 shows that discrimination 
was 100% in all cases. 
Table 22. Discriminant frequencies in hearts of Slamf1-/- and BALB/c mice infected with different strains of T. 
cruzi at 14 d.p.i. 
 
The DAPC analysis in the hearts at 21 d.p.i. was able to discriminate 91.7% in our model, which 
53.8% and 37.9% are explained in first (x-axis) and second (y-axis) principal components, 
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respectively. We found three different clusters associated with the strains of T. cruzi. Table 23 shows 
that discrimination was 100% for all strain, except for BALB/c heart infected with Y strain. 
Table 23. Discriminant frequencies in hearts of Slamf1-/- and BALB/c mice infected with different strains of T. 
cruzi at 21 d.p.i. 
 
4.4.3.3 Heart Correlation Networks 
 
We draw a network with the correlations of the gene expression of the immunoregulatory genes 
and the parasite loads in hearts of BALB/c and Slamf1-/-infected with the different strains of T. cruzi. 
All the correlations found at 14 d.p.i. were positive and with a significance of p<0.001. Using the 
Cytoscape software we visualized the correlation between the strains and compared the resulting 
BALB/c and the Slamf1-/- networks. Appearance and disappearance in the correlations between 
BALB/c and Slamf1-/- at the different days post-infection indicate the role of Slamf1 receptor in the 
infection with the different strains of T. cruzi. Statistical significance of the correlations are shown in 
the appendix section 8 (Table S 13 and Table S 14). 
The resulting network at 14 d.p.i. was composed of 21 secondary nodes and 56 edges (Figure 38 A) 
and Slamf1-/- was composed of 21 secondary nodes and 52 edges (Figure 38 B), with 3 as the 
maximum degree of connectivity of a node and 1 as the minimum and the different strains of T. 
cruzi were used as central nodes.  
We found several correlations between the three parasite strains in BALB/c hearts of mice at 14 
d.p.i., being the rest of the correlations only common between the Dm28c and VFRA cl1 strains. In 
the Slamf1-/- hearts of mice also several correlations were common between the three strains but 
correlation between Dm28c and Y, and Y with VFRA cl1 were found. In the Slamf1-/- hearts of mice 
infected with the Dm28c and VFRA cl 1 strains we found exclusive correlations. 
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Figure 38. Networks of the hearts of BALB/c and Slamf1-/-mice. A. BALB/c hearts at 14 d.p.i. B. Slamf1-/- mice 
at 14 d.p.i. Networks were generated and represented as indicated in the Methods section. 
At 21 d.p.i., the hearts of BALB/c mice infected with the different strains of T. cruzi presented a 
network composed of 21 secondary nodes and 58 edges (Figure 39 A) whereas in Slamf1-/- it was 
composed of 21 secondary nodes and 42 edges (Figure 39 B).  
 
Figure 39. Networks of the hearts of BALB/c and Slamf1-/-mice. A. BALB/c hearts at 21 d.p.i. B. Slamf1-/- mice 
at 21 d.p.i. Networks were generated and represented as indicated in the Methods section. 
Correlations in BALB/c hearts of mice infected with the different parasite strains were mostly 
common between the three strains. In this case several common correlations between the strains Y 
and Dm28c were also found, two negatives for both strains, one positive for both also and one 
positive for Y but no for Dm28c. In contrast in Slamf1-/- hearts of mice the common correlation were 
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mostly between Dm28c and VFRA cl1, and only one positive correlation between Arg1-Irg1 where 
found in the infection with Y strain that was common with the others strains. Besides, a strain 
exclusive positive correlation was found in the case of Dm28c.  
4.4.3.4 Heart Protein Expression 
 
We evaluated the same proteins as in the spleen (iNOS, NOX2, COX-2 and Arg-1) in the heart and in 
addition YAP-1, an indicator of cardiomyocyte proliferation (Figure 40). iNOS expression was higher 
in the heart of mice infected with Y, and in the absence of SLAMF1 there was a decrease in their 
expression at 21 d.p.i. compared with BALB/c. Similar results on iNOS expression were observed 
when infected with VFRA cl1 although the expression was much lower. Finally, there was slight 
increase in iNOS expression with the Dm28c that was similar in both BALB/c and Slamf1-/-mice. 
Interestingly, in hearts of mice infected with Y strain there were higher levels of iNOS, Arg-1 and 
COX-2 than in the ones infected with Dm28c and VFRA cl1, also indicative of a more aggressive 
infection. Moreover SLAMF1 deficiency lowered iNOS levels while it further increased Arg-1 and 
COX-2 in Y strain infected hearts. 
The NOX2 expression was much higher at 14 d.p.i. in the hearts of mice infected with Y strain 
compared with Dm28c and VFRA cl1, where the increment were at 21 d.p.i.  
 YAP-1 expression was higher in hearths of BALB/c mice infected with Y strain, follow by VFRA cl1 
and the lowest in Dm28c correlating with the hypertrophy values. Interesting, SLAMF1 deficiency 
resulted in a diminished expression. 
 
Figure 40. Protein Expression level in heart of BALB/c and Slamf1-/- mice infected with Different Strains of T. 
cruzi. Expression levels of iNOS, Arg-1, COX-2, NOX2 and YAP-1 at 14 and 21 d.p.i. and their respective controls. 
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4.4.4 LIVER 
4.4.4.1 Hepatomegaly and Parasite Load  
 
In the case of the liver we evaluated the hepatomegaly generated by T. cruzi. We weighted the liver 
of the sacrificed animals to evaluate the hepatomegaly at 14 and 21 d.p.i. and dividing the liver 
weight (mg) by the body weight (g) to calculate the liver weight/body weight ratio.  
Hepatomegaly was induced by infection with the 3 strains in a similar fashion (Figure 41 A and B). 
We found higher hepatomegaly in BALB/c compared with Slamf1-/- mice for all strains. As in the 
spleen, but in contrast to heart hypertrophy, ǁe didŶ͛t fiŶd a ĐoƌƌelatioŶ ďetǁeeŶ the paƌasite load 
(Figure 41 C and D) and hepatomegaly, with Spearman correlation of 0.3165 and significance of 
p<0.005. Dm28c and Y in BALB/c mice present similar hepatomegaly but the parasite load is lower in 
Dm28c compared with Y or VFRA cl1.  Interestingly, livers infected with VFRA cl1 presented higher 
parasite load in the Slamf1-/- than BALB/c mice, indicating that SLAMF1 may help to control the 
infection in the liver. 
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Figure 41. Hepatomegaly and parasite load of BALB/c and Slamf1-/- mice infected with the different strains 
of T. cruzi at 14 and 21 d.p.i. A. Hepatomegaly at 14d.p.i B. Hepatomegaly at 21d.p.i. C. Parasite load at 14 
d.p.i and D. Parasite load at 21d.p.i. Means and Standard errors of the means ± (SEM) of 5 mice per group are 
represented. The asterisks indicate the statistical significance, t-student (*p<0.05, **p<0.005 and ***p<0.001), 
when comparing the infected BALB/c and Slamf1-/- mice. 
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4.4.4.2 Liver Gene Expression 
 
The summary of the gene expression of the enzymes, cytokines and parasite load is presented in 
Table 24. We found an overexpression for almost all genes evaluated at 14 d.p.i. that decreased at 
21 d.p.i. in BALB/c. A similar global pattern was found in Slamf1-/- livers of infected mice despite 
there was lower parasite load. However, some genes as Il6 had higher expression in Slamf1-/- at 14 
d.p.i., except for Dm28c. 
Table 24. Summary of expression of immunoregulatory genes and parasite load in liver of BALB/c and 
Slamf1-/- mice infected with different strains of T. cruzi. Gene expression was determined by RT-qPCR and RQ 
value were obtained after normalizing value from infected respect to no-infected livers. Results are shown in 
Figure S  16 (Enzymes) and Figure S  17 (Cytokines).  Parasite loads (T.cruzi) correspond to value from Figure 41. 
For each gene and parasite load a color code was given from high (Red) to low (Green). 
 
The analysis of discriminant of principal components was performed with the gene expression of the 
2 enzymes, 4 cytokines and the parasite load at 14 and 21 d.p.i. 
 
Figure 42. Discriminant Analyze of Principal Components (DAPC). These scatterplots show the first two 
principal components of the DAPC of data according to the livers infected with the different T. cruzi strains. A. 
14d.p.i. B. 21 d.p.i. The diagrams show clusters of with the different strains of T. cruzi Dm28c (Blue dashed 
line), Y (Red dashed line) and VFRA (Green dashed line). 
The DAPC analysis in the livers at 14 d.p.i. was able to discriminate 99.7% in our model, which 71% 
and 28.7% are explained in first (x-axis) and second (y-axis) principal components. We found 5 
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different clusters: One for the infection with the Dm28c in BALB/c and Slamf1-/- mice indicative of 
similar response in both groups, other two clusters for the infections with Y one for infection in 
BALB/c and the other in Slamf1-/- mice, and the last two cluster with the infections of the VFRA cl1, 
one for infection in BALB/c and the other Slamf1-/- mice. This suspect that SLAMF1 deficiency affect 
liver response more in Y and VFRA cl1 than in Dm28c. The percent of discrimination is on Table 25 
shows that discrimination was 100% in all cases. 
Table 25. Discriminant frequencies in livers of Slamf1-/- and BALB/c mice infected with different strains of T. 
cruzi at 14 d.p.i. 
 
The DAPC analysis in the livers at 21 d.p.i. was able to discriminate 84.8% in our model, which 54.5% 
and 30.3% are explained in first (x-axis) and second (y-axis) principal components. We found 4 
different clusters in this case. One for BALB/c and Slamf1-/- mice with Dm28c, the Slamf1-/- mice 
infected with the Y and the NI mice; the second one is the cluster infected with Y in BALB/c mice, 
and the last two clusters include the infections with the VFRA cl1, one for infection in BALB/c and 
the other in Slamf1-/- mice.  The percent of discrimination is on Table 26 shows that discrimination 
was 100% in all cases, except for the infections in Slamf1-/- infected with Dm28c and Y strains. 
Table 26. Discriminant frequencies in livers of Slamf1-/- and BALB/c mice infected with different strains of T. 
cruzi at 14 d.p.i. 
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4.4.4.3 Liver Correlations Network 
 
As in the other organs evaluated, we generated a network with the correlations of the gene 
expression of the immunoregulatory genes and the parasite load in the livers of BALB/c and Slamf1-/-
infected with the different strains of T. cruzi. All the correlations found at 14 d.p.i. were positive and 
with a significance of p<0.001. Using the software Cytoscape we visualized the correlations between 
the strains and compared the networks of BALB/c and the Slamf1-/-. Appearance and disappearance 
in the correlations between BALB/c and Slamf1-/- livers at the different days of sacrificed indicate the 
role of SLAMF1 receptor in the infection with the different strains of T. cruzi are explained in the 
appendix section 8 (Table S 15 and Table S 16). 
 
We found in the livers of BALB/c mice infected with the different strains of T. cruzi and sacrificed at 
14 d.p.i. that the resulting network was composed of 15 secondary nodes and 29 edges (A) and 
Slamf1-/- was composed of 13 secondary nodes and 16 edges (B), with 3 as the maximum degree of 
connectivity of a node and 1 as the minimum and the different strains of T. cruzi were used as 
central nodes. We found three correlations in common between the three strains in the liver of 
BALB/c mice, two between Dm28c and Y, and six between Y and VFRA cl1 which had also some 
strain exclusive correlations. In contrast, fewer correlations were found in the liver of Slamf1-/- at 14 
d.p.i. not a single correlation with the Y strain, two correlations in common between Dm28c and 
VFRA cl1 and the rest were strain exclusive correlations. 
 
Figure 43. Networks of the livers of BALB/c and Slamf1-/-mice. A. BALB/c liver at 14 d.p.i. B. Slamf1-/- liver at 
14 d.p.i. Networks were generated and represented as indicated in the Methods section. 
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At 21 d.p.i. we found in the livers of BALB/c mice infected with the different strains of T. cruzi that 
the resulting network was composed of 15 secondary nodes and 45 edges (A) whereas Slamf1-/- was 
composed of 15 secondary nodes and 44 edges (B). 
 
Figure 44. Networks of the livers of BALB/c and Slamf1-/-mice. A. BALB/c liver at 21 d.p.i. B. Slamf1-/- liver at 
21 d.p.i. Networks were generated and represented as indicated in the Methods section. 
The liver of BALB/c mice correlation network involves only common correlations between the three 
strains evaluated, but while Y presents just positive correlations Dm28c and VFRA cl1 present both 
negative and positive, indicating a rather similar immune response at this point in the liver for both 
strains. Similarly, in the liver of Slamf1-/- mice almost all the correlations where shared by the three 
strains evaluated except one between Dm28c and VFRA cl1. Interestingly, in contrast to BALB/c, only 
Y strain presented negative correlations in Slamf1-/- mice. This indicates an important effect of 
SLAMF1 deficiency in the immune response in the liver for Y strain.  
4.4.4.4 Liver Protein expression 
 
Finally, as in the spleen and heart the expression of iNOS, NOX2, COX-2 and Arg-1 were evaluated. 
The level of iNOS was higher at 21 d.p.i., in BALB/c mice infected with all strains. In the case of 
Slamf1-/- infected mice, higher levels of iNOS were found for the Dm28c strain but not for the Y and 
VFRA cl1 strains at 21 d.p.i. COX-2 was higher in the infections with Dm28c and Y in BALB/c and 
Slamf1-/-mice at 21 d.p.i. Again the higher expression in the infection with VFRA cl1 was at 14 d.p.i. 
No greater differences were observed in Slamf1-/- infection with COX-2 as compared to BALB/c. The 
expression of NOX2 was higher in BALB/c mice at 21 d.p.i. for Dm28c, as for Y infection where again 
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higher as at 14 for VFRA cl1. SLAMF1 deficiency results in lower levels of NOX2 as compared to 
infection in BALB/c mice. High expression of Arg-1 was found in the liver as it was expected, because 
of the expression of this enzyme in the liver. 
 
Figure 45. Protein Expression level in liver of BALB/c and Slamf1-/- mice infected with Different Strains of T. 
cruzi. Expression levels of iNOS, NOX2, COX-2 and Arg-1 at 14 and 21 d.p.i. and their respective controls. 
4.5 THE EFFECT OF ITACONIC ACID ON PARASITE REPLICATION 
Irg1 is coding for an enzyme producing itaconic acid, which is an organic compound that inhibits 
isocitrate lyase, the key enzyme of the glyoxylate shunt, a pathway essential for microorganism 
growth under specific conditions, as parasites (Michelucci et al., 2013). The Irg1  gene showed the 
highest level of expression in heart tissue of BALB/c mice infected with the Y strain, and it is 
expression is related to SLAMF1, since there was increased Irg1 expression in Slamf1-/- compared to 
BALB/c at 14 d.p.i. (Figure 46 A). Thus, since infection and immune response in the heart mainly 
determine the outcome of the disease we looked for this metabolite in the hearts of BALB/c mice in 
previous metabolomic study (Gironès et al., 2014). Figure 46 B show that itaconate was 
undetectable in NI hearts but progressively incremented in infected hearts. 
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Figure 46. Irg1 expression and Itaconic acid production in heart of BALB/c heart infected with Y strain. A.Irg1 
gene expression by RT-qPCR. B. Itaconic acid relative levels (ScaledImpData) determined by Metabolomics.  
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Since Irg1 expression has been also associated to antimicrobial effects (Michelucci et al., 2013) we 
performed a preliminary study of its effect on parasite replication using epimastigotes, the 
replicative form of the parasite in the vector of the disease, of 15 different strains of T. cruzi and 
grouped them by strain type or DTUs since previous studies have found correlation of drug 
susceptibility with strains DTUs (Aquilino et al., 2012; Pineda et al., 2015). All T. cruzi strains were 
sensible to itaconate (Figure 47). Reference strains showed considerable variation in treatment 
sensitivity, TcI were the more resistant (IC50:48.51mM) and TcV were the more susceptible 
(IC50:16.30mM). The results were reproducible in two independent experiments, and indicate the 
potential of stronger derivatives of this metabolite with higher affinity for the Isocitrate lyase for the 
treatment of T. cruzi infection (Cordes et al., 2015).  
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Figure 47. In vitro activity of Itaconic Acid against epimastigotes of T. cruzi. 
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5 DISCUSSION 
 
Chagas disease is a highly heterogeneous and complex (several clinical manifestations and phase, 
many way of transmission) disease. Moreover, the influence of host genetics, especially in 
experimental infection, is becoming to be recognized. If this were not enough, recently a great 
genetic heterogeneity has been described for the parasite. However, most of the reported 
publications in the field have been performed with only one strain of parasite, one strain of mice 
combination. This has led to many apparently contradictory results.   
The role of the genetic background of the host and the high genetic variability by T. cruzi are crucial 
to understand Chagas disease.  The high genetic variability of T cruzi is a new problem to be solved 
in Chagas disease.  The parasite has been classified in 6 different DTUs, but the lack of clear 
associations between the DTUs and the clinical manifestations plus the drug resistance associated 
with the DTUs, are an obstacle for understanding the mechanism of infection by T. cruzi to address 
those problems. We use two mouse strains with different genetic background and 6 different strains 
of T. cruzi, representing each of the 6 DTUs, to understand the host-parasite interaction in 
macrophages, since this cell type is also considered key in the elimination or dissemination of the 
parasite.  
We arbitrarily divided macrophage infection in 3 phases based in previous evidence (Maganto-
Garcia et al., 2008; Zhao et al., 2013). From 0 to 1 h.p.i. where most of the binding of the parasite 
takes place (Interaction). From 1 to 6 h.p.i., where all parasites bound are internalized by endocytic 
mechanism (Internalization) and later they escape to the cytoplasm where they proliferate (6 to 24 
h.p.i.). We did choose longer times to avoid macrophage lysis by the parasite, which seriously 
confound the data. Nevertheless, proliferation usually expand from 48 to 72 h.p.i. 
We found a clear effect of mouse genetic background in the T. cruzi infection, where BALB/c 
peritoneal macrophages were more susceptible to the infection of T. cruzi than C57BL/6, no matter 
the strains of T. cruzi or the phase of the intracellular infection. It is worth mentioning that BALB/c 
and C57BL/6 basal gene expression in NI macrophages was similar except for Arg1 with higheƌ ∆CT 
(Figure S 1) in BALB/c macrophages, which means higher basal gene expression than in C57BL/6 
macrophages. Arg-1 is a M2 marker and it is greater basal level in BALB/c macrophages could be 
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guiding an ant-inflammatory response after T. cruzi infection. In addition, Cybb and Tnf showed 
higher basal expression in Tlr2-/- and Slamf1-/- macrophages respect to C57BL/6 and BALB/c, 
respectively, being the last ones very similar. Thus these small variations should be taken into 
account in the subsequent analysis that illustrates changes from basal levels of non-infected 
macrophages. These would be in agreement with the lower induction of pro-inflammatory genes, as 
Tnf in BALB/c macrophages. The induction of Slamf1 gene expression was similar in different mouse 
and parasite strains at 1h, but decreased thereafter, with great variations between parasite strains. 
The lower parasite load in all phases analyzed in C57BL/6 macrophages was associated with an in 
general higher gene expression of macrophage activation genes which indicate a better defense 
mechanism in C57BL/6 macrophages compared with the BALB/c macrophages. This difference 
between BALB/c and C57BL/6 have been already documented in other intracellular parasites as 
Leishmania (Rabhi et al., 2013). 
In particular, major differences were observed in the interaction phase, where enzymes and 
cytokines expression were lower in BALB/c than C57BL/6 macrophages. This indicates faster 
triggering of activation in C57BL/6 that may be is a key to control infection. However, Tnf and Slamf1 
gene expression was similar. At the internalization phase, Irg1 and Il1b presented higher levels in 
C57BL/6 than BALB/c macrophages, and Tlr2 expression incremented in several conditions. As 
expected, the greatest variability was observed at the intracellular proliferation phase since the 
intracellular parasite may affect many signals transduction pathways, where Dm28c infected 
macrophages showed the highest parasite load in BALB/c and the lowest in C57BL/6. However, 
there were some exceptions. Thus, we found in BALB/c macrophages infected with T. cruzi strains 
higher gene expression of Tnf and Slamf1 during the interaction and Il1b and Tlr2 during the 
internalization. Also, we found the Irg1 overexpressed during the internalization in BALB/c 
macrophages, Irg1 was also previously shown to be expressed in mouse macrophages under 
different TLR ligand stimulations and contributes to immune responses through the production of 
ROS (Tallam et al., 2016).  
Interestingly, it has been described that the infection by T. cruzi induces high levels of iNOS and 
large amounts of NO in cultured macrophages with secretion of Tnf, Il6 and Il1b (Zanluqui, 2015). 
The higher expression of the Slamf1, and especially Tlr2 receptors in BALB/c macrophages, 
compared with C57BL/6, since TLR-2 is required for the attachment/entry of all strains could 
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indicate that this receptor conduces by a positive feedback mechanism to higher replication in 
BALB/c macrophages.   
The DAPC analysis showed a clear grouping between the BALB/c and C57BL/6 peritoneal 
macrophages, for all strains showing again how different is the response to the T. cruzi infection 
depending on the mouse genetic background. Internalization phase showed the best separation 
between the different backgrounds, likely because in this phase we found bigger differences 
between an activation in the BALB/c and C57BL/6 infections. The higher levels of Tnf associated with 
the high parasite load may play a crucial role in the susceptibility of the BALB/c macrophages, 
despite being considered as early replicative cytokine (Munoz-Fernandez et al., 1992) and suggest 
that parasite load is directly triggering of TNF. 
Curiously, the analysis of correlations in the three phases showed much more negative correlations 
associated with the C57BL/6 than BALB/c macrophages. An explanation to these could be that a lack 
of down-regulation between the cytokines and enzymes in the BALB/c macrophages leads to higher 
parasite load. Our results showed that BALB/c macrophages were more susceptible to the infection 
with all the strains of T. cruzi, but this could be different in other type of cells as dendritic cells, 
natural killer, cardiomyocytes, etc... 
We have previously described some correlation between cytokines and DTUs in patients, but this 
was only done in TcI and TcII and mixed infections. Thus any correlation with our in vitro data in 
macrophages is not guaranteed. Presumably, strain-specific recognition by other components of the 
immune system (Antibodies, B cells, or T cells), could lead to the differential responses observed in 
patients (Poveda et al., 2014). Our studies in macrophages involving all the possible different strain 
of T. cruzi supports the convenience of further studies in patients to get relevant conclusions. 
5.1  TLR2 PLAYS A CRUCIAL ROLE IN THE ENTRY OF ALL STRAINS OF T. CRUZI IN MACROPHAGES.  
 
TLR2 plays a role both in controlling the entry of several pathogens as well as to determine the 
activation of the immune response in the host.  In the case of T. cruzi it has been described that 
TLR2 is necessary for the endocytosis of Y strain parasites in macrophages (Maganto-Garcia et al., 
2008). 
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Figure 48. Effect of TLR2 deficiency in the macrophage model of infection with T. cruzi. The figure shows that 
all strains of T. cruzi behaved similarly in Tlr2-/- macrophages: there was less parasite contact with 
macrophages during interaction phase, lower activation of the immunoregulatory genes during the 
internalization phase, and lower parasite loads at the intracellular proliferation phase compared to C57BL/6 
macrophages. 
 
Our results, confirm the crucial role of this receptor in the entry of all different T. cruzi strains 
studied. A model of infection in Tlr2-/- macrophages was drawn according with our results. Figure 48, 
shows the putative role of TLR2 receptor during the different phases of T. cruzi infection in 
peritoneal macrophages. We found that the deficiency of Tlr2-/- in peritoneal macrophages inhibited 
the interaction of the different strains of T. cruzi.  During the internalization a lower induction of the 
immunoregulatory genes associated with low parasite loads was found in the Tlr2-/-macrophages 
comparing with the infected C57BL/6 macrophages. Finally, as a result of the low amounts of 
parasite able to infect the macrophages we found a lower parasite load in the intracellular 
proliferation phase. 
The DAPC analysis demonstrated the clustering of the infections in Tlr2-/- macrophages with all 
strains of T. cruzi and with the respective non-infected controls (C57BL/6 and Tlr2-/-) clustered 
together. Contrarily, infections in C57BL/6 macrophages grouped a part from the rest. This clearly 
corroborated the crucial role of TLR2 in the infection determined by their involvement in 
recognition. 
However, once the binding an entry has taken place, the influence of TLR2 deficiency was variable 
among strains. Thus, despite 90% reduction in binding at 1 h.p.i. for Y and M6421 cl6 and 50% for 
VFRA cl1, the efficiency in the internalization for Y or the intracellular proliferation of VFRA cl1, 
results in similar parasite output in Tlr2-/- macrophages as compared to C57BL/6. 
103 
 
This indicates that differences in the amount of the expression of GILPs or other surface proteins of 
the parasite associated with TLRs or other receptors, may also contribute to binding to the host in 
later times. Thus, it has been reported that G, Y and Tulahuén strains contain ceramide, while CL 
Brener strain contains a mixture of alkylacylglycerol  and dihydropceramide species in their surface, 
recognized by TLR2 and TLR4, respectively (Ropert et al., 2002).  
5.2 SLAMF1 ACTS AS A STRAIN-DEPENDENT SENSOR IN T. CRUZI INFECTION MEDIATED BY NOX2. 
 
SLAMF1 is an important receptor in myeloid cells, controlling the entry and replication of different 
pathogens as measles virus and gram negative bacteria. Previously, our group described that 
SLAMF1 incremented susceptibility to infections with the Y strain both in vitro and in vivo (Calderón 
et al., 2012). We extended this study to different strains and found that the SLAMF1 receptor is 
important to control the T. cruzi infection in peritoneal macrophages, where the deficiency of this 
receptor resulted in lower parasite load in comparison with the BALB/c macrophages, as in the case 
of the Y strain, only for 5 out of 6 strains of T. cruzi, but not for VFRA cl1 strain. 
According to our results we propose a model (Figure 49), where parasite load at the interaction 
phase in the Slamf1-/- macrophages was reduced compared to BALB/c macrophages which indicates 
that SLAMF1 is required for the entry of T. cruzi for Dm28c, Y, M6421 cl6 and Bug2148 cl1 strains of 
T. cruzi evaluated, but not for the VFRA cl1. At the internalization phase, the SLAMF1 receptor 
regulates the production of NOX and ROS in the phagosome that eliminate pathogens in the 
parasitophorous vacuole (C. Ma et al., 2012). We found higher levels of NOX2 gene and ROS in 
Slamf1-/- macrophages and lower parasite load infected with all strains, except for VFRA cl1, that 
showed the opposite, lower NOX2 and ROS levels and higher parasite load, demonstrating the 
effectiveness of NOX2 and ROS for parasite control.  
This enhancement of ROS and NOX2 in the absence of SLAMF1 is somehow surprising since in 
bacterial infection SLAMF1 deficiency results in decreased NOX2 activity and ROS production (Berger 
et al., 2010; C. Ma et al., 2012). 
It has been described that the SLAMF1 receptor plays the role of bacterial sensor, where SLAMF1 
induces production of PI3P, which positively regulates the activity of the NOX2 enzyme and 
phagolysosomal maturation for the elimination of Gram negative, but no Gram positive, bacteria 
(Ma et al. 2012). In contrast, we found that the deficiency of SLAMF1 increased the amounts of 
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NOX2 and ROS expression in the parasitophorous vacuole the role of these molecules is 
controversial, some authors propose ROS as necessary for parasite replication while the others 
suggest an microbicidal role (Goes et al., 2016).We found an association between the parasite load 
and the expression of NOX2 and ROS, where the higher the parasite load the lower amounts of 
NOX2 and ROS. Thus, in our model SLAMF1 acts as a strain-dependent sensor in T. cruzi infection 
mediated by NOX2. The deficiency of SLAMF1 reduced parasite load in infections with Dm28c to 
Bug2148 cl1 strains, but increased with VFRA cl1 strain. 
 
Figure 49. Effect of SLAMF1 deficiency in the macrophage model of infection with T. cruzi. The figure shows 
that T. cruzi strains caused similar and different effects in Tlr2-/- compared to C57BL/6 macrophages.  There 
was less parasite contact with macrophages during interaction phase in infections with all the strains. During 
the internalization phase there was higher expression of Il6 and lower expression of Il1b and Irg1 for all the 
strains; VFRA cl1 showed lower expression of Il10, Cybb  (NOX2) and lower ROS production than other strains; Y 
strain showed lower expression of Arg1 and Il10 than other strains; and M6421 cl6 showed lower expression of 
Tnf than other strains. Finally, at the intracellular proliferation phase all the strains showed less parasite load 
compared to C57BL/6 macrophages, except VFRA cl1 strain. 
Preliminary studies from our laboratory suggest that the T. cruzi trans-sialidases are possible ligands 
of the SLAMF1 receptor. The importance of this molecule lies in that T. cruzi is unable to synthesize 
sialic acids de novo and needs to take from the host. Trans-sialidases are expressed in great 
amounts on the surface membrane of trypomastigotes and during the invasion in host cells and are 
necessary for successful infection (Frasch, 2000). Those trans-sialidase properties will confer to 
trans-sialidase-SLAMF1 interaction a prominent role in T.cruzi infection in myeloid cells since them 
all also expressed high levels of SLAMF1 on the surface (C. Ma et al., 2012). The relationship 
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between DTUs and trans-sialidases is still unclear, but evolutionary events did show differences in 
transialidase expression in different strains. The expression of this complex family of virulent surface 
molecules may be a key to better understand the mechanism of infection and its relationship with T. 
cruzi evolution. In our case it could explain why SLAMF1 receptor is acting as a pathogen sensor. 
5.3 SLAMF1 ROLE IN VIVO INFECTION 
 
The experimental mouse model of T.cruzi infection is thought to be very similar to human Chagas 
disease, at cellular, molecular and disease outcome level.  However, reports show apparent 
contradictions depending on the mouse strains and T.cruzi used. We studied the susceptible BALB/c 
mouse with three different T. cruzi strains having different levels of infection and severity, trying to 
simulate the diverse possible outcomes or pathologies in humans. Our results show high mortality 
with the Y strain during the acute phase. For the other two strains Dm28c and VFRA cl1 the infection 
was less aggressive. However, we found relatively high parasitemia in BALB/c mice infected with the 
VFRA cl1 despite none of them died. Thus, we did not find clear association between the 
parasitemia and the severity of the disease, despite the previous report  (Tarleton et al., 1996). This 
relationship is likely true for the same strain (higher parasitemia-higher disease) but clearly not 
when comparing different strains. 
 
In humans TcI presents a broad geographical distribution and has been associated with chronic 
cardiomyopathy. Even though we used mice with susceptible background (BALB/c) and the strain 
Dm28c a TcI presented the highest parasite load in peritoneal macrophage infections, the infection 
was the less virulent. In agreement with precious reports a 100% of the mice survived to the acute 
infection and we did not find parasites in blood, probably because of the use of a lower inoculum 
(2000 parasites/mouse) than the previously described wheƌe BALB/Đ ŵiĐe iŶfeĐted ǁith ≤ ϱϬϬϬ 
parasite/mouse which presented some parasite in blood (de Melo Medeiros et al., 2010). 
Previous results in the laboratory indicated that during in vivo infection with the Y strain, alterations 
in myeloid populations are progressively observed in bone marrow, then spleen and finally 
infiltrating cardiac tissue (Gonzalez, 2014). Thus, one could think that a good control of parasite 
replication in the spleen would lead to lower parasite loads in the other organs as we observed. 
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Figure 50. Effect of SLAMF1 deficiency in mice infection. The figure shows a summary of gene expression of 
the immunoregulatory genes in spleen, heart and liver during acute phase (21 d.p.i.) in Slamf1-/- mice infected 
with the different strains of T. cruzi compared with BALB/c mice. Infections with the Dm28c and Y strains 
presented lower parasite load compared to BALB/c mice, in contrast the infection in Slamf1-/- infected with the 
VFRA cl1 presented higher parasite load compared with BALB/c. 
 
The lack of parasites in blood and the great ability of Dm28c to infect macrophages in vitro, plus the 
presence of low parasite load in the spleen and the liver, and even less in heart, suggests that in vivo 
others immune cells may control the infection. These possibility will be in agreement with the 
͞TƌojaŶ hoƌse͟ hypothesis (Calderón et al., 2012; Messenger et al., 2015). Alternatively, it is possible 
that Dm28c infects others cell types like cardiomyocytes and SLAMF1 deficiency in those cells may 
impair parasite replication in the heart. 
Our results, in BALB/c mice infected with Dm28c strain showed a lower parasite load in Dm28c 
comparison with the mice infected with Y and VFRA cl1. The highest parasite load at 21 d.p.i. was 
found in the liver followed by the spleen and heart, with 5.25, 4.92 and 1.89 (pg T. cruzi DNA/ mg 
total DNA) X106, respectively. The higher presence in the spleen and liver, could indicate a tropism 
of this strain towards these organs. Previous studies with Dm28c failed to display inflammatory 
iŶfiltƌate aŶd shoǁed ƌaƌe aŵastigote Ŷests eǀeŶ afteƌ iŶoĐulatiŶg ǁith ≤ ϱϬϬϬ paƌasite/ŵouse 
(Calvet et al., 2004; de Melo Medeiros et al., 2010), this is consistent with our results where we 
found very low parasite load in the heart.  In the Slamf1-/- mice the parasite load was even lower 
than in the BALB/c mice having a reduction of 80.38% in the liver, 78.45% in the spleen and 17.98% 
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in the heart. The reduction of the parasite load in the Slamf1-/- mice suggest the importance of this 
receptor in the entry of the Dm28c in the host cells as shown in macrophages.  
In fact, the spleen of mice infected with Dm28c strain showed higher expression of macrophage 
activation genes at 14 d.p.i. than with the other 2 strains, indicating that an early control of the 
infection results in a more efficient elimination of the parasite. This points out to an efficient 
immune response to Dm28c for control the infection in contrast to Y infection. The absence of 
SLAMF1 expression even increased gene expression indicating of better activation and further 
decreased parasite load, indicating a detrimental role of this receptor. We also found higher gene 
expression at 21 d.p.i. in Slamf1-/- than in BALB/c mice, although it was lower than at 14 d.p.i.  
The lack of changes in the heart indicates that Dm28c strain has preferential tropism for spleen and 
liver tissues in this mouse model. The liver and the spleen play an important role in the elimination 
of the parasite or other pathogens. We conclude in base to our results that the more affected organ 
to the infection with the strain Dm28c during acute phase was the liver.    
The increment of iNOS in spleen cells of the mice infected with the Y strain has been associated with 
damage in this organ due to toxicity of NO (Abrahamsohn and Coffman, 1995). The increment of the 
iNOS and higher levels in the expression of Th1 cytokines has been detected also in the liver of mice 
infected with the same strain (Novaes et al., 2015). However, we could no detect iNOS protein in the 
spleen samples for any strain. However, higher amounts of NOX2 were found at 21 d.p.i. in both 
BALB/c and Slamf1-/-, indicating a fast parasite elimination by the host.  The amount of iNOS in the 
heart infected with Dm28c were similar for BALB/c and Slamf1-/- with low expression compared with 
the Y strain.  Taking into account all the above, we suggest that, host elimination in liver and spleen 
is very likely the reason why Dm28c parasites do not get to infect the heart, rather than the 
differential tissue tropism hypothesized before. 
Finally, the results obtained with the Dm28c strain illustrate the importance of preserving infection 
of heart tissue for a better outcome of the disease. 
TcII strains are the most associated with cardiomyopathy in Latin America, where most of the 
human cases have been reported infected with this DTU. The Y strain is a TcII has been used in 
several immunological studies and is lethal in BALB/c mouse model even with low (50 
parasites/mouse) doses (Sanoja et al., 2013). Previous studies in infected Slamf1-/- with the Y strain 
demonstrated a complete resistance of them to the parasite in comparison with infected BALB/c 
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mice (Calderón et al., 2012). In agreement with those, our results show a survival of a 30% and 100% 
in BALB/c and Slamf1-/- mice, respectively. 
We found that BALB/c mice infected with Y strain at 21 d.p.i. presented higher parasite load in the 
heart (255.24 (pg T. cruzi DNA/ mg total DNA) X106), followed by the spleen (32.02 (pg T. cruzi DNA/ 
mg total DNA) X106) and liver (28.89 (pg T. cruzi DNA/ mg total DNA) X106). The Slamf1-/- mice 
infected with the strain Y presented also a reduction of the parasite load in all the organs. In the 
heart the parasite load was reduced in a 75.5%, in the spleen 46.78% and in the liver 70.7%.  This 
indicates a high heart tropism of the Y strain. 
Cardiac damage has been associated with the infection with the Y strain (Calderón et al., 2012) 
which showed here the highest parasite load in comparison with the Dm28c and VFRA cl1 strains in 
this organ. An early induction (14 d.p.i.) of the immune response genes was observed in BALB/c that 
decreased in Slamf1-/- hearts of infected mice, except for Irg1, which presented higher levels in 
Slamf1-/-. These results illustrate the importance of this gene not previously studied in the context of 
T. cruzi infection. Irg1 produces itaconic acid which was recently described as a marker of M1 
macrophages with anti-mycobacterial activity (Jha et al., 2016; Michelucci et al., 2013). We found 
that itaconic acid has an inhibitory activity against all strains of T. cruzi with different IC50 according 
to their DTU classification, as it has been described for many other inhibitors (Aquilino et al., 2012). 
The high expression of iNOS and high parasite load in the hearts of BALB/c mice infected with Y 
strain may cause more damage and eventually the death of the animals by cardiac dysfunction. We 
found lower amounts of Arg1 in the hearts of BALB/c than in Slamf1-/- mice, an enzyme that has 
been associated with mouse susceptibility to T. cruzi infection (Cuervo et al., 2008). Higher amounts 
of this protein were found in the spleen of the BALB/c mice at 21 d.p.i. only when infected with the 
lethal Y strain.  This confirms the presence of MDSC in Y strain and also could indicate that the 
highest levels of MDSC during T. cruzi infection are related to heart disease, since Dm28c or VFRA 
cl1 express Arg-1 in very low or undetectable levels. As in the macrophages higher levels of NOX2 in 
Slamf1-/- mice were associated with lower parasite load. 
The differences observed with the  Y strain in in vitro and in vivo models, which change from poorly 
infected macrophages to lethal infections in mice,  demonstrates the use of different host cells in 
the dissemination of the parasite and a strain/DTU-specific recognition by the immune system 
(Poveda et al. 2014). 
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We have described previously that the Y strain is characterized by the presence of high numbers of 
MDSCs expressing iNOS, Arg-1 and COX-2 in heart tissue. Here we show that strains behave 
differently, being NOX2 at high levels as well as others enzymes characteristic of MDSC at lower 
levels for some strains. 
As in the results obtained In vitro for the BALB/c and Slamf1-/- macrophages infected with the VFRA 
cl1 the deficiency of SLAMF1 receptor incremented the parasite load in the organs analyzed. At 21 
d.p.i., the spleen of BALB/c mice presented the higher parasite load, followed by the heart and liver, 
with 29, 13.38 and 5.25 (pg T. cruzi DNA/ mg total DNA) X106. In contrast, the higher parasite load in 
Slamf1-/- was found in the spleen, followed by the liver and finally the heart. Also, we found an 
increment in the parasite load of the Slamf1-/- organs, 83.90% in the liver, 30.85% in the heart and 
20.78% in the spleen. 
The mice infected with the Y shows a similar to acute cardiomyopathy in humans, while VFRA cl1 is 
similar to chronic cardiomyopathy.  
Taken together our results indicate an extreme variability of the immunopathological response to T. 
cruzi putting a word caution in reaching any conclusion in the mouse model based on a single 
mouse/parasite strain combination.   
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6 CONCLUSIONS 
 
1. BALB/c are more susceptible to the T. cruzi infection than C57BL/6 macrophages with all the 
parasite strains studied. 
2. Trypanosoma cruzi genetic variability greatly affected parasite replication in macrophages, 
being some parasite strains more infective than others. 
3. TLR2 receptor is necessary for the entry of parasites of all T. cruzi strains studied and also 
affect different phases of macrophage in vitro infection, except for the Y strain in which 
intracellular proliferation was not affected by the TLR2 deficiency. 
4. SLAMF1 acts as a strain-dependent sensor in T. cruzi macrophage in vitro infection, being 
parasite intracellular proliferation restricted by ROS production which was higher in Slamf1-/- 
than in BALB/c macrophages for all the strains, except after infection with the VFRA cl1 
strain. 
5. In vivo, the most infective strain in BALB/c mice was Y, followed by VFRA cl1 and finally 
Dm28c. Dm28c strain induced earlier activation of immune response in spleen of BALB/c 
mice that developed a milder infection without detectable parasitemia, presented less 
lower parasite load in heart tissue, and less MDSCs marker expression than mice infected 
with the other strains.  
6. The Slamf1-/- mice showed lower parasite load than the BALB/c infected with Dm28c and Y 
strains in all the organs studied. In contrast, in VFRA cl1 infection the parasite load tended to 
be higher in Slamf1-/- than BALB/c in liver and heart. These results are in agreement with 
what we found in vitro, supporting the ŵaĐƌophage ͞TƌojaŶ Hoƌse͟ ŵodel. 
7. The Slamf1-/- mice are resistant to mortality induced by Y strain infection having less MDSC 
markers in the heart at 21 dpi. 
8. There is an extreme variability in the immunopathological response depending on the 
mouse/parasite strain combination. Thus, conclusions based on experiments performed 
with single parasite/mouse strain combinations should be taken with caution. 
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9. Infectivity of the parasite strains in vitro and in vivo not always correlated indicating that 
other immune cells with different susceptibility to infection are controlling the outcome of 
the disease in vivo, which should be further studied. 
10. Irg1 eǆpƌessioŶ aŶd itaĐoŶiĐ aĐid, aŶ iŶhiďitoƌ of pathogeŶ͛s isoĐitƌate lǇase, ǁas deteĐted iŶ 
heart of mice infected with the Y strain. Itaconic acid inhibited the growth of several 
parasite strains of different DTUs in vitro indicating that parasite isocitrate lyase inhibitors 
could be useful for treatment of Chagas disease.  
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CONCLUSIONES 
 
1. Los macrófagos BALB/c son más susceptibles a la infección que los C57BL/6 en todas las 
cepas de T. cruzi estudiadas 
2. La variabilidad genética de T. cruzi afectó en gran medida la replicación del parásito, siendo 
unas cepas más infectivas que otras. 
3. El receptor TLR2 es necesario para la entrada de parásitos de todas las cepas de T. cruzi 
estudiadas y afecta las distintas fases de la infección in vitro en macrófagos, a excepción de 
la cepa VFRA cl1 que no se vio afectada por la deficiencia en TLR2. 
4. El receptor SLAMF1 se comporta como un sensor cepa-dependiente en la infección de 
macrófagos in vitro, estando la replicación intracelular restringida por la producción de ROS, 
que fue mayor en macrófagos Slamf1-/- que en BALB/c para todas las cepas de parásito, a 
excepción de la cepa VFRA cl1. 
5. In vivo, la cepa Y fue la más infectiva, seguida de la cepa VFRA y finalmente la Dm28c. Ésta 
última indujo una activación de la respuesta inmunológica temprana en el bazo de ratones 
BALB/c, que desarrollaron una infección más leve sin parasitemia detectable, más baja carga 
parasitaria y menos presencia de MDSCs en corazón que las demás cepas estudiadas. 
6. Los ratones Slamf1-/- mostraron menor carga parasitaria que los BALB/c infectados con las 
cepas DM28c e Y en todos los órganos estudiados. Por el contrario, con la cepa VFRA cl1 la 
carga parasitaria tendió a ser mayor en hígado y corazón de ratones Slamf1-/- que en BALB/c, 
apoǇaŶdo el ŵodelo del ŵaĐƌófago Đoŵo ͞Caďallo de TƌoǇa͟. 
7. Los ratones Slamf1-/- son resistentes a la mortalidad inducida por la infección con la cepa Y 
presentando una expresión de marcadores de MDSCs menor en corazón a 21 d.p.i. 
8. Existe una gran variabilidad en la respuesta inmunopatogenica dependiendo de la 
combinación parasito/ratón utilizada. Por lo tanto, las conclusiones basadas en estudios 
utilizando combinaciones únicas de parasito/ratón deben tomarse con cautela. 
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9. La infectividad de las cepas in vitro e in vivo no siempre correlacionó indicando que otras 
células inmunes con distinta susceptibilidad a la infección están controlando el desarrollo de 
la enfermedad in vivo, aspecto que merece estudiarse en el futuro. 
10. La expresión de Irg1 y el ácido itacónico, un inhibidor de la isocitrato liasa de patógenos, 
fueron detectados en el corazón de ratones BALB/c infectados con la cepa Y. El ácido 
itacónico inhibió el crecimiento de muchas cepas de distintas DTUs in vitro, indicando que 
inhibidores de la isocitrato liasa podrían ser útiles para el tratamiento de la enfermedad de 
Chagas. 
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8 APPENDIX 1 
8.1 FIGURES 
8.1.1 Control ∆CT Values 
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Figure S 1. Non Infected macrophages.  
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Figure S  2. Non-infected mice controls. A. Spleen. B. Heart C. Liver.  
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8.1.2 Mouse Genetic Background 
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Figure S  3. Kinetics of enzymes gene expression in peritoneal macrophages of BALB/c and C57BL/6 infected 
with parasite of different DTU´s, in a ratio of 5 Parasites: 1 macrophages. A. Arg1. B. Irg1. C. Cybb. Standard 
error of the mean ± (SEM) are represented.  The asterisks indicate the statistical significance, t-student 
(*p<0.05, **p<0.005 and ***p<0.001), between BALB/c and C57BL/6 macrophages. 
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Figure S  4. Kinetic of enzymes gene expression in peritoneal macrophages of BALB/c and C57BL/6 infected 
with parasite of different DTU´s, in a ratio of 5:1 Parasites, macrophage. . A. Il1b. B. Il6. C. Il10 D. Tnf. 
Standard error of the mean ± (SEM) are represented.  The asterisks indicate the statistical significance, t-
student (*p<0.05, **p<0.005 and ***p<0.001), between BALB/c and C57BL/6 macrophages. 
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Figure S  5. Kinetic of cytokines gene expression in peritoneal macrophages of BALB/c and C57BL/6 infected 
with parasite of different DTU´s, in a ratio of 5:1 Parasites, macrophage. A. Slamf1. B. Tlr2. Standard error of 
the mean ± (SEM) are represented.  The asterisks indicate the statistical significance, t-student (*p<0.05, 
**p<0.005 and ***p<0.001), between C57BL/6 and BALB/c macrophages 
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8.1.3 TLR2 in macrophages 
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Figure S  6. Kinetic of enzymes gene expression in peritoneal macrophages of Tlr2-/- and C57BL/6 infected 
with parasite of different DTU´s, in a ratio of 5:1 Parasites, macrophage. A. Arg1. B. Irg1. C. Cybb. Standard 
error of the mean ± (SEM) are represented.  The asterisks indicate the statistical significance, t-student 
(*p<0.05, **p<0.005 and ***p<0.001), between Tlr2-/- and C57BL/6 macrophages. 
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Figure S  7. Kinetic of cytokines gene expression in peritoneal macrophages of Tlr2-/- and C57BL/6 infected 
with parasite of different DTU´s, in a ratio of 5:1 Parasites, macrophage. A. Il1b. B. Il6. C. Il10 D. Tnf. 
Standard error of the mean ± (SEM) are represented.  The asterisks indicate the statistical significance, t-
student (*p<0.05, **p<0.005 and ***p<0.001), between Tlr2-/- and C57BL/6 macrophages. 
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Figure S  8. Kinetic of cytokines gene expression in peritoneal macrophages of Tlr2-/- and C57BL/6 infected 
with parasite of different DTU´s, in a ratio of 5:1 Parasites, macrophage. A. Slamf1. B. Tlr2. Standard error of 
the mean ± (SEM) are represented.  The asterisks indicate the statistical significance, t-student (*p<0.05, 
**p<0.005 and ***p<0.001), between C57BL/6 and Tlr2-/- macrophages. 
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8.1.4 SLAMF1 in macrophages 
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Figure S  9.Kinetic of enzymes gene expression in peritoneal macrophages of Slamf1-/- and BALB/c infected 
with parasite of different DTU´s, in a ratio of 5:1 Parasites, macrophage. A. Arg1. B. Irg1. C. Cybb. Standard 
error of the mean ± (SEM) are represented.  The asterisks indicate the statistical significance, t-student 
(*p<0.05, **p<0.005 and ***p<0.001), between BALB/c and Slamf1-/- macrophages. 
 
142 
 
Dm28c
10 - 2
10 - 1
100
101
102
103
104
105
**
**
**
Y
***
**
**
M6421 cl6
****
*
10R26
0 6 12 18 24
10 - 2
10 - 1
100
101
102
103
104
105 **
**
**
Bug2148 cl1
0 6 12 18 24
**
**
VFRA cl1
0 6 12 18 24
***
**
Hours post-infection
R
Q
BALB/c
Slamf1-/-
A. Il1b
 
Dm28c
10 - 1
100
101
102
103
104
105
*
**
*
Y
*
**
*
M6421 cl6
**
**
10R26
0 6 12 18 24
10 - 1
100
101
102
103
104
105
**
*
Bug2148 cl1
0 6 12 18 24
*
**
VFRA cl1
0 6 12 18 24
*
Hours post-infection
R
Q
BALB/c
Slamf1-/-
B. Il6 
 
143 
 
Dm28c
10 - 1
100
101
Y
*
M6421 cl6
*
10R26
0 6 12 18 24
10 - 1
100
101
102
*
Bug2148 cl1
0 6 12 18 24
*
VFRA cl1
0 6 12 18 24
Hours post-infection
R
Q
BALB/c
Slamf1-/-
C. Il10 
 
Dm28c
10 - 2
10 - 1
100
101
102
103
104
* **
*
Y
*
**
M6421 cl6
*
**
*
10R26
0 6 12 18 24
10 - 2
10 - 1
100
101
102
103
104
*
Bug2148 cl1
0 6 12 18 24
*
VFRA cl1
0 6 12 18 24
**
*
Hours post-infection
R
Q
BALB/c
Slamf1
D. Tnf 
 
Figure S  10. Kinetic of cytokines gene expression in peritoneal macrophages of Slamf1-/- and BALB/c 
infected with parasite of different DTU´s, in a ratio of 5:1 Parasites, macrophage. A. Il1b. B. Il6. C. Il10 D. Tnf. 
Standard error of the mean ± (SEM) are represented.  The asterisks indicate the statistical significance, t-
student (*p<0.05, **p<0.005 and ***p<0.001), between BALB/c and Slamf1-/- macrophages. 
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Figure S  11. Kinetic of cytokines gene expression in peritoneal macrophages of Slamf1-/- and BALB/c infected 
with parasite of different DTU´s, in a ratio of 5:1 Parasites, macrophage. A. Slamf1. B. Tlr2. Standard error of 
the mean ± (SEM) are represented.  The asterisks indicate the statistical significance, t-student (*p<0.05, 
**p<0.005 and ***p<0.001), between BALB/c and Slamf1-/- macrophages. 
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8.1.5 Spleen 
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Figure S  12. Gene expression in the spleen Slamf1-/- and BALB/c mice infected with Dm28c, Y and VFRA cl1 
the data represent the results of groups 5 mice per group, the data were normalized with respect to NI mice. 
A. Irg1. B. Cybb. Represented the Standard error of the mean ± (SEM).  The asterisk indicate the statistical 
significance, t-student (*p<0.05, **p<0.005 and ***p<0.001), comparing the infected BALB/c and Slamf1-/- 
mice. 
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Figure S  13. Gene expression in the spleen Slamf1-/- and BALB/c mice infected with Dm28c, Y and VFRA cl1 
the data represent the results of groups 5 mice per group, the data were normalized with respect to NI mice. 
A. Il1b. B. Il6. C. Il10 D. Tnf. Represented the Standard error of the mean ± (SEM).  The asterisk indicate the 
statistical significance, t-student (*p<0.05, **p<0.005 and ***p<0.001), comparing the infected BALB/c and 
Slamf1-/-mice. 
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8.1.6 Heart 
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Figure S  14. Gene expression in heart of Slamf1-/- and BALB/c mice infected with Dm28c, Y and VFRA cl1 the 
data represent the results of groups 5 mice per group, the data were normalized with respect to NI mice.  A. 
Arg1. B. Irg1. C. Cybb. Represented the Standard error of the mean ± (SEM).  The asterisk indicate the 
statistical significance, t-student (*p<0.05, **p<0.005 and ***p<0.001), comparing the infected BALB/c and 
Slamf1-/- mice. 
 
148 
 
Dm28c
0 7 14 21
10 - 1
100
101
102
103
*
Y
0 7 14 21
****
VFRA cl1
0 7 14 21
****
Dm28c
0 7 14 21
10 - 1
100
101
102
103
104
*
*
Y
0 7 14 21
**
VFRA cl1
0 7 14 21
**
Dm28c
0 7 14 21
10 - 1
100
101
102
103
*
**
Y
0 7 14 21
**
VFRA cl1
0 7 14 21
**
**
Dm28c
0 7 14 21
10 - 1
100
101
102
103
**
Y
0 7 14 21
**
VFRA cl1
0 7 14 21
**
R
Q
Days post-infection
A. Ilb1
BALB/c
Slamf1
-/-
R
Q
Days post-infection
B. lI6
BALB/c
Slamf1
-/-
R
Q
Days post-infection
C. Il10
BALB/c
Slamf1
-/-
R
Q
Days post-infection
D. Tnf
BALB/c
Slamf1
-/-
 
Figure S  15. Gene expression in heart  Slamf1-/- and BALB/c mice infected Dm28c, Y and VFRA cl1 the data 
represent the results of groups 5 mice per group, the data were normalized with respect to NI mice. A. Il1b. 
B. Il6. C. Il10 D. Tnf. Represented the Standard error of the mean ± (SEM).  The asterisk indicate the statistical 
significance, t-student (*p<0.05, **p<0.005 and ***p<0.001), comparing the infected BALB/c and Slamf1-/-
mice. 
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8.1.7 Liver 
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Figure S  16. Gene expression in liver of Slamf1-/- and BALB/c mice infected with Dm28c, Y and VFRA cl1 the 
data represent the results of groups 5 mice per group, the data were normalized with respect to NI mice. A. 
Irg1. B. Cybb. Represented the Standard error of the mean ± (SEM).  The asterisk indicate the statistical 
significance, t-student (*p<0.05, **p<0.005 and ***p<0.001), comparing the infected BALB/c and Slamf1-/- 
mice. 
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Figure S  17. Gene expression in liver  Slamf1-/- and BALB/c mice infected with Dm28c, Y and VFRA cl1 the 
data represent the results of groups 5 mice per group, the data were normalized with respect to NI mice. A. 
Il1b. B. Il6. C. Il10 D. Tnf. Represented the Standard error of the mean ± (SEM).  The asterisk indicate the 
statistical significance, t-student (*p<0.05, **p<0.005 and ***p<0.001), comparing the infected BALB/c and 
Slamf1-/-mice. 
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8.1.8 Histopatology Heart 
 
Figure S  18. Histologic of cardiac tissue of BALB/c and Slamf1-/-heart infected with the different trains of T. 
cruzi at 14 d.p.i. Arrows indicate amasigote nested. 
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8.2 TABLE 
8.2.1 Reference Strains 
Table S 1. Reference strains and corresponding discrete typing units (DTUs).  
 
Strain DTUs Country Host/Vector
92101601P cl1 TcI Georgia, Usa Didelphis marsupialis
CA-1 TcI Argentina Homo sapiens
Colombiana TcI Colombia Homo sapiens
Cuica cl1 TcI Sao Paulo, Brazil Philander opossum
Cutia Cl1 TcI Espirito Santo, Brazil Dasprocta aguti
Davis 9.90 TcI Tegucigalpa, Honduras Triatoma dimidiata
Dm28c TcI Carabobo, Venezuela Didelphis marsupialis
Dm7 TcI Casanare, Colombia Didelphis marsupialis
G TcI Amazonas, Brazil Opossum
Gamba cl1 TcI Sao Paulo, Brazil Didelphis azarae
JEM C TcI Boyaca, Colombia Homo sapiens
Jose TcI Paraiba, Brazil Homo sapiens
K-98 TcI Argentina Homo sapiens
PALC TcI Casanare, Colombia Rhodnius prolixus
Sylvio X10 cl1 TcI Para, Brazil Homo sapiens
Td11C TcI Boyaca, Colombia Triatoma dimidiata
X10/1 TcI Para, Brazil Homo sapiens
YuYu TcI Minas Gerais, Brazil Triatoma infestans
12SF TcII Bahia, Brazil Homo sapiens
21SF TcII Bahia, Brazil Homo sapiens
Esmeraldo cl3 TcII Bahia, Brazil Homo sapiens
IVV cl4 TcII Cuncumen, Chile Homo sapiens
MAS cl1 TcII Minas Gerais, Brazil Homo sapiens
Peruvian TcII Peru Homo sapiens
Tu18 cl1 TcII Tupiza, Bolivia Triatoma dimidiata
Y TcII Sao Paulo, Brazil Homo sapiens
3663 TcIII Amazonas, Brazil Oanstrongylus geniculatus
3869 TcIII Amazonas, Brazil Homo sapiens
4182 TcIII Amazonas, Brazil Rhodnius brethesi
CM17 TcIII Meta, Colombia Dasypus sp.
M5631 cl5 TcIII Para, Brazil Dasypus novemcinctus
M6421 cl6 TcIII Para, Brazil Homo sapiens
X109/2 TcIII Makthlawiya, Paraguay Canis familiaris
10R26 TcIV Santa cruz, Bolivia Aotus sp
4167 TcIV Amazonas, Brazil Rhodnius brethesi
92122102R TcIV Georgia, Usa Procyon lotor
CanIII cl1 TcIV Para, Brazil Homo sapiens
Dog Theis TcIV Oklahoma, USA Canis familiaris
92.80 cl 2 TcV Santa Cruz, Bolivia Homo sapiens
Bug2148 cl1 TcV Rio Grande do Sul, Brazil Triatoma infestans
Bug2149 cl10 TcV Rio Grande do Sul, Brazil Triatoma infestans
MN cl 2 TcV Region IV, Chile Homo sapiens
NR cl3 TcV Salvador, Chile Homo sapiens
Sc43 cl1 TcV Santa Cruz, Bolivia Triatoma infestans
SO3 cl5 TcV Potosi, Bolivia Triatoma infestans
CL TcVI Rio Grande do Sul, Brazil Triatoma infestans
CL Brener TcVI Rio Grande do Sul, Brazil Triatoma infestans
P63 cl1 TcVI Makthlawiya, Paraguay Triatoma infestans
RA TcVI Argentina Homo sapiens
Tulahuen TcVI Tulahuen, Chile Homo sapiens
Tulahuen cl2 TcVI Tulahuen, Chile Homo sapiens
VFRA TcVI Francia, Chile Triatoma infestans
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8.2.2 Mouse Genetic Background 
Table S 2. Gene Expression and parasite load correlations in BALB/c (Right) and C57BL/6(Left) peritoneal 
macrophages infected with different strains of T. cruzi in the interaction (1h). 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
Arg1 ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns Arg1
Irg1 ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
p< 0,001p<0.005p<0.05 p<0.05p<0.005p< 0,001
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Bearing in that gene expression in most cases was higher in C57BL/6 than BALB/c macrophages, we 
analyzed positive and negative gene expression correlation for each mouse strain upon infection at 
different time.Table S 2 shows the correlation during the Interaction: 
 Dm28c: BALB/c macrophages present only positive correlations between Tnf-Cybb, Arg1-
Tnf, Il1b-Il10 and Il10-Il6. In contrast, correlations of Cybb-Arg1, Il6-Arg-1, Il10-Cybb, Il6-Il1b 
and Tnf-Il6 changes from positive in BALB/c to negative in C57BL/6 macrophages. Positive 
correlation between Il10-Arg1, T. cruzi-Tlr2 and Il1b-Irg1 and negative correlation between 
Il1b-Cybb was found for C57BL/6 macrophages. 
 Y: We found only positive correlation for both mouse genetic backgrounds.  In BALB/c 
macrophages that correlation were Arg1-Il1b, Arg1-Il6, Arg1-10, Arg1-Tnf, Il1b-Il6, Il1b-Il10,  
 Il1b-Tnf, Il6-Il10, Il-6Tnf, Il10-Tnf and Slamf1-Tnf. Positive correlation between Irg1-Tnf, 
Cybb-Tnf, T. cruzi-Tlr2 and Cybb-Il10 was found for C57BL/6 macrophages. 
 M6421 cl6: BALB/c macrophages present only positive correlations between Cybb-T. cruzi. 
In contrast, the correlation between Arg1-Irg1 changes from positive in BALB/c to negative 
in C57BL/6 macrophages. Positive correlation between Il6-Arg1 and Slamf1-T. cruzi, and 
negative correlations between Irg1-Il6 and Cybb-Slamf1 were found for C57BL/6 
macrophages.  
 10R26: BALB/c macrophages present positive correlation between Il1b-Cybb, Il6-Cybb, Il6-
Il1b, Tnf-Il1b, Tnf-Il6, Tlr2-Il1b and Tlr2-Il6, and negative correlations between Tlr2-Slamf1. 
In contrast, the correlation between Arg1-Irg1 changes from positive in BALB/c to negative 
in C57BL/6 macrophages. Positive correlation between Arg1-Il10, Irg1-Il6, Irg1-Slamf1 and 
Cybb-Slamf1, and negative correlations between Arg1-Cybb, Arg1-Slamf1, Arg1-Tlr2, Irg1-
Il10 and Il10-Tlr2 were found for C57BL/6 macrophages.  
 Bug2148 cl1: BALB/c macrophages present positive correlation between Cybb-Irg1, Tnf-
Cybb and Il10-Il6. Positive correlation between Cybb-Il6, and negative correlations between 
was T. cruzi-Tlr2 found for C57BL/6 macrophages. Correlation between T. cruzi-Slamf1 
changes from positive in BALB/c to negative in C57BL/6 macrophages. 
 VFRA cl1: BALB/c macrophages present positive correlation between Arg1-Il6, Arg1-Tnf, 
Il1b-Il6, Il1b-Il10, Il1b-Tnf, Il6-Il10 and Il10-Tnf. C57BL/6 macrophages present also positive 
correlations between Arg-I1b, Irg1-Il6, Irg1-Tnf and Cybb-Il10. 
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Table S 3. Gene Expression and parasite load correlations in BALB/c (Right) and C57BL/6(Left) peritoneal 
macrophages infected with different strains of T. cruzi in the internalization (6h). 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns  ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
p< 0,001p<0.005 p<0.05 p<0.05 p<0.005p< 0,001
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Table S 3 shows gene expression and parasite load correlations during Internalization: 
 Dm28c: BALB/c macrophages present positive correlation between Arg1-Il10, Irg1-Il6 and 
Il6-Slamf1. Positive correlation between Cybb-Tnf and Il10-Tnf, and negative correlations 
between T. cruzi-Slamf1 and T. cruzi-Tlr2 were found for C57BL/6 macrophages.  
 Y: Positive correlation between Cybb-Il10 and Il1b-Tlr2, and negative correlations between 
Cybb-Il6 and T. cruzi-Tlr2 were found for BALB/c macrophages. Positive correlation between 
Il6-Tnf, and negative correlations between Arg1-Il10 was found for C57BL/6 macrophages.  
 M6421 cl6: Only positive correlations were found in both mouse genetic background, 
where in BALB/c were Arg1-Irg1, Arg1-Il6, Irg1-Il1b, Irg1-Il6, Cybb-Il6, Il1b-Il6 and T. cruzi-
Tlr2; and in C57BL/6 were Il6-Tnf and Slamf1-Tlr2. 
 10R26: Positive correlation in BALB/c was found between Cybb-Il1b. Only negative 
correlation were found in C57BL/6 macrophages. Only negative correlation were found in 
C57BL/6 macrophages, Cybb-Tnf and Il6-Tlr2. 
 Bug2148 cl1: The correlation between T. cruzi-Slamf1 changes from positive in BALB/c to 
negative in C57BL/6 macrophages. Positive correlation between Irg1-Cybb, Irg1-Il6 and 
Slamf1-Tlr2, and negative correlations between Arg1-Il6 was found for BALB/c. 
 VFRA cl1: We found only correlation in BALB/c macrophages where positive were Arg1-
Cybb, Arg1-Il10, Arg1-Tnf and Cybb-Il10, and negative was Il6-Tlr2. 
Finally, Table S 4 present the correlations during the intracellular proliferation. 
 Dm28c: We found only correlation in C57Bl/6 macrophages where positive was Il10-Cybb, 
and the negative was Slmaf1-Tlr2. 
 Y: BALB/c macrophages presented only positive correlation between Cybb-Tnf, Il6-Tnf and 
Tlr2-T. cruzi. C57BL/6 present a positive correlation between Slamf1-Tlr2, and negatives 
correlation between Arg1-Irg1 and Slamf1-Tlr2. 
 10R26: Positive correlation were found in BALB/c between Il6-Tnf, Slamf1-Tlr2 and Slamf1-
T. cruzi.In the case of C57BL/6 the positive correlation were Arg1-Il1b, Arg1-Il6, Arg-Tlr2 and 
Il1b-Il6, the negative correlation was Tlr2-T. cruzi. 
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Table S 4. Gene Expression and parasite load correlations in BALB/c (Right) and C57BL/6(Left) peritoneal 
macrophages infected with different strains of T. cruzi in the intracellular proliferation (24h). 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
p< 0,001p<0.005 p<0.05 p<0.05 p<0.005p< 0,001
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 Bug2148 cl1: Only positive correlations were found in BALB/c macrophages between Arg1-
Cybb, Tnf-Slamf1 and Slamf1-Tlr2.  The correlation between Tnf-Tlr2 changes from positive 
in BALB/c to negative in C57BL/6 macrophages. A positive correlation was found in C57BL/6 
between Arg1-Il6, and negatives correlation between Il1b-Il10, Slamf1-T. cruzi and Tlr2-T. 
cruzi. 
 M6421 cl6: For both background we found positive correction. BALB/c were Irg1-Il1b, Cybb-
Il10, Il1b-Tlr2 and Slamf1-Tlr2. C57BL/6 were Il6-Cybb and Il10-Tnf. 
 VFRA cl1: Only positive correlations were found in BALB/c macrophages between Irg1-Il10, 
Irg1-Tnf, Il1b-Il6 and Il10-Tnf. The correlation between Slamf1-T. cruzi changes from positive 
in BALB/c to negative in C57BL/6 macrophages. The positive correlation between Cybb-Il1b 
was found in C57BL/6 macrophages. 
Table S 5 shows the correlation during the Interaction: 
 Dm28c: Positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Arg1-Tnf and Irg1-Tnf, and a negative correlation between Irg1-Il6. 
The correlations that disappear from C57BL/6 to Tlr2-/- macrophages were the positive 
between Arg1-Il1b, Arg1-Il10, Cybb-Il6, Il1b-Tnf and Tlr2-T. cruzi, and the negatives Arg1-
Cybb, Cybb-Il1b, Cybb-Il10 and Il10-Il6.   
 Y: Positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Arg1-Irg1, Arg1-Tnf and Il1b-Il6, and negative correlations were 
Arg1-Il1b, Arg1-Il6, Irg1-Il1b, Irg1-Il6, Il1b-Tnf and Il6-Tnf. All the correlations that disappear 
from C57BL/6 to Tlr2-/- macrophages were the positive between Cybb-Il10, Cybb-Tnf and 
Tlr2-T. cruzi. 
 M6421 cl6: Only positive correlations associated with the Tlr2 deficiency were found in Tlr2-
/- macrophages between Irg1-Il1b and Cybb-Tnf. The correlations that disappear from 
C57BL/6 to Tlr2-/- macrophages was the positive between Arg1-Il6, and the negatives Arg1-
Irg1, Irg1-Il6, Cybb-Slamf1 and Slamf1-T. cruzi. 
 
 
 
159 
 
8.2.3 TLR2 in macrophages 
Table S 5. Gene expression and parasite load correlation between C57BL/6 (Right) and Tlr2-/- (Left) 
peritoneal macrophages infected with different strains of T. cruzi in the interaction (1h). 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
Arg1 ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
p< 0,001p<0.005 p<0.05 p<0.05 p<0.005p< 0,001
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 10R26: Positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Arg1-Il1b, Irg1-Il1b, Il1b-Il10 and Slamf1-T. cruzi, and the negative 
correlation between Il6-Tnf. The correlations between Arg1-Irg1, Arg1-Cybb and Irg1-Il10 
changes from positive in C57BL/6 to negative in Tlr2-/- macrophages. The correlations that 
disappear from C57BL/6 to Tlr2-/- macrophages were the positive between Irg1-Il6, Irg1-
Slamf1, Irg1-Tlr2, Cybb-Slamf1 and Slamf1-Tlr2, and the negatives were Arg1-Slamf1, Arg1-
Tlr2 and Il10-Tlr2. 
 Bug2148 cl1: Only positive correlations associated with the Tlr2 deficiency were found in 
Tlr2-/- macrophages between Cybb-Il10 and Il1b-Tnf. The correlations that disappear from 
C57BL/6 to Tlr2-/- macrophages were the positive between Irg1-Tnf, Cybb-Il6 and Slamf1-T. 
cruzi. 
 VFRA cl1: Only positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Arg1-Tnf, Irg1-Cybb and Irg1-Il1b. The correlations that disappear 
from C57BL/6 to Tlr2-/- macrophages were the positive between Arg1-Il1b, Irg1 Il6, Irg-Tnf, 
Cybb-Il10, Il6-Tnf and Tlr2-Tnf. 
Table S 6 shows the correlation during the Internalization: 
 Dm28c: Positive correlation associated with the Tlr2 deficiency was found in Tlr2-/- 
macrophages between Cybb-Il1b, and a negative correlation between Il1b-Il10. The 
correlations between Cybb-Il10 changes from positive in C57BL/6 to negative in Tlr2-/- 
macrophages. The correlations that disappear from C57BL/6 to Tlr2-/- macrophages were 
the positive between Il10-Tnf and Slamf1-Tlr2, and the negatives Slamf1-T. cruzi and Tlr2-T. 
cruzi.   
 Y: Positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Cybb-Irg1, Il1b-Irg1, Il1b-Cybb, Tnf-Irg1, Tnf-Cybb and Tnf-Il1b. The 
correlations that disappear from C57BL/6 to Tlr2-/- macrophages were the positive between 
Il6-Tnf, and the negative Arg1-Il10. 
 M6421 cl6: Positive correlation associated with the Tlr2 deficiency was found in Tlr2-/- 
macrophages between Il10-Irg1, and the negatives Il6-Cybb and Tnf-Il1b. The correlations 
correlations that disappear from C57BL/6 to Tlr2-/- macrophages were the positive between 
Il1b-Il6, and the negative Il6-Tlr2.  
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Table S 6. Gene expression and parasite load correlation between C57BL/6 (Right) and Tlr2-/- (Left) 
Peritoneal macrophages infected with different strains of T. cruzi in the internalization (6h). 
  
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
p< 0,001p<0.005 p<0.05 p<0.05 p<0.005p< 0,001
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Table S 7 shows the correlation during the Intracellular proliferation: 
 Dm28c: Positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Arg1-Il1b and Il10-Tnf, and the negatives Arg1-Cybb and Arg1-Il6. 
The correlation that disappear from C57BL/6 to Tlr2-/- macrophages was the positive 
between Cybb-Il10, and negative Slamf1-Tlr2. 
 Y: Positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Cybb-Il1b, Tnf-Cybb and Il1b-Tnf, and a negative correlation 
between Slamf1-Arg1. The correlation that disappear from C57BL/6 to Tlr2-/- macrophages 
was the positive between Slamf1-Tlr2, and the negatives Arg1-Irg1 and Slamf1-T. cruzi.   
 M6421 cl6: Positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Il1b-Cybb, Cybb-Tnf and Il1b-Tnf. The correlations that disappear 
from C57BL/6 to Tlr2-/- macrophages were the positive between Cybb-Il6, Il10-Tnf and 
Slamf1-T. cruzi. 
 10R26: Positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Il10-Cybb, Cybb-Tnf, Cybb-Slamf1 and Tnf-Slamf1, and the negatives 
Arg1-Cybb, Arg1-Tnf and Arg1-Slamf1. The correlations that disappear from C57BL/6 to Tlr2-
/- macrophages were the positive between Arg1-Il1b, Arg1-Il6, Arg-Tlr2 and Il1b-Il6, and the 
negative Tlr2-T. cruzi.  
 Bug2148 cl1: Positive correlations associated with the Tlr2 deficiency were found in Tlr2-/- 
macrophages between Irg1-Cybb, Irg1-Il1b, Irg1-Il6 and Cybb-Il1b. The correlations that 
disappear from C57BL/6 to Tlr2-/- macrophages were the positive between Arg1-Il6, Tnf-Tlr2 
and Slamf1-T. cruzi, and the negatives Il1b-Il10 and Tlr2-T. cruzi. 
 VFRA cl1: Only a negative correlation associated with the Tlr2 deficiency was found in Tlr2-/- 
macrophages between Irg1-Slamf1. The correlation that disappear from C57BL/6 to Tlr2-/- 
macrophages was the positive between Cybb-Il1b, and the negative Slamf1-T. cruzi 
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Table S 7. Gene expression and parasite load correlation between C57BL/6 (Right) and Tlr2-/- (Left) 
peritoneal macrophages infected with different strains of T. cruzi in the intracellular proliferation (24h). 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
Arg1 ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
p< 0,001p<0.005 p<0.05 p<0.05 p<0.005p< 0,001
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8.2.4 SLAMF1 in macrophages 
Table S 8 shows the correlation during the Interaction: 
 Dm28c) Positive correlations associated with the Slamf1 deficiency were found in Slamf1-/- 
macrophages between Arg1-Irg1, Arg1-Cybb, Arg1-Tlr2, Irg1-Cybb, Irg1-Il6, Irg1-Tnf and Il6-
Tlr2. The correlations that disappear from BALB/c to Slamf1-/- macrophages were the 
positive between Arg1-Il1b, Cybb-Il6, Cybb-Tnf, Il1b-Il6, Il1b-Il10 and Il6-Il10 
 Y: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-/- 
macrophages between Irg1-Tnf, Cybb-Il6 and Il10-T. cruzi, and the negative Tnf-Tlr2. The 
correlation between Arg1-Il6 changes from positive in BALB/c to negative in Slamf1-/- 
macrophages. The correlations that disappear from BALB/c to Slamf1-/- macrophages were 
the positive between Arg1-Il1b, Arg1-Il10, Arg1-Tnf, Il1b-Il6, Il1b-Il10, Il1b-Tnf, Il6-Il10, Il6-
Tnf, Il10-Tnf and Slamf1-Tlr2.  
 M6421 cl6: Positive correlations associated with the Slamf1 deficiency were found in 
Slamf1-/- macrophages between Arg1-Cybb, Arg1-Il6, Arg1-Il10, Cybb-Il1b, Cybb-Il6, Cyb-Il10, 
Irg1-Tlr2, Il1b-Il6, Il1b-Il10, Il6-Il10, Il6-Tnf and Il10-Tnf. The correlations that disappear from 
BALB/c to Slamf1-/- macrophages were the positive between Arg1-Irg1 and Cybb-T. cruzi. 
 10R26: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-/- 
macrophages between Irg1-Cybb, Irg1-Il1b, Irg1-Il6, Irg1-Il10, Irg1-Tnf, Cybb-Il10, Cybb-Tnf, 
Il1b-Il10, Il6-Il10 and Il10-Tnf. The correlations that disappear from BALB/c toSlamf1-/- 
macrophages were the positive between Arg1-Irg1, Irg1-Tlr2, Il1b-Tlr2 and Il6-Tlr2, and the 
negative Slamf1-Tlr2. 
 Bug2148 cl1: Positive correlations associated with the Slamf1 deficiency were found in 
Slamf1-/- macrophages between Arg1-Il10 and Cybb-Il6. The correlations that disappear from 
BALB/c to Slamf1-/- macrophages were the positive between Irg1-Cybb, Irg1-Tnf and Cybb-
Tnf, and the negatives Slamf1-T. cruzi and Tlr2-T. cruzi. 
 VFRA cl1: Positive correlation associated with the Slamf1 deficiency was found in Slamf1-/- 
macrophages between Arg1-Il1b. . The correlations that disappear from BALB/c to Slamf1-/- 
macrophages were the positive between Arg1-Il6, Arg1-Tnf, Il1b-Il6, Il1b-Tnf, Il6-Il10, Il6-Tnf and 
Il10-Tnf. 
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Table S 8. Gene Expression and parasite load correlations in BALB/c (Right) and Slamf1-/- (Left) peritoneal 
macrophages infected with different strains of T. cruzi in the interaction (1h). 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
Arg1 ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns Il6
Il10 ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns Il10
Tnf ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns Irg1
Cybb ns ns ns ns ns Cybb
Il1b ns ns ns ns ns Il1b
Il6 ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
p< 0,001 p<0.005 p<0.05 p<0.05 p<0.005 p< 0,001
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Table S 9. Gene Expression and parasite load correlations in BALB/c (Right) and Slamf1-/- (Left) peritoneal 
macrophages infected with different strains of T. cruzi in the internalization (6h). 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns  ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
p< 0,001 p<0.005 p<0.05 p<0.05 p<0.005 p< 0,001
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Table S 9 shows the correlation during the Internalization: 
 Dm28c: The correlations that disappear from BALB/c to Slamf1-/- macrophages were the 
positive between Irg1-Il6, Cybb-Il10, Il6-Slamf1 and Slamf1-Tlr2. 
 Y: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-/- 
macrophages between Arg1-Il10, Irg1-Il1b, Irg1-Il10, Cybb-Il1b, Il1b-Il6, Il1b-Il10 and Il6-Il10. 
The correlation between Cybb-Il6 changes from negative in BALB/c to positive in Slamf1-/- 
macrophages. The correlation that disappear from BALB/c to Slamf1-/- macrophages was the 
positive between Il1b-Tlr2. 
 M6421 cl6: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-
/- macrophages between Arg1-Cybb, Ag1-Il10, Arg1-Tnf and Cybb-Tnf. The correlations that 
disappear from BALB/c to Slamf1-/- macrophages were the positive between Arg1-Irg1, 
Arg1-Il6, Irg1-Il1b, Irg1-Il6, Cybb-Il6, Il1b-Il6 and Tlr2-T. cruzi. 
 10R26: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-/- 
macrophages between Arg1-Irg1 and Il10-Tnf. The correlation that disappear from BALB/c 
to Slamf1-/- macrophages was the positive between Cybb-Il1b, and the negative Slamf1-T. 
cruzi. 
 Bug2148 cl1: Positive correlations associated with the Slamf1 deficiency were found in 
Slamf1-/- macrophages between Irg1-Il1b and Tlr2-T. cruzi, and the negative Arg1-Cybb.  
 VFRA cl1: Negative correlation associated with the Slamf1 deficiency was found in Slamf1-/- 
macrophages between Il1b-T. cruzi. The correlation between Arg1-Cybb changes from 
positive in BALB/c to negative in Slamf1-/- macrophages. The correlations that disappear 
from BALB/c to Slamf1-/- macrophages were the positive between Arg1-Il10, Arg1-Tnf and 
Cybb-Il10, and the negative Il6-Tlr2. 
Table S 10 shows the correlation during the Intracellular proliferation: 
 Dm28c: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-/- 
macrophages between Arg1-Il6 and Arg1-T. cruzi.  
 Y: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-/- 
macrophages between Irg1-Il6, Irg1-Il10, Il1b-Il10 and Il1b-Tnf. The correlations that 
disappear from BALB/c to Slamf1-/- macrophages were the positive between Cybb-Tnf and 
Il6-Tnf.The correlations that disappear from BALB/c to Slamf1-/- macrophages were the 
positive between Irg1-Cybb, Irg1-Il6, Slamf1-Tlr2 and Slamf1-T. cruzi, and the negative Arg1-
Il6. 
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Table S 10. Gene Expression and parasite load correlations in BALB/c (Right) and Slamf1-/- (Left) peritoneal 
macrophages infected with different strains of T. cruzi in the intracellular proliferation (24 h). 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
Arg1 ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns ns ns Cybb
Il1b ns ns ns ns ns ns ns ns ns Il1b
Il6 ns ns ns ns ns ns ns ns Il6
Il10 ns ns ns ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns ns Tnf
Slamf1 ns ns ns ns ns ns ns ns ns Slamf1
Tlr2 ns ns ns ns ns ns ns ns ns Tlr2
T.cruzi ns ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf Slamf1 Tlr2 T.cruzi
p< 0,001 p<0.005 p<0.05 p<0.05 p<0.005 p< 0,001
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 M6421 cl6: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-
/- macrophages between Irg1-Tnf and Cybb-Il6. The correlations that disappear from BALB/c 
to Slamf1-/- macrophages were the positive between Irg1-Il1b, Cybb-Il10, Il1b-Tlr2, Slamf1-
Tlr2 and Slamf1-T. cruzi. 
 10R26: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-/- 
macrophages between Arg1-Cybb, Cybb-Il10 and Il1b-Il10. The correlations that disappear 
from BALB/c to Slamf1-/- macrophages were the positive between Il6-Tnf, Slamf1-Tlr2 and 
Slamf1-T. cruzi. 
 Bug2148 cl1: Positive correlations associated with the Slamf1 deficiency were found in 
Slamf1-/- macrophages between Irg1-Il1b and Irg1-Il6, and the negative Irg1-Il10. The 
correlations that disappear from BALB/c to Slamf1-/- macrophages were the positive 
between Arg1-Cybb, Tnf-Slamf1, Tnf-Tlr2 and Slamf1-Tlr2. 
 VFRA cl1: Positive correlations associated with the Slamf1 deficiency were found in Slamf1-/- 
macrophages between Cybb-Il1b and Cybb-Il10, and the negative Irg1-T. cruzi. The 
correlations that disappear from BALB/c to Slamf1-/- macrophages were the positive 
between Irg1-Il10, Irg1-Tnf, Il1b-Il6, Il10-Tnf and Slamf1-T. cruzi. 
8.2.5 Spleen 
Table S 11. Gene Expression and parasite load correlations in the spleens of BALB/c (Right) and Slamf1-/- 
(Left) mice infected with different strains of T. cruzi at 14 d.p.i. Red Color positive correlation p<0.001. 
 
Irg1 Cybb Il1b Il6 Il10 Tnf T.cruzi
Irg1 ns Irg1
Cybb ns Cybb
Il1b ns ns ns Il1b
Il6 ns ns ns Il6
Il10 ns ns ns ns Il10
Tnf ns ns ns ns ns Tnf
T.cruzi ns ns ns ns ns ns T.cruzi
Irg1 ns Irg1
Cybb ns ns Cybb
Il1b ns ns ns Il1b
Il6 ns ns ns ns Il6
Il10 ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns Tnf
T.cruzi ns ns ns ns ns ns T.cruzi
Irg1 ns Irg1
Cybb ns ns Cybb
Il1b ns Il1b
Il6 ns ns Il6
Il10 ns ns Il10
Tnf ns Tnf
T.cruzi ns ns ns ns ns ns T.cruzi
Irg1 Cybb Il1b Il6 Il10 Tnf T.cruzi
p< 0,001 p< 0,001
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Appearance and disappearance in the correlations between the spleen of BALB/c and Slamf1-/- mice 
at 14d.p.i. indicate the role of SLAMF1 receptor in the infection with the different strains of T. cruzi 
(Table S 11). 
 Dm28c: Positive correlations associated with the SLAMF1 deficiency were found in spleen of 
Slamf1-/- mice between Cybb-Il1b, Cybb-Il6, Cybb-Il10, Cybb-Tnf, Il1b-Il6, Il1b-Tnf, Il6-Il10, Il6-
Tnf and Il10-Tnf.  
 Y: Positive correlations associated with the SLAMF1 deficiency were found in spleen of 
Slamf1-/- mice between Irg1-Il6, Irg1-Il10, Irg1-Tnf, Il1b-Il6, Il1b-Tnf, Il6-Il10, Il6-Tnf and Il10-
Tnf, and the negatives Cybb-Il1b, Cybb-Il10 and Cybb-Tnf. The correlation between Irg1-Il1b 
changes from negative in BALB/c to positive in Slamf1-/- mice. 
 VFRA cl1: Positive correlations associated with the SLAMF1 deficiency were found in spleen 
of Slamf1-/- mice between Irg-Il10 and the negative Irg1-Cybb. The correlation that disappear 
from the spleen of BALB/c to Slamf1-/- mice was Il6-Tnf. The correlation between Irg1-Tnf, 
Cybb-Il6 and Cybb-Il10 changes from positive in BALB/c to negative in Slamf1-/- mice, and 
negative to positive was Cybb-Il1b. 
Table S 12. Gene Expression and parasite load correlations in the spleens of BALB/c (Right) and Slamf1-/- 
(Left) mice infected with different strains of T. cruzi at 21 d.p.i. Red Color positive correlation p<0.001. 
 
 
Irg1 Cybb Il1b Il6 Il10 Tnf T.cruzi
Irg1 ns Irg1
Cybb ns Cybb
Il1b ns ns ns Il1b
Il6 ns ns ns ns Il6
Il10 ns ns ns ns ns Il10
Tnf ns ns ns ns ns ns Tnf
T.cruzi ns ns ns ns ns ns T.cruzi
Irg1 ns Irg1
Cybb ns Cybb
Il1b ns Il1b
Il6 ns Il6
Il10 ns Il10
Tnf ns ns Tnf
T.cruzi ns ns ns ns ns ns T.cruzi
Irg1 ns Irg1
Cybb ns ns ns Cybb
Il1b ns ns Il1b
Il6 ns Il6
Il10 ns Il10
Tnf ns Tnf
T.cruzi ns ns ns ns ns ns T.cruzi
Irg1 Cybb Il1b Il6 Il10 Tnf T.cruzi
p< 0,001 p< 0,001
Negative CorrelationPositive Correlation
BALB/c
B
A
L
B
/c
T
c
V
I (V
F
R
A
 c
l1
)
S
la
m
f1
-/-
T
c
I (D
m
2
8
c
)
T
c
II (Y
)
Slamf1
-/-
T
c
I 
(D
m
2
8
c
)
T
c
II
 (
Y
)
T
c
V
I 
(V
F
R
A
 c
l1
)
171 
 
The correlation in the spleen at 21 d.p.i. are explained on Table S 12. 
 Dm28c: Positive correlations associated with the SLAMF1 deficiency were found in spleen of 
Slamf1-/- mice between Irg1-Il1b, Irg1-Il6, Irg1-Il10, Irg1-Tnf, Cybb-Il1b, Cybb-Il6, Cybb-Il10, 
Cybb-Tnf, Il1b-Il6, Il1b-Il10, Il1b-Tnf, Il6-Il10, Il6-Tnf and Il10-Tnf.  
 Y: Negative correlation associated with the Slamf1 deficiency was found in spleen of Slamf1-
/- mice between Cybb-Tnf. The correlation between Irg1-Cybb, Irg1-Il1b, Irg1-Il10, Irg1-Tnf, 
Il6-Il10 and Il6-Tnf changes from positive in BALB/c to negative in Slamf1-/- mice. 
 VFRA cl1: The correlations that disappear from the spleen of BALB/c to Slamf1-/- mice were 
the positive between Cybb-Il1b, and the negative were Cybb-Il6 and Il1b-Il6. The correlation 
between Irg1-Tnf, Cybb-Il6 and Cybb-Il10 changes from negative in BALB/c to positive in 
Slamf1-/- mice 
8.2.6 Heart 
Appearance and disappearance in the correlations between the heart of BALB/c and Slamf1-/- mice 
at 14 d.p.i. indicate the role of SLAMF1 receptor in the infection with the different strains of T. cruzi 
(Table S 13), all correlations were positive. 
 Dm28c: The correlations that disappear from the heart of BALB/c to Slamf1-/- mice were the 
positive between Irg1-Il10 and Irg10-Tnf.  
 Y: Positive correlations associated with the Slamf1 deficiency were found in spleen of 
Slamf1-/- mice between Irg1-Cybb, Cybb-Il1b and Cybb-Il10. The correlations that disappear 
from the heart of BALB/c to Slamf1-/- mice were the positive between Irg1-Il6 and Il1b-Il6. 
 VFRA cl1: The correlations that disappear from the heart of BALB/c to Slamf1-/- mice were 
the positive between Cybb-Il6, Cybb-Il10 and Il6-Il10. 
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Table S 13. Gene Expression and parasite load correlations in the hearts of BALB/c (Right) and Slamf1-/- (Left) 
mice infected with different strains of T. cruzi at 14 d.p.i. Red Color positive correlation p<0.001. 
 
The correlation in the heart at 21 d.p.i. are explained on Table S 14. 
 Dm28c: Negative correlation associated with the Slamf1 deficiency was found in heart of 
Slamf1-/- mice between Irg1-Il1b. The correlation between Arg1-Ir1, Arg1-Il10, Cybb-Il6, Il1b-
Il6,  and Il6-Tnf changes from negative in BALB/c to positive in Slamf1-/- mice, and the 
positive to negative Arg1-Cybb, Arg1-Il1b, Arg1-Tnf and Irg1-Il6. 
 Y: The correlations that disappear from the heart of BALB/c to Slamf1-/- mice were the 
positive between Arg1-Il6, Arg1-Il10, Irg1-Il6, Irg1-Il10, Cybb-Il1b, Cybb-Tnf, Il1b-Tnf and Il6-
Il10 , and the negative Arg1-Cybb, Arg1-Il1b, Arg1-Tnf, Irg1-Cybb, Irg1-Il1b, Irg1-Tnf, Cybb-
Il6, Cybb-Il10, Il1b-Il6, Il1b-Il10, Il6-Tnf and Il10-Tnf. 
 VFRA cl1: Positive correlations associated with the SLAMF1 deficiency we found in spleen of 
Slamf1-/- mice between Il1b-Tnf, Il6-Il10, Il6-Tnf and Il10-Tnf. The correlations that disappear 
from the heart of BALB/c to Slamf1-/- mice was the negative between Cybb-Il6. The 
correlation between Arg1-Il1b, Cybb-Il10, Cybb-Tnf, Il1b-Il6 and Il1b-Il10 changes from 
negative in BALB/c to positive in Slamf1-/- mice, and positive to negative were Irg1-Il10 and 
Irg1-Tnf. 
 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf T.cruzi
Arg1 ns Arg1
Irg1 ns ns ns Irg1
Cybb ns Cybb
Il1b ns Il1b
Il6 ns Il6
Il10 ns Il10
Tnf ns Tnf
T.cruzi ns ns ns ns ns ns ns T.cruzi
Arg1 ns Arg1
Irg1 ns ns ns ns Irg1
Cybb ns ns Cybb
Il1b ns ns ns ns ns Il1b
Il6 ns ns Il6
Il10 ns ns ns ns ns Il10
Tnf ns Tnf
T.cruzi ns ns ns ns ns ns ns T.cruzi
Arg1 ns Arg1
Irg1 ns Irg1
Cybb ns ns ns Cybb
Il1b ns Il1b
Il6 ns ns Il6
Il10 ns Il10
Tnf ns Tnf
T.cruzi ns ns ns ns ns ns ns T.cruzi
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Table S 14. Gene Expression and parasite load correlations in the hearts of BALB/c (Right) and Slamf1-/- (Left) 
mice infected with different strains of T. cruzi at 21 d.p.i. Red Color positive correlation p<0.001. 
 
8.2.7 Liver 
Appearance and disappearance in the correlations between the liver of BALB/c and Slamf1-/- mice at 
14 d.p.i. indicate the role of SLAMF1 receptor in the infection with the different strains of T. cruzi 
(Table S 15) all correlations were positive. 
 Dm28c: Positive correlations associated with the Slamf1 deficiency were found in spleen of 
Slamf1-/- mice between Irg1-T. cruzi and Cybb-Il1b.  
 Y: The correlations that disappear from the liver of BALB/c to Slamf1-/- mice were the 
positive between Irg1-Cybb, Irg1-Il1b, Irg1-Il6, Irg1-Il10, Irg1-Tnf, Cybb-Il1b, Cybb-Il10, Il1b-
Il6, Il1b-Il10, Il1b-Tnf, Il6-Il10 and Il10-Tnf. 
 VFRA cl1: Positive correlations associated with the Slamf1 deficiency were found in spleen of 
Slamf1-/- mice between Irg1-Il10 and Il1b-Il10. The correlations that disappear from the liver 
of BALB/c to Slamf1-/- mice were the positive between Irg1-Cybb, Irg1-Il6, Cybb-Il1b, Cybb-Il6 
and Il1b-Il6. 
 
 
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf T.cruzi
Arg1 ns Arg1
Irg1 ns Irg1
Cybb ns Cybb
Il1b ns ns Il1b
Il6 ns Il6
Il10 ns Il10
Tnf ns Tnf
T.cruzi ns ns ns ns ns ns ns T.cruzi
Arg1 ns ns ns ns ns ns Arg1
Irg1 ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns Cybb
Il1b ns ns ns ns Il1b
Il6 ns ns ns Il6
Il10 ns ns Il10
Tnf ns Tnf
T.cruzi ns ns ns ns ns ns ns T.cruzi
Arg1 ns Arg1
Irg1 ns Irg1
Cybb ns ns Cybb
Il1b ns Il1b
Il6 ns Il6
Il10 ns ns Il10
Tnf ns ns ns ns Tnf
T.cruzi ns ns ns ns ns ns ns T.cruzi
Arg1 Irg1 Cybb Il1b Il6 Il10 Tnf T.cruzi
p< 0,001 p< 0,001
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Table S 15. Gene Expression and parasite load correlations in the livers of BALB/c (Right) and Slamf1-/- (Left) 
mice infected with different strains of T. cruzi at 14 d.p.i. Red Color positive correlation p<0.001. 
 
The correlation in the liver at 21 d.p.i. are explained on Table S 16. 
Table S 16. Gene Expression and parasite load correlations in the livers of BALB/c (Right) and Slamf1-/- (Left) 
mice infected with different strains of T. cruzi at 21 d.p.i. Red Color positive correlation p<0.001. 
 
 Dm28c: The correlation between Irg1-Il1b, Irg1-Il6, Cybb-Il1b, Cybb-Il6, Il1b-Il10, Il1b-Tnf, Il6-
Il10 and Il6-Tnf changes from negative in BALB/c to positive in Slamf1-/- mice. 
Irg1 Cybb Il1b Il6 Il10 Tnf T.cruzi
Irg1 Irg1
Cybb ns ns ns ns Cybb
Il1b ns ns ns ns ns Il1b
Il6 ns ns ns ns ns Il6
Il10 ns ns ns ns ns Il10
Tnf ns ns ns ns ns Tnf
T.cruzi ns ns ns ns ns ns T.cruzi
Irg1 ns ns ns ns ns ns Irg1
Cybb ns ns ns ns ns Cybb
Il1b ns ns ns ns Il1b
Il6 ns ns ns ns Il6
Il10 ns ns Il10
Tnf ns ns ns Tnf
T.cruzi ns ns ns ns ns ns T.cruzi
Irg1 ns ns ns ns Irg1
Cybb ns ns ns Cybb
Il1b ns ns ns Il1b
Il6 ns Il6
Il10 ns ns ns Il10
Tnf ns Tnf
T.cruzi ns ns ns ns ns ns T.cruzi
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 Y: The correlation that disappear from the liver of BALB/c to Slamf1-/- mice was the positive 
between Irg1-Cybb. The correlations that disappear from the heart of BALB/c to Slamf1-/- 
mice was the negative between Cybb-Il6. The correlation between Irg1-Il1b, Irg1-Il6, Irg1-
Il10, Irg1-Tnf, Cybb-Il1b, Cybb-Il6, Cybb-Il10, Il1b-Tnf and Il6-Tnf changes from positive in 
BALB/c to negative in Slamf1-/- mice. 
 VFRA cl1: The correlation between Irg1-Cybb, Irg1-Il1b,  Cybb-Il1b, Cybb-Il6,Cybb-Il10, Cybb-
Tnf, Il1b-Il6,  Il1b-Il10 and Il1b-Tnf changes from negative in BALB/c to positive in Slamf1-/- 
mice. 
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a b s t r a c t
Chagas disease is caused by the protozoan Trypanosoma cruzi. This parasite is transmitted to humans
mainly through the faeces of infected triatomine ‘‘kissing’’ bugs, by blood transfusions or organ donation
from infected donors, and can be transmitted from mother to child. This disease is endemic in the
Americas, where Bolivia has up to 28.8% prevalence in general population. Increased migration to Europe
has made it emerge in countries where it was previously unknown, being Spain the second country in
number of patients after the United States. T. cruzi is an organism with a rich genetic diversity, what
has been grouped into six discrete typing units (DTUs). Some authors have linked these DTUs either to
specific geographical distribution or to the different clinical presentations. Nevertheless little is known
about its distribution in migrant populations. Our aim was to describe the T. cruzi strains isolated from
a population of chronically infected Bolivian patients attending our clinic in Madrid. Thirty-three consec-
utive patients meeting this condition were selected for the study. Molecular characterization was per-
formed by an algorithm that combines PCR of the intergenic region of the mini exon-gene, the 24Sa
and 18S regions of rDNA and the variable region of the satellite DNA. A descriptive analysis was
performed and associations between epidemiological/clinical data and the different DTUs were tested.
Twenty-seven out of thirty-three patients had their DTU detected. Mean age was 36 years (IQR
31–43.3) and 23 were women (76.7%). The median time since arrival to Spain was 60 months
(IQR 43–81). The most common DTU were TcV, TcIV and TcI. Four patients had cardiac involvement: 2
had TcV and 2 could not have their DTU determined. TcIII was not isolated from any patient. DTUs dis-
tribution in migrant population seems to be similar to that observed in the patients’ countries of origin.
 2013 Elsevier B.V. All rights reserved.
1. Introduction
Chagas disease is caused by the protozoan parasite Trypanosoma
cruzi. It has an acute initial form that is asymptomatic for most pa-
tients and a chronic form that manifests with cardiac, digestive, or
cardiodigestive involvement after the acute infection. Patients can
remain in a chronic indeterminate stage for decades, although
every year 2–5% progress to a clinical stage. This disease is endemic
in the Americas, and prevalence has reached 28.8% in the general
population (Moncayo and Silveira, 2009). Increased migration to
Europe means that Chagas disease has emerged in countries where
it was previously unknown (Schmunis and Yadon, 2010). It is par-
ticularly frequent in Spain, which is the second country in number
of cases after the US (Pérez-Molina et al., 2012). The increasing
number of diagnoses made during the last decade have intensified
the burden on the Spanish health system, which now has to
streamline identification and treatment of a disease that was pre-
viously classed as tropical (Navarro et al., 2012). Many other Euro-
pean countries have faced a similar problem, and it is estimated
that this disease goes undiagnosed in 92–96% of cases in its chronic
indeterminate form (Basile et al., 2011).
Different typing methods have made it possible to identify sev-
eral ancestral parasite lineages, and six near-clades (TcI to TcVI)
have been identified. These near-clades are known as discrete typ-
ing units (DTU), which have been defined as ‘‘sets of stocks that are
genetically more related to each other than to any other stock and
that are identifiable by common genetic, molecular or immunolog-
ical markers’’ (Zingales et al., 2009). DTUs have been linked to spe-
cific geographical distributions and various clinical presentations,
and data on the isolation of T. cruzi in vectors, reservoirs, and
human samples from different origins have added to our knowledge
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of the evolution and distribution of the species in the Americas
(Burgos et al., 2010; Ramírez et al., 2010; Zingales et al., 2012).
Nevertheless, little is known about the exact distribution this species
in the migrant population.
2. Objective
Our hypothesis was that the presence of the most common
DTUs in a specific endemic area would be uniform in migrants
from that area; however, we cannot predict whether biological
characteristics such as degree of persistence in blood, tissue tro-
pism, or absence of reinfection could modify the distribution of
DTUs in non-endemic areas. Our aim was to describe the T. cruzi
strains identified from a population of chronically infected Bolivian
patients attending our clinic in Madrid.
3. Methods
We conducted a cross-sectional observational study. Thirty-
three consecutive Bolivian patients who were chronically infected
with T. cruziwere selected from those attended at our clinic during
the period 2010–2011. They all had positive results in two serolog-
ical tests: in-house IFAT and ELISA (ARCHITECT Chagas ELISA test,
BiosChile, Abbott Laboratories,Wiesbaden, Germany). Our in-house
IFAT was prepared with a combination of cultured epimastigote
antigens (Mc, T, and Dm28), and human IgG (bioMérieux) was
used as a marker. Thirteen patients had a positive PCR result in
blood. Molecular characterization was performed using an algo-
rithm combining the PCR of the intergenic region of the mini-exon
gene, the 24Sa and 18S regions of rDNA, and the variable region of
the satellite DNA, as described elsewhere (Ramírez et al., 2013). The
primers used were kinetoplast DNA (primers 121 [50-AAATAATGTA
CGGGKGAGATGCATGA-30] and 122 [50-GGTTCGATTGGGGTTGGT
GTAATATA-30]) and the tandem repeat satellite region from
T. cruzi (primers cruzi1 [50-ASTCGGCTGATCGTTTTCGA-30] and cru-
zi2 [50-AATTCCTCCAAGCAGCGGATA-30] (Liarte et al., 2009). The
molecular markers used were the intergenic region of the non-
transcribed mini-exon gene (primers TCC [50-CCC CCC TCC CAG
GCC ACA CTG-30], TC1 [50-GTG TCC GCC ACC TCC TTCGGG CC-30],
and TC2 [50-CCT GCA GGC ACA CGT GTG TGT G-30]) (Souto et al.,
1996). All mini-exon gene PCR assays were performed using two
primers instead of a multiplex PCR assay to determine the presence
of mixed infections. Thus, PCR was applied using the primers TCC-
TC1 and TCC-TC2. Segments containing the D7 domain of LSU rDNA
were amplified from genomic DNA by PCR using the trypanoso-
matid conserved primers D75 (50-GCAGATCTTGGTTGGCGTAG-30)
and D76 (50-GGTTCTCTGTTGCCCCTTTT-3) (Briones et al., 1999), as
well as A10 with primers pr1 (5-CCGCTAAGCAGTTCTGTCCATA-3)
and pr3 (5-GCTTTATTACCCCATGCCACAG-3) (Burgos et al., 2010).
We performed a descriptive analysis and tested associations be-
tween epidemiological and clinical data and the different DTUs. We
specifically analyzed age, sex, cardiac or digestive involvement,
and time since arrival in Spain. Qualitative data were analyzed
using the v2 and Fisher exact tests; quantitative data were ana-
lyzed using the t test.
4. Results
DTUs were identified in 27 of the 33 patients. Mean age was
36 years (IQR, 31-43.3), and 23 patients were women (76.7%).
The median time since arrival in Spain was 60 months (IQR, 43-
81). These characteristics were similar to those of the population
commonly attended at our clinic. DTU was not characterized in
six patients. The most prevalent DTU was TcV (n = 15, 45.5%),
followed by TcIV (n = 5, 15.2%) and TcI (n = 1, 3%). Six patients
presented a combination of two different DTUs: two patients
(6.1%) presented TcI in combination with TcIV, two (6.1%) had TcIV
with TcV, one (3%) had TcI and TcV, and one (3%) had TcII and TcVI.
TcIII was not identified in any patient (Fig. 1).
Cardiac involvement was detected in four patients. One patient
had completed treatment during 2008 and presented right bundle
branch block, which had been stable for five years of follow-up,
although his DTU was not determined. Another patient also pre-
sented right bundle branch block; he received treatment in 2010,
and his DTU was characterized as TcV. This TcV was also detected
in a patient presenting ventricular extrasystoles, left anterior fas-
cicular block, and incomplete right bundle branch block that had
never been treated. Finally, DTUs were not characterized in a
patient with a pacemaker for severe bradycardia. Findings regard-
ing cardiac involvement were insufficient to test associations.
Neither age nor sex nor time elapsed from arrival to Spain was
significantly associated with any specific DTU. Similarly, no
significant association was found with these three parameters
when DTUs were grouped into TcV (whether alone or in combina-
tion with other DTUs) and non-TcV.
5. Discussion
In order of frequency, the most common DTUs identified in our
sample were TcV, TcIV, and TcI. Consistent with published data on
Bolivian patients (del Puerto et al., 2010), we also found a high
number of mixed infections. TcII and TcVI coinfected only one pa-
tient; this finding seems reasonable, as both these DTUs are rarely
reported in Bolivia. No TcIII was detected, maybe because it is asso-
ciated with sylvatic cycles and is rarely present in human infection
(Zingales et al., 2012).
The largest series characterizing DTUs in Bolivians to date found
TcV and TcI to be the most common near-clades. However, this
study excluded specific probes to detect TcIV (del Puerto et al.,
2010). Using these specific probes, we found that TcIV was the sec-
ond most frequent DTU. A study performed in Venezuela also
found TcIV to be the second most common cause of human infec-
tion (Carrasco et al., 2012). TcIV has been linked to sylvatic cycles
and has been reported in the context of acute oral outbreaks in
tropical wet areas of Colombia and Brazil (Monteiro et al., 2012;
Ramirez et al., 2013). A recent report also related this DTU to an
oral outbreak in Bolivia (Santalla Vargas, 2012). Finally, TcIV has
Fig. 1. DTUs distribution in a Bolivian population.
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recently been detected in dogs, suggesting a potential role in
domestic transmission (Ramírez et al., 2013).
Our study is limited by its small sample size and the fact that
we did not record the exact geographical origin of our patients at
the beginning of the study.
Ours is the first study to characterize the T. cruzi genome in an
adult migrant population in Europe. Given that the distribution of
DTUs in non-endemic countries could be comparable to that of
endemic countries, the molecular genetics of the DTUs of T. cruzi
and its potential associations with clinical outcomes warrant
further study.
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Abstract
Background: Chagas disease caused by the protozoan Trypanosoma cruzi is an important public health problem in Latin
America. The immunological mechanisms involved in Chagas disease pathogenesis remain incompletely elucidated. The
aim of this study was to explore cytokine profiles and their possible association to the infecting DTU and the pathogenesis
of Chagas disease.
Methods: 109 sero-positive T. cruzi patients and 21 negative controls from Bolivia and Colombia, were included. Flow
cytometry assays for 13 cytokines were conducted on human sera. Patients were divided into two groups: in one we
compared the quantification of cytokines between patients with and without chronic cardiomyopathy; in second group we
compared the levels of cytokines and the genetic variability of T. cruzi.
Results: Significant difference in anti-inflammatory and pro-inflammatory cytokines profiles was observed between the two
groups cardiac and non-cardiac. Moreover, serum levels of IFN-c, IL-12, IL-22 and IL-10 presented an association with the
genetic variability of T.cruzi, with significant differences in TcI and mixed infections TcI/TcII.
Conclusion: Expression of anti-inflammatory and pro-inflammatory cytokines may play a relevant role in determining the
clinical presentation of chronic patients with Chagas disease and suggests the occurrence of specific immune responses,
probably associated to different T. cruzi DTUs.
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Introduction
Chagas disease is considered by the World Health Organization
(WHO) as one of the most important public health problems in
Latin America, with an estimate of 7 million people infected and
110 million people at risk of contracting the disease [1,2]. Recent
evidence has also indicated that Chagas disease has migrated to
non-endemic regions posing a significant social threat [3]. This
parasitic disease is caused by the protozoan Trypanosoma cruzi,
transmitted by different routes: via the feces of infected triatomine
bugs, contaminated blood transfusion, oral (contaminated food/
juices), vertical transmission, organs transplantation and laborato-
ry accidents. Approximately 60% of patients in the chronic phase
are clinically asymptomatic, around 30% manifest cardiomyopa-
thy, 8% megavisceral syndromes and the remaining 2% both
cardiomyopathy and digestive involvement [4,5,6,7].
Two main hypotheses regarding the pathogenesis of Chagas
disease have been proposed. One based on parasite persistence,
and a second hypothesis based on adverse human host immune
response to the infection, causing autoimmune aggression [8]. In
the acute phase of the disease the host is able to control the
infection in three different but complementary ways: i) Detection
and direct destruction of the parasite by cells such as macrophages
and dendritic cells, ii) activation of dendritic cells and macro-
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phages that present antigen stimulation for the activation of the
antigen-specific immune responses and iii) detection of infection by
non-hematopoietic cells, which are the principal targets of the
invasion by T. cruzi [9]. In the chronic phase, antigens that are
elicited by the immune response are mediated by T cells, which
play an important role in the progression of the disease. Studies in
children with the indeterminate form have shown a high frequency
of pro-inflammatory monocytes and regulatory cells compared
with healthy subjects [10]. Thus, it is believed that expression of
cytokines and their kinetics are important key factors influencing
the development and progression of the disease. In fact, the
balance between excessive pro-inflammatory cytokines and anti-
inflammatory cytokines may be critical in the development of the
chronic phase of the disease [5,8,11]. Studies on the specific role of
cytokines in the immune response against T. cruzi have been
recently reported and demonstrate that large amounts of Th1 pro-
inflammatory cytokines such as Interferon Gamma (IFN-c),
Tumor Necrosis Factor Alpha (TNF-a) are related to cardiac
disease [12]. It is also known that these cytokines are regulated by
anti-inflammatory cytokines in low concentrations such as
interleukin 10 and 5 (IL-10 and IL-5) [13]. Altogether, these data
suggest a link between parasite infection, immune response
polarization, and specific organ damage. Thus, cytokines may be
used as biomarkers in order to identify the immune factors that
influence disease progression has been carried out in different
pathologies such as malaria, yellow fever, HIV infection, and also
in Chagas disease [14,15,16]. It is believed that in these infectious
diseases deregulation of host inflammatory responses play an
important role and the profile of cytokines may be used as
biomarkers of disease progression. Consequently, the character-
ization of these profiles may lead to future selection of treatment
strategies targeting specific inflammatory pathways [17].
Several investigators have attempted to associate T. cruzi genetic
variability and the different clinical manifestations of Chagas
disease. The genetic variability within the T. cruzi taxon has been
demonstrated using biological, biochemical and molecular mark-
ers, and has been grouped into six Discrete Typing Units (DTUs),
TcI-TcVI [18,19]. TcI is mostly related to the sylvatic cycle in the
Amazon region with sporadic cases in the domestic foci recently
named TcIDOM [20]. However, TcI has recently gained relevance
since it has been associated with severe cardiomyopathic
manifestations in patients from Argentina and Colombia
[19,21,22,23]. TcII is the principal agent of Chagas disease in
the Southern Cone of America and Triatomainfestans is the principal
vector. TcV and TcVI, are derived from the hybridization
between TcIII and TcII/TcIV and the cycle of transmission is
mainly domestic [18,24]. These DTUs are related not only to
heart disease but also to megavisceral syndromes [25,26]. TcIII
and TcIV are mainly related to the sylvatic cycle of transmission
and scarce evidence of human infection has been reported
[27,28,29].
The aim of this study was to evaluate the different cytokine
profiles in Chagasic patients with and without chronic cardiomy-
opathy to correlate these cytokine profiles in patients infected with
the different T.cruziDTUs in order to establish whether these
factors may be involved in the pathogenesis of Chagas disease.
Our results show that specific anti-inflammatory and pro-
inflammatory cytokine modulation is correlated with the clinical
presentation of chronic patients with Chagas disease and suggests
the occurrence of specific immune responses, probably associated
to different T. cruzi DTUs.
Results
Signature Profiles
Group I: CARD vs. NON-CARD. To identify possible
markers of infection, and more specifically of cardiomyopathy,
we measured seric cytokines in 16 patients with cardiomyopathy
(CARD), 38 non-cardiac chagasic patients (NON-CARD), and 9
non-infected individuals (CONTROL). As expected in the case of
immune responses against infection, cytokine production greatly
varies among individuals, rendering inaccurate the use of the
mean as central indicator. We thus used the mean of cytokine
concentration, the latter being evaluated by the mean fluorescence
intensity (MFI) of beads bound to cytokines recognized by
immunofluorescence. The overall median of each individual
MFI cytokine was calculated (IL-1b=63.32, IL-2= 49.28, IL-
4 = 45.92, IL-5 = 58.24, IL-6 = 276, IL-9= 181.4, IL-10= 85.68,
IL-12p70= 54.6, IL-13= 33.04, IL-17A= 44.8, IL-22= 82.88,
IFN-c=48.8 and TNF-a=108.6) from patients of different
clusters. These values were used as the cut-off mark to tag the
cell population from each patient as being a high or low cytokine
producer (Figure S1 in File S1). Then, in each group and for each
cytokine, results were expressed as the frequency of individuals
with a concentration of seric cytokine higher than the median of all
samples (Figure 1). The assembling of the ascendant frequency of
high cytokine producers for CONTROL generated the reference
cytokine signature applied to identify changes in the overall
cytokine signature from the CARD and NON-CARD groups. The
results showed that the frequency of high cytokine producers in the
CARD and NON-CARD groups was lower than in the
CONTROL group.
A switch among anti-inflammatory and pro-inflammatory
cytokines profiles in the CARD and NON-CARD groups of
patients was observed. The NON-CARD patients showed higher
frequency of anti-inflammatory cytokines and lower frequency of
pro-inflammatory cytokines while the CARD displayed higher
pro-inflammatory and lower anti-inflammatory cytokines. The
cytokines involved in the anti-inflammatory profile were IL-13, IL-
5 and IL-10 and those in the pro-inflammatory profile were: IL-2,
IL-6, IL-9 and IL12 (FIGURE 2).
Group II: T. cruzi variability. As for Group I,overallme-
dian of each MFI cytokine wascalculated (IL-1b=292,32, IL-
2 = 224, IL-4= 209.44, IL-5 = 251.44, IL-6 = 1197, IL-9 = 792.4,
IL-10= 369.6, IL-12p70= 228.48, IL-13= 160.16, IL-
17A=207.76, IL-22= 547.12, IFN-c=198.24 and TNF-
a=465.92). These values were used as the cut-off mark to tag
the cell population from each patient as being a high or low high
cytokine producers(Figure S2 in File S1). Assembling of the
ascendant frequency of high cytokine producers for CONTROL
generated the reference cytokine signature applied to identify
changes in the overall cytokine signature from all other groups:
TcI, TcII and Mixed TcI/TcII (FIGURE 3).
A pro-inflammatory pattern was observed for all infected
groups, but no particular pattern could be associated to the
different DTUs. The frequency of cytokines in TcI, TcII and
Mixed TcI/TcII showed lower frequency as compared with the
CONTROL levels.
All the quantitative results provided by the cytometry system are
included and can be found in Tables S1 and S2 in File S2.
Statistical Analysis
This analysis aimed to establish associations between levels of
cytokines and the clinical manifestation (CARD or IND) and/or
the genetic variability of T.cruzi (TcI, TcII and Mixed TcI/TcII).
Analysis of principal components was performed with the 13
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cytokines studied. The principal components for the study group
CARD vs NON-CARD were IL-12= 0.990, IFN-c=0.990, IL-
1 = 0.920, IL-6 = 0.915 and IL-9= 0.895 which explained the
model in 80.4% of the variation in the dataset; for the study group
II T. cruzi DTUs the principal components were IFN-c=0.882,
IL-12= 0.822, IL-22= 0.817 and IL-10= 0.805 explaining
75.42% of variation (Tables S3 to S8 in File S2).
Finally, discriminant analysis was performed to observe which
proportion of the selected components were actually able to group
the study groups; for study group I (CARD vs NON-CARD) the
components group in the right cluster (when both real and theory
group coincide) : NON-CARD=21/38 (55.3%), CAR=16/16
(100%) and CONTROL=5/9 (55.6%) (FIGURE 4 a); and for the
study group II (T. cruzi DTUs) the components group in the right
cluster TcI = 19/20 (95%), TcII = 3/20(15%), Mixed TcI/
II = 13/15(86,7%) and CONTROL=10/12(83,3%) (FIGURE 4
b). These results show a clear profile in patients with CARD, and
an association between levels of cytokines and the variability of
T.cruzi (TcI, TcII and Mix TcI/TcII)(Tables S9 and S10 in File
S2.).
Discussion
An important finding of this study was a switch between the
anti-inflammatory cytokines IL-13, IL-5 and IL-10 and pro-
inflammatory cytokines IL-2, IL-6, IL-9 and IL-12 among CARD
and NON-CARD groups. These findings suggest that regulation
(differential regulation of cytokine synthesis) may play an
important role in the development of Chagas cardiomyopathy.
The anti-inflammatory/pro-inflammatory cytokine profile
switch found between patients with Chagas cardiomyopathy and
those infected but still in the NON-CARD stage of the disease is
compatible with the hypothesis that the progression of human
Chagas disease from asymptomatic to severe forms, is related with
a lack of adequate immune modulation [8]. While an appropriate,
inflammatory, response may be beneficial in early stages of
infection, the lack of control of this response later on the outcome
of the disease will allow for the establishment of tissue damage.
This hypothesis is in agreement with the finding that IL-10 levels
were diminished in comparison to levels of TNF- a and IFN-c in
CARD patients, in contrast with the opposite profile (higher levels
of IL-10 than levels of TNF- a and IFN-c) in indeterminate form
patients [8]. These findings are also in keeping with a recent report
documenting increased matrix metalloproteinases 2 and 9 in T.
cruziseropositive subjects with and without Chagas cardiomyopa-
Figure 1. Cytokine Signatures with Frequency of Subjects with High Cytokine Levels. The diagrams were plotted using the global median
of each MFI cytokine index as the cut-off mark to identify higher levels. The ascendant frequency of high cytokine producers at the with (CARD) and
without Chagas cardiomyopathy (NON-CARD) was demonstrated by bar graphics. The ascendant frequency of high cytokine producers of the
CONTROL group was used to generate the reference cytokine signature curves that were applied to identify changes in the overall cytokine signature
from all other groups.
doi:10.1371/journal.pone.0091154.g001
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thy manifestations [30]. However, previous reports have not
documented that these pro-inflammatory cytokines play an
important role in producing Chagas disease immunomodulation
disequilibrium [8,31,32].
Pro-inflammatory cytokines involved in the switch were IL-2,
IL-9, IL-6 and IL-12. The role of the last two cytokines has already
been studied in Chagas disease. Thus, the presence of high levels
of IL-6 in CARD patients was correlated with the severity of
myocardium damage, in Peruvian and Colombian populations
[33]. Another study determined the role of genetic polymorphism
in the IL-12, and it was the C allele of IL-12B 39UTR that acted as
a risk factor and influenced the susceptibility to develop
cardiomyopathy in Chagas disease [34]. Our results are in
agreement with these studies and additionally document that
these cytokines have higher levels in CARD patients compared to
NON-CARD patients. On the other hand, the anti-inflammatory
cytokines involved in the switch were IL-13, IL-5 and IL-10. IL-10
was the most important anti-inflammatory cytokine studied in the
Chagas disease, and it has been shown that NON-CARD patients
display higher levels of IL-10 in comparison to cardiac patients
[8,35]. Other investigators evaluated the SNP’s in indeterminate
and CARD populations, and also divided the cardiac patients
between those with non-dilated and dilated hearts, finding
different allele and genotype frequencies among them; also, a
correlation was found between the allele A of -1082G/A in the IL-
10 and low levels in CARD patients [36].
On the other hand, the relationship of the genetic variability of
the parasite and host characteristics with pathogenesis is increas-
ingly recognized as an important factor in the understanding of
Chagas disease. In all our groups independent of the genetic
variability of the infecting T.cruzi DTUs a pro-inflammatory
profile was observed. Moreover, all those groups manifested a pro-
inflammatory profile similar to the one we found in the study
group I (CARD and NON-CARD). However, the TcII and Mixed
groups showed higher levels of cytokines compared to the TcI,
where the levels did not exceed 50%. It is interesting to speculate
that the lack of a highly specific profile associated to a particular
infecting-DTU is likely due the pleiotropic and somewhat
redundant role of many cytokines. For all DTUs groups the
profile is pro-inflammatory, and probably this pro-inflammatory
profile will eventually lead to the same clinical manifestation
(cardiomyopathy), regardless of the different DTUs with which the
patients were infected and of some particular cytokine responses
which are DTU-dependent. Thus, we found higher levels of the
cytokines IL-6 for TcI, IL-1 for TcII and of IL-22 for Mixed TcI/
TcII. This is relevant, since it is known that IL-6 is secreted by T
cells and macrophages, IL-1 by macrophages and lymphocytes,
and IL-22 by dendritic cells and T cells [37].
Presumably, DTU-specific recognition by the immune system
(Antibodies, B cells, or T cells), could lead to the differential
responses observed. Thus the DTUs-differential recognition by
host receptors, that recognized pathogen patterns and their
cognate pathogen associated molecular patterns (PAMPs), could
be linked with the observed different induction of pro-inflamma-
tory cytokines. In this regard, previous reports, demonstrated that
GPI-anchors from T.cruzi surface antigens triggered the synthesis
Figure 2. Comparative Cytokine Signatures of NON-CARD and CARD. The diagram is a comparison between the signing of the NON-CARD
(&) and CARD (&). There is a switch between pro-inflammatory with the boxes in solid line (IL-6, IL-2, IL-9 and IL-12) and anti-inflammatory with the
boxes in dashed line (IL-5,IL-13 and IL-10) cytokines; the CARD have higher frequencies of proinflammatory cytokines and lower levels of
inflammatory cytokines, whereas the opposite occurs in the case of NON-CARD.
doi:10.1371/journal.pone.0091154.g002
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of IL-12 by macrophages and dendritic cells through toll-like
receptor 2 (TLR-2) dependent activation [38]. In addition, TLR-9
that recognizes T. cruziCpG-rich DNA also stimulated the
production of IL-12, IFN-c and TNF-a by macrophages. The
glycoinositolphospholipid from epimastigotes of T. cruzi is recog-
nized as TLR-4 in which also trigger IL-12, IL-2 and TNF. In
addition, other cells, known to be infected T. cruzi, as myocytes
and adipocytes, may contribute to the cytokine profile observed.
Since IL-6 is also produced by adipocytes [9].
The DAPC analysis showed a clear grouping for the CARD
patients but not for NON-CARD patients. This result may be due
to the fact that some patients in the NON-CARD group could be
eventually more predisposed to develop cardiomyopathy or mega-
viscera syndrome explaining why cytokine levels are not homo-
geneous for this group. In the study group, the DAPC analysis
suggests that there is association between the genetic variability of
T. cruzi (Tc I, Tc II and Mixed TcI/TcII) and the levels of some
cytokines. We found again in both groups, I and II, that IL-12,
IFN-c, IL-6 and IL-1 are the principal components and thus they
may play an important role in Chagas disease pathophysiology.
Also, differences in the frequency of high producers of IL-17
among in patients infected with different DTUs were found: 0%
for TcI, 60% for TcII and 40% for mixed infection (TcI/TcII).
Those differences may lead to slightly different outcomes of the
disease. In this regard, previous studies showed that patients with
less aggressive cardiomyopathy forms of the disease produce
higher levels of IL-17 [39], suggesting that in our study the patients
with more severe cardiomyopathy infection would be those with
TcI followed by those with mixed infection and finally those
infected with TcII.
In summary, pro-inflammatory profile is associated to CARD
patients and anti-inflammatory profile to NON-CARD patients.
The fact that the levels of cytokines were different for patients
infected with different parasite DTUs suggests a specific immune
response, probably associated to DTUs. A novel contribution of
this study is the possibility of using IL-12, IFN-c, IL-6 and IL-1 as
prognostic biomarkers of Chagas Disease. Future studies should be
carried out covering the geographical wide-range of DTUs and
other human populations, in order to validate these cytokines as
biomarkers as well as finding the plausible association between
DTUs-epitope and Chagas Disease clinical manifestations.
Figure 3. Comparison of Immunological Signatures between patients with chronic chagasic cardiomyopathy infected with different
DTU’s. The diagram is a comparison between the signing of the TcI (&), Tc II (&), Mixed TcI+TcII (&) and CONTROL (%). Cytokines with frequency
equal or higher than 50% are in boxes.
doi:10.1371/journal.pone.0091154.g003
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Materials and Methods
Human Sera
Following WHO criteria for Chagas disease diagnosis, two
serological tests (ELISA and IIF) were employed to enroll the
patients. According to these diagnostic test results, a total of 109
serum samples from Chagas patients and 21 serum samples from
healthy donors were assayed, aged 40 to 50 years living in rural
areas of Colombia and Bolivia (77 individuals from Santander,
Colombia and 53 from Cochabamba and Tarija, Bolivia). Chagas
patients were classified as without cardiomyopathy (NON-CARD
=38) when they were seropositive with no evidence of cardiac
disease (based on the absence of symptoms, physical signs and of
normal X-ray, electrocardiogram and/or echocardiogram). Pa-
tients with chronic Chagas cardiomyopathy (CARD=71) were
characterized according to clinical criteria and abnormalities in
chest X-ray, electrocardiogram and/or echocardiogram. The
presence of other acute, hepatic, renal or psychiatric diseases
were a motive for exclusion criteria.
The studies were conducted in two groups of individuals: the
first one to compare the differences in the quantification of
cytokines in patients with and without chronic cardiomyopathy
and control individuals; and the second one to compare the
differences between the levels of cytokines and the genetic
variability of T. cruzi.
Group I (CARD and NON-CARD), included 54 serum samples
from Chagas patients, 38 being classified as NON-CARD and 16
patients as CARD, and 9 serum samples from CONTROL
individuals. The selection criteria of the patients groups were
trying based on the assumption of obtaining the percentage to
simulate the % of Chronic Chagasic manifestation reports 38/54
chagasicpatientes (70.37% NON-CARD) against not Chronic
Chagasicmanifestationnd 16/54 (29.62% CARD).
Group II (T. cruzi DTUs), included 55 serum samples from
Chagas patients with chronic cardiomyopathy and 12 CON-
TROL individuals. Twenty patients were typed as TcI, 20 as TcII
and 15 mixed TcI/II. These sera were previously genotyped by
Ramirez et al. 2010, where the initial sample size was 240 patients.
Only 20/240 patients were genotyped as Mixed infection being
TcI+ TcII (5/20 sera were contaminated with bacteria and
subsequently excluded)we use the same sample size of patients for
the others DTUs for optimal statistical analyzes.
Experimental ethics. Written and oral consent was obtained
in all patients included as part of the BENEFIT trial (Benznidazole
Evaluation for Interrupting Trypanosomiasis), the study is
approved by all local and national Institutional Review Board
(ClinicaAboodShaio, Hospital de la Policia, Fundacion Cardio-
vascular de San Gil Santander), the study is approved by the
Ethics Research Committe of the World Health Organization as
one of the funding agencies of the BENEFIT trial.
Cytokine Quantification and Flow Cytometry Acquisition
Fluorescent bead-based flow cytometry assays for 13 anti-
inflammatory and pro-inflammatory cytokines was performed by
duplicate (Human Th1/Th2/Th9/Th17/Th22 13plex FlowCy-
tomix Multiplex, Bender MedSystems GmbH, eBioscience), on
human sera (without in-vitro stimulation), following the manufac-
turer’s protocol. Briefly, combining 2 different bead sizes and 6 or
7 fluorochrome densities for each population (thus fluorescence
intensities, with an emission maximum in the far red range), 13
different bead populations are defined, each one associated to a
specific antibody. Cytokines are trapped by these antibody-bead
Figure 4. Discriminant Analysis of Principal Components (DAPC). 4A. DAPC for with and without cardiomyopathy Chagas patients and
CONTROLS. The diagram show a cluster of 100% for CARD (Red circle), 55,3% for NON-CAR (Cian Circel) and 55,6% for the CONROL (N). 4B. DAPC of
patients with chronic Chagas cardiomyopathy infected with different DTU’s and CONTROLS: The diagram shows a cluster of 95% for TcI (Blue Circle),
15% for Tc II (Magenta Circle), 86,7% for mix TcI/TcII (Green Circle) and 83,3% for the CONTROL (N).
doi:10.1371/journal.pone.0091154.g004
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complexes, and then recognized by another antibody in solution;
the latter is previously bound to a secondary antibody coupled to
phycoerythrin (PE).
Sample reading was performed in BIO FACS Canto IITM
Becton Dickinson (BD) cytometer and analyzed with eFlowCyto-
mix Pro software (Cat. No. BMS8402FF). After acquiring 30,000
events/microwell, cytokine concentration was analyzed according
to manufacturer’s recommendation. After gating the two bead
sizes on a dot plot with forward scatter (FSC) and side scatter
(SSC), events were plotted according to fluorescence emission at
700 nm (bead-contained fluorochrome, intensity corresponding to
cytokine identity) and at 595 nm (PE emission peak, intensity
corresponding to cytokine concentration). Fluorescence intensity
will further refer to the intensity recorded at 595 nm.
Signatures Analyses
The cytokine profile was first assessed by identifying low and
high cytokine producers, as previously reported [40]. Briefly, after
the establishment of the overall median of Median of Fluorecence
Intensity (MFI), each cytokine subsets from all sub-groups were
tagged as they displayed low or high cytokine production. The
percentage of sub-groups showing high cytokine indexes was
calculated for each one. The ascendant frequency of high cytokine
indexes of controls was then used as the reference cytokine curves
to identify changes in the overall cytokine patterns from all other
sub-groups. Each axis represents the frequency (%) of volunteers
showing high cytokine indexes.
Statistical Analysis
Statistical analyses of the data were carried out using GraphPad
Prism software 5.0 and Statistical Package for the Social Sciences
17, SPSS. Discriminant Analysis of Principal Components (DAPC)
was performed, to assess the association between the different
cytokines and the clinical manifestation of Chagas disease (CARD
or NON-CARD) and/or the variability of T.cruzi (TcI, TcII and
Mixed TcI/TcII). The totals of components considered were able
to explain up to 80% of the model. The analysis of cytokine
signatures was performed using the control cytokine signature as
the reference curve, and significant differences were considered
when the values emerged outside the quartile of the reference
signature.
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Abstract
Chagas disease is caused by Trypanosoma cruzi infection, being cardiomyopathy the more frequent manifestation. New
chemotherapeutic drugs are needed but there are no good biomarkers for monitoring treatment efficacy. There is growing
evidence linking immune response and metabolism in inflammatory processes and specifically in Chagas disease. Thus,
some metabolites are able to enhance and/or inhibit the immune response. Metabolite levels found in the host during an
ongoing infection could provide valuable information on the pathogenesis and/or identify deregulated metabolic pathway
that can be potential candidates for treatment and being potential specific biomarkers of the disease. To gain more insight
into those aspects in Chagas disease, we performed an unprecedented metabolomic analysis in heart and plasma of mice
infected with T. cruzi. Many metabolic pathways were profoundly affected by T. cruzi infection, such as glucose uptake,
sorbitol pathway, fatty acid and phospholipid synthesis that were increased in heart tissue but decreased in plasma.
Tricarboxylic acid cycle was decreased in heart tissue and plasma whereas reactive oxygen species production and uric acid
formation were also deeply increased in infected hearts suggesting a stressful condition in the heart. While specific
metabolites allantoin, kynurenine and p-cresol sulfate, resulting from nucleotide, tryptophan and phenylalanine/tyrosine
metabolism, respectively, were increased in heart tissue and also in plasma. These results provide new valuable information
on the pathogenesis of acute Chagas disease, unravel several new metabolic pathways susceptible of clinical management
and identify metabolites useful as potential specific biomarkers for monitoring treatment and clinical severity in patients.
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Introduction
Chagas disease, caused by the protozoan parasite Trypanosoma
cruzi, affects approximately 8 million people worldwide [1] and
kills more than 15,000 each year, thus representing a major cause
of morbidity and mortality in endemic countries [2]. Chagasic
cardiomyopathy is the most serious and frequent manifestation in
T. cruzi infected patients in the chronic phase of the disease. Acute
Chagas disease is an often nonspecific and frequently unrecog-
nized condition, but acute infection associated to congenital cases
and oral transmission can have a fatal outcome in humans [3].
Myocarditis, although uncommonly reported and difficult to
diagnose, is uniformly present during acute infection. Moreover,
endomyocardial biopsies taken when patients are diagnosed
during this phase of the disease consistently reveal acute
myocarditis, even if the patient is asymptomatic [4]. The ranges
of acute cardiac pathogenesis are characterized by pericardial
effusion, pericarditis, ventricular enlargement with dysfunction or
congestive heart failure or both [5]. In the chronic phase,
myocardial inflammation associated to mononuclear infiltrate is
a common finding in histological sections, although the spatial
association between parasites and inflammatory infiltrate is
controversial and manifests as heart failure, arrhythmia, heart
block, thromboembolism, stroke, and sudden death. Chronic
Chagasic Cardiomyopathy is characterized by its severity, as well
as by a worse prognosis when compared with other cardiomyop-
athies [6].
T. cruzi has a complex life cycle involving several stages in both
vertebrates and insect vectors. It infects and replicates in
macrophages and cardiomyocytes as well as many other cell types
[2]. However, the pathogenesis is thought to be dependent on an
immune-inflammatory reaction to a low-grade infection [7,8]. To
date no vaccine is available [9] and current drugs have many side
effects [10]. Some chronic asymptomatic patients are currently
treated with those drugs, although its efficacy has not been clearly
demonstrated yet, basically because there is no useful surrogate
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marker for clinical improvement and therapeutic efficacy. In the
meantime, follow up of the treated patients by PCR turned out to
be the only way to guide physicians to deal with the disease
[11,12]. Several studies on biomarkers of cure have been proposed
based on seronegativization of antibodies, lytic antibodies,
hemostatic parameters, natriuretic peptides, recombinant antigens
and proteomic assays [13] but none of them seems to be
particularly sensitive. Thus, new biomarkers are needed to
monitor responses to treatment.
Global metabolomic analysis is a powerful tool to understand
the pathophysiology of parasite infection as well as to identify
biomarkers of disease, as it has been done for dilated cardiomy-
opathy [14]. Thus, identification of metabolic conditions could
provide a deeper knowledge of the pathophysiology and the
immunopathology as well of being of clinical value, since
restoration of those metabolites to basal levels could be beneficial
for the host during acute infection. On the other hand, they could
be also useful as biomarkers. The current paucity of effective
preventive or therapeutic options is another strong motivation for
the study of host-parasite metabolism interplay.
Moreover, metabolic function can clearly affect the activity of
the immune system [15,16,17]. In this regard, in acute T. cruzi
infection there are major immunological changes [18], that in
some cases are linked to the production of amino acid metabolites,
as kynurenine, a product of indolamine 2,3 dioxygenase (IDO)
enzymatic activity from tryptophan, which is supposed to control
parasite growth [19,20]. In addition, the levels of L-arginine,
modulated by Arginase enzymatic activity, deeply affect the
activity of T lymphocytes in experimental T. cruzi infection in
mice [21]. Thus, the knowledge of the metabolic alterations will
help to understand the course of the infection.
Since T. cruzi is able to replicate intracellularly, it will likely
affect infected host cell metabolism. Thus, metabolic changes were
observed in vitro after infection with the parasite in endothelial
cells [22]. In addition, Garg et al performed microarray analysis of
the cardiomyocyte mitochondrial metabolism during in vivo
infection showing deficiencies in mitochondrial oxidative phos-
phorylation-mediated ATP generation that plays an important
role in cardiac homeostasis [23]. More recently, Caradonna et al.
using a genome-scale functional screen identified interconnected
metabolic networks centered around host energy production,
nucleotide metabolism, pteridine biosynthesis, and fatty acid
oxidation as key processes that fuel intracellular T. cruzi growth
in HeLa cells in vitro [24].
However, there are no reports to date on global metabolomic
analysis during in vivo T. cruzi infection. Moreover, metabolite
levels during infection may reflect not only host metabolism but
also the possible contribution of parasite-derived metabolites,
which has never been assessed before. Thus, here we studied the
metabolic profile in heart and plasma from T. cruzi infected mice.
The results unravel many new aspects of metabolic alterations that
can be useful for better understanding the pathogenesis of this
disease and to better control T. cruzi infection as well as showing
the potential of particular metabolites as biomarkers of this disease.
Materials and Methods
Mice and parasites
Young adult (6 to 8-week-old) BALB/c female mice were
transported from Charles River Laboratories and hosted in a
controlled environment. In vivo infections performed with Y T.
cruzi strain (obtained from Dr. John David, Department of
medicine, Harvard Medical School, Boston, Massachusetts,
U.S.A.). Blood trypomastigotes were routinely maintained by
infecting IFNc receptor-deficient mice (129 Ifngrttm1Agt/J) [25]
purifying them from their blood. These mice were a gift from
Manfred Kopf (Max-Planck-Institute for Immunobiology, Frei-
burg). Parasitemia levels were checked every two-three days by
microscopic inspection and counting of parasites in a 5 ml drop of
the tail vein blood as described [26]. Real time qPCR was
performed as described [27].
Ethics statement
This study was carried out in strict accordance with the
European Commission legislation for the protection of animals
used for scientific purposes (Directive 2010/63/EU). Mice were
maintained under pathogen-free conditions at the Centro de
Biologı´a Molecular Severo Ochoa (CSIC-UAM) animal facility.
The protocol for the treatment of the animals was approved by the
‘‘Comite´ de E´tica de Investigacio´n de la Universidad Auto´noma
de Madrid’’, Spain (permit CEI-47-899). Animals had unlimited
access to food and water. They were euthanized in a CO2
chamber and all efforts were made to minimize their suffering.
Experimental design
Global biochemical profiles were determined in methanol
extracts derived from mouse heart tissue and plasma from two
independent experiments including uninfected mice (n = 6) and
mice infected with 2,000 blood trypomastigotes of the Y strain of
T. cruzi (see supplemental experimental information for details),
and sacrificed at 14 (n= 6) and 21 days post-infection (n= 6).
Plasma and heart tissue were elicited. To prevent blood
coagulation, syringes were impregnated with heparin, and plasma
was obtained from the supernatant immediately after centrifuga-
tion of the blood and frozen at 280uC. Hearts were perfused with
Author Summary
Chagas disease, caused by Trypanosoma cruzi, is the most
common cause of cardiomyopathy in Latin America. After
the acute phase myocarditis, the disease becomes asymp-
tomatic, and many years later some patients may develop
Chagas cardiomyopathy. Treatment is available, but causes
side effects. Thus, new drugs are needed, but there are no
good tools to assess treatment efficacy. We performed the
first global metabolomics analysis in heart tissue and
plasma from mice infected with T. cruzi along the infection.
We have identified more than 200 biochemicals (around 2/
3 of total) that significantly differed in heart and 100
(around 1/3) in plasma. Some of those show extremely
marked and highly significant differences. More impor-
tantly, our results unravel many new aspects of metabolic
alterations that can be useful for: a) better understanding
the pathogenesis of this disease; b) provide new clinic-
pathological data of T. cruzi infection that can be
potentially used for a better clinical management of
Chagasic patients; c) define several metabolites as poten-
tial biomarkers of this disease. Thus, our study identifies
common biomarkers of cardiomyopathy but more impor-
tantly specific candidate biomarkers of acute Chagas
Disease Cardiomyopathy, not observed in a clinically
similar disease Idiopathic Dilated Cardiomiopathy. Allan-
toin, kynurenine and p-cresol sulfate, that can be easily
detected in serum, are highly promising candidates. In
summary, we think our results would help to better
understand the pathogenesis and management of the
disease and offer new candidate biomarkers for monitor-
ing the severity of the disease and treatment efficacy.
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10 ml of phosphate buffered saline (PBS) and heparin to remove
blood and immediately frozen at 280uC. Samples were prepared
following instructions from Metabolon (see supplemental experi-
mental information for details).
Parasite DNA quantitative real time PCR
At different days post infection mice were euthanized in a CO2
chamber and blood and heart tissue were collected. Hearts were
perfused with PBS and heparin (1 U/ml) and were minced into
small pieces with a sterile scalpel and DNA was isolated with High
PurePCR Template preparation Kit, Roche. For T. cruzi
detection, we followed the qPCR assay described by [27]. Briefly,
100, 10, 1, 0.1 and 0.01 pg of DNA purified from Y strain
epimastigotes were used to generate the standard curve. Exper-
imental heart tissue qPCR reactions contained 100 ng of genomic
DNA. Murine Tnf gene qPCR reactions were set up for
normalization and expressed as pg Parasite DNA/ng heart tissue
DNA.
Biochemical sample preparation
Samples were prepared following Metabolon’s instructions.
Briefly, heart tissue was defrosted at room temperature (RT) and
cut with sterile surgical blade. Approximately 80 mg of tissue were
weighed and disposed in 2 ml eppendorf tubes. Heart tissue was
heat-inactivated at 50uC for 30 min. 1600 ml of the extraction
methanol solvent A (containing standards resuspended in 80%
HPLC grade Methanol; Sigma Aldrich 494291, CAS 67-56-1)
were added to the sample. Plasma was defrosted at RT. 100 ml of
plasma was transferred to a new tube and any parasites present in
plasma were heat-inactivated at 50uC for 30 min. Then, plasma
was combined with 450 ul of extraction Metabolon solvent B
(containing standards resuspended in 100% HPLC grade Meth-
anol; Sigma Aldrich 494291, CAS 67-56-1). After incubation
for 24 h at RT, samples were stored at 280uC until shipment in
dry ice.
Metabolomic analysis
The extracted samples were split into equal parts for analysis on
the gas chromatography (GC)/mass spectrometry (MS) and liquid
chromatography (LC)/MS platforms. Instrument variability was
determined by calculating the median relative standard deviation
(RSD) for the internal standards that were added to each sample
prior to injection into the mass spectrometers. Overall process
variability was determined by calculating the median RSD for all
endogenous metabolites (i.e., non-instrument standards) present in
100% of the Matrix samples, which are technical replicates of
pooled samples. Values were normalized in terms of raw area
counts (OrigScale). For a single day run, this is equivalent to the
raw data. Each biochemical in OrigScale is rescaled to set the
median equal to 1 and expressed as imputed normalized counts for
each biochemical (ScaledImpData).
Principal components analysis
Principal component analysis (PCA) is a mathematical proce-
dure that uses an orthogonal transformation to convert a set of
observations of possibly correlated variables into a set of values of
linearly uncorrelated variables called principle components. This
transformation is defined in such a way that the first principal
component has the largest possible variance (that is, accounts for
as much of the variability in the data as possible), and the second
component in turn has the highest variance possible under the
constraint that it is orthogonal to (i.e., uncorrelated with) the
preceding component. Thus, data set interpretation is that the
stratification of metabolites by component 1 may have the greatest
contribution to separating the metabolic signature of these samples
followed by component 2.
Statistical analysis
Pair-wise comparisons of data from infected mice respect non-
infected (0 dpi) were performed by Welch’s two sample t-tests
using the program ‘‘R’’ http://cran.r-project.org/.
Figure 1. Parasite burden and mice survival during T. cruzi infection. Parasite burden in blood and survival were monitored every two-three
days as described in material and methods section. (A) Parasitemia. (B) Parasite DNA quantification by qPCR as described in the methods. (C) Mice
survival. (D) Representative heart tissue section stained with H&E showing amastigote nests (white arrow) and mononuclear cell infiltration (black
arrow). (E) Principal component analysis in heart tissue samples. (F) Principal component analysis in plasma samples.
doi:10.1371/journal.pntd.0003337.g001
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Results
Experimental T. cruzi infection
Infection of BALB/c mice with the Y strain of T. cruzi
produced high parasitemia in the second and third week post-
infection (Figure 1A) and no survival was observed by 34 dpi
(Figure 1B). In a simultaneous experiment parasite DNA in heart
tissue increased up to 21 days post-infection (dpi), the last day
analyzed before the end of the experiment (Figure 1C). Besides,
histological analysis of the heart at 21 dpi showed heart damage,
with intense myocarditis and amastigote nests (Figure 1D).
Metabolic changes
We selected samples at 14 dpi and 21 dpi from heart tissue
and plasma 21 dpi for metabolic analysis, corresponding to the
acute phase of infection. We performed a global metabolomic
analysis and we detected a total of 325 compounds of known
identity (named biochemicals) in heart extract and 306
compounds in plasma extract (Table S1). Following log
transformation and imputation with minimum observed values
for each compound, Welch’s two-sample t-test was used to
identify biochemicals that differed significantly between exper-
imental groups. Our analysis identified more than 200
biochemicals (around 2/3) that differed significantly in heart
and 100 (around 1/3) in plasma.
Multiple metabolites were altered upon T. cruzi infection, and
Principal component analysis (PCA) revealed that, in heart tissue,
T. cruzi infection was accompanied by distinct biochemical
changes compared to control animals (Figure 1E). Components
1 and 2 could be decomposed into several metabolite levels that
explained 44.21% and 12.08% of the total variation, respectively.
Thus, samples from control and infected mice at 14 dpi grouped
separately in the analysis, although more heterogeneity was
observed by day 21 post-infection in heart tissue (Figure 1E).
Similarly, in plasma, components 1 and 2 explained 35.71% and
15.40%, respectively, and discriminated biochemicals in control
and infected mice at 21 dpi, despite the greater heterogeneity
observed in this case between individual mice (Figure 1F). PCA
components used for the heart and plasma are shown in
supplementary tables S2 and S3, respectively, which list the
metabolites contributing to the stratification of the PCA profiles.
In this files, the coefficient value of each metabolite for component
1 and component 2 are represented. The larger the positive or
negative coefficients value for a given metabolite, the greater its
contribution to separating the metabolic profiles and thus the
better candidate it may be as a biomarker. We will highlight below
the more relevant changes in several pathways.
Glucose metabolism
Compared to uninfected counterparts, glucose levels were
elevated in heart tissue by days 14 and 21 post-infection
(Figure 2A). This observation likely reflects an increase in glucose
uptake considering glucose levels declined in infected plasma over
time (Figure 2B). This also agrees with the observed increase of the
sorbitol pathway metabolites, sorbitol and fructose, in the heart.
Besides, multiple glycolytic intermediates including glucose-6
phosphate and fructose-6-phosphate and the end products
pyruvate and lactate were also significantly elevated in infected
heart tissue, but not in plasma (Figure 2A and B, respectively). In
contrast, reduced glucose shuttling to the pentose phosphate
pathway (PPP) was observed in response to infection as marked by
lower levels of ribulose and sedoheptulose-7-phosphate. Thus,
infected hearts have increased glycolysis.
Tricarboxylic acid cycle (TCA)
In infected heart tissue, the TCA cycle intermediates,
succinylcarnitine and fumarate decreased (Figure 3A). This TCA
cycle imbalance in the heart may be indicative of decreased
oxidative metabolism, potentially resulting from succinate dehy-
drogenase (SDH) and electron transport complex II dysfunction.
However, all of the TCA cycle metabolites, including succinate,
were diminished in plasma of infected mice (Figure 3B).
Lipid metabolism
Following infection, long chain fatty acids such as palmitate,
stearate and oleate increased in heart tissue, but reduced in the
plasma (Figure 4A and 4B, respectively). Although changes in fatty
acid levels may be indicative of a difference in synthesis,
malonylcarnitine levels were significantly diminished in infected
tissue, suggesting a limited capacity for lipid biogenesis. Instead,
Figure 2. Carbohydrate pathways. (A) Graphs represent the
ScaledImpData of different biochemicals of the glycolytic, sorbitol and
pentose phosphate pathways from heart tissue. (B) Same as in A from
plasma samples. Samples from control uninfected mice are in white
boxes, from mice sacrificed at 14 dpi in light gray boxes and from mice
sacrificed at 21 dpi in dark grey boxes. Statistically significant
differences respect to uninfected mouse samples are denoted, *p#0.05.
doi:10.1371/journal.pntd.0003337.g002
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uptake of lipids from plasma and fatty acid b-oxidation in the
heart tissue may be altered considering that long chain carnitine
conjugate lipids such as palmitoylcarnitine and oleoylcarnitine
were much higher in infected animals and may reflect increased
lipid transport into the mitochondria, as evidenced by lower levels
of carnitine.
Phospholipid metabolism
The phospholipid catabolite glycerophosphorylcholine (GPC)
was elevated in heart tissue after infection (Figure 4C). This may
be indicative of a change in phospholipid dynamics since it was
accompanied by much higher levels of multiple lysolipids such as
1-linoleoylglycerophosphoethanolamine and 1-palmitoleoylglycer-
ophosphocholine that may reflect enhanced hydrolysis of phos-
pholipids or lipid bodies. In contrast, these metabolites were
diminished or unaltered in the plasma of infected animals
(Figure 4D). Additionally, phospholipid precursors as choline,
choline phosphate, ethanolamine, and phosphoethanolamine
especially at late time points also accumulated in infected heart
tissue and may be indicative of an increased capacity for
phospholipid synthesis, and thus very high accumulation of
phospholipids in the heart of infected animals.
Branched chain amino acid metabolism (BCAA)
Heart tissue from T. cruzi infected mice possessed higher levels
of the BCAAs leucine, isoleucine and valine (Figure 5A).
Differences in BCAA levels can reflect changes in their degrada-
tion and utilization. In this sense, the downstream products 2-
methylbutyrylcarnitine, isovalerylcarnitine and alpha-keto acids
(3-methyl-2-oxovalerate and 4-methyl-2-oxopentanoate) were sig-
nificantly elevated in heart. Additionally, BCAA catabolites
including the alpha-keto acids were also increased in plasma
(Figure 5B).
Nucleotide metabolism
Compared to uninfected controls, heart tissue from T. cruzi
infected mice dramatically exhibited much lower levels of multiple
purine nucleotides and related metabolites such as adenine,
inosine, and hypoxanthine being the levels of adenine almost
depleted (Figure 6A). Such metabolites indicate severe alterations
in redox homeostasis. In addition, heme, another product of redox
activity increased 20–30 times in the infected heart (Figure 6B). In
contrast, higher levels of xanthosine, xanthine, urate and allantoin
were found in heart tissue from infected mice (Figure 6A). Similar
to heart tissue, lower levels of inosine and increased allantoin were
found in plasma (Figure 6C). These results may reflect a decrease
in synthesis as supported by lower levels of pentose phosphate
pathway metabolism. However, more likely purine degradation
may be strongly enhanced as evidenced by the great accumulation
of the downstream catabolic products xanthosine, urate, and
allantoin in infected hearts.
Tryptophan metabolism
Tryptophan and some of its metabolites as kynurenine, c-
glycosyltryptophan and 3-indoxyl sulfate were increased in heart
tissue (Figure 7A) as well as kynurenine and c-glycosyltryptophan
in plasma from infected mice (Figure 7B).
p-Cresol sulfate
p-Cresol sulfate is part of the phenylalanine and tyrosine
metabolism, and it was found strongly increased both in heart
tissue and plasma from infected mice (Figure 7C and 7D,
respectively). p-Cresol sulfate is likely a microbial metabolite that
is found in urine and blood and likely derives from secondary
metabolism of p-Cresol.
Discussion
Chagas is a complex disease with acute and chronic phases
showing cardiac alterations. Although, the immunopathogenesis is
relatively well established, there are still several issues poorly
Figure 3. Tricarboxyilic acid cycle. (A) Graphs represent the
ScaledImpData of different biochemicals of the tricarboxyilic acid cycle
from heart tissue samples. (B) Same as in A from plasma samples.
Samples from control uninfected mice are in white boxes, from mice
sacrificed at 14 dpi in light gray boxes and from mice sacrificed at
21 dpi in dark grey boxes. Statistically significant differences respect to
uninfected mouse samples are denoted, *p#0.05.
doi:10.1371/journal.pntd.0003337.g003
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understood. Among those: why a minority of asymptomatic
patients become symptomatic after several years?; and which is the
reason for the different clinical manifestations?. Besides, few drugs
are available to date, which present adverse effects that many
patients cannot tolerate. Thus, new drugs are urgently needed,
and to achieve that, a deeper knowledge of clinical pathophysi-
ology is required. In this respect, metabolomics may help to better
characterize the pathophysiology of the disease as well as to define
new biomarkers.
In an unprecedented study, we performed global metabolomic
analysis in plasma and heart of mice infected with the T. cruzi Y
strain. This parasite strain has been considered reticulotropic by
many authors in the field. However, other authors claim that the
strain might have suffered a change from reticulotropic to
myotropic/cardiotropic through time [28]. In agreement with
the last, in our experimental model it infects cardiomyocytes [29],
produces a characteristic histologic alterations as homogeneous
pancarditis with inflammatory infiltrates along epicardium, a high
epicardial and sub-epicardial inflammation that was homogenous
in auricles and ventricles, myeloid and lymphoid infiltration and
intra-myocardial perivasculitis [30] resembling damage observed
in Chagasic patients [31]. Moreover, Our analysis revealed that
following infection there are many significant biochemical
alterations in heart and plasma of infected animals, which are
much more evident both in number of changes and in fold
variations in the heart, the target organ of T. cruzi infection. Our
results have identified more than 200 biochemicals (around 2/3)
that differed significantly in heart and 100 (around 1/3) in plasma.
Some of those showed extremely marked and highly significant
differences. More importantly, our results unravel many new
aspects of metabolic alterations that can be useful for better
understanding the pathogenesis of this disease and to better
control T. cruzi infection as well as showing the potential of
particular metabolites as biomarkers. Our study identifies common
biomarkers of cardiomyopathy but more importantly specific
candidate biomarkers of acute Chagas Disease Cardiomyopathy,
not observed in a clinically similar disease as Idiopathic Dilated
Cardiomyopathy.
Alterations include amino acid metabolism, glucose utilization,
the TCA cycle, nucleotide catabolism, and membrane lipid
Figure 4. Fatty acid and phospholipid metabolism. (A) Graphs represent the ScaledImpData of different biochemicals of fatty acid metabolism
from heart tissue. (B) Same as in A from plasma samples. (C) Same as in A of different biochemicals of phospholipid metabolism from heart tissue
samples. (D) Same as in C from plasma samples. Samples from control uninfected mice are in white boxes, from mice sacrificed at 14 dpi in light gray
boxes and from mice sacrificed at 21 dpi in dark grey boxes. Statistically significant differences respect to uninfected mouse samples are denoted,
*p#0.05.
doi:10.1371/journal.pntd.0003337.g004
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pathways. Glucose can be utilized to support a variety of
physiological processes including energy generation, fatty acid
synthesis, and nucleotide biogenesis. Our results show that
compared to control uninfected animals, glucose levels were
elevated in heart tissue by days 14 and 21 post-infection. This
observation may reflect an increase in glucose uptake considering
that glucose levels declined in infected plasma over time.
Furthermore, the accumulation of the sorbitol pathway metabo-
lites (sorbitol and fructose) in the heart, but not in plasma, may be
an indication of enhanced glucose uptake since excess glucose is
often reduced to sorbitol by aldose reductase. Consequently,
higher levels of sorbitol can contribute to the generation of
advanced glycation end products (AGE) that have been associated
with the development of heart failure in other diseases [32]. In
addition, multiple glycolytic intermediates including glucose-6
phosphate and fructose-6-phosphate and the end products lactate
and pyruvate were significantly elevated in infected heart tissue
and may be indicative of increased glycolysis. In this regard,
accelerated rates of glycolysis can be indicative of hypertrophy of
the heart [33] that accompanies many forms of heart dysfunction,
a hallmark of Chagas disease [34]. Thus, these alterations in
glycolytic metabolism may be associated with increased cardiac
stress in T. cruzi infected hearts and require further investigation.
In contrast, reduced glucose shuttling to the pentose phosphate
pathway (PPP) was observed in response to infection, which is
required for the biogenesis of nucleotides and the regeneration of
NADPH necessary for glutathione reduction and anabolic
reactions. Thus, diminished PPP metabolism may restrict the
biosynthetic capacity of the heart and contribute to altered redox
homeostasis.
Altered glycolytic metabolism suggested that the TCA cycle
may also differ following T. cruzi infection. In fact, in T. cruzi
infected mice an imbalanced TCA cycle in the heart is likely
indicative of decreased oxidative metabolism, potentially resulting
from succinate dehydrogenase (SDH) and electron transport
complex II dysfunction. This would be in agreement with previous
studies where chagasic hearts showed mitochondrial respiratory
chain impairment [35]. Since the heart has perpetually high
energy demands related to the maintenance of processes such as
ion transport, calcium homeostasis, and sarcomeric function, the
fact that TCA cycle mediated oxidative metabolism may be
diminished following infection may ultimately induce metabolic
stress in cardiac tissue. In this respect, disruption of the Krebs
cycle is often implicated in energetic imbalances characteristic of
myocardial ischemia [36,37]. Alternatively, those selective differ-
ences in succinate may be explained by interference of those
metabolites by T. cruzi metabolism due to fumarate reductase and
succinate dehydrogenase enzymatic activities expressed by this
parasite [38].
In addition to protein synthesis, branched chain amino acids
(BCAA) can be degraded to replenish the TCA cycle and facilitate
fatty acid synthesis. Furthermore, diverse injuries and heart
diseases are reported to increase consumption of BCAAs. In
agreement, heart tissue from T. cruzi infected mice possessed
higher levels of the BCAAs isoleucine, leucine and valine.
Differences in BCAA levels can reflect changes in degradation
and amino acid utilization. Additionally, multiple BCAA catab-
olites including the alpha-keto acids 3-methyl-2-oxovalerate and 4-
methyl-2-oxopentanoate and the downstream products 2-methyl-
butyrylcarnitine and isovalerylcarnitine were significantly elevated
in these tissues as well as plasma. Thus, these observations may
reflect an increase in amino acid and muscle turnover following
infection.
Fatty acids are a critical source of energy for mitochondrial
oxidation and cellular ATP generation. Following infection, long
chain fatty acids such as palmitate, stearate, and oleate were
elevated in heart tissue, but reduced in plasma. Although changes
in fatty acid levels may be indicative of a difference in synthesis,
malonylcarnitine levels were significantly diminished in infected
tissue, suggesting a limited capacity for lipid synthesis. On the
contrary, long chain carnitine conjugate lipids such as palmitoyl-
carnitine and oleoylcarnitine were high suggesting that lipid
transport into the mitochondria may be increased. Collectively,
these observations suggest that lipid accumulation due to fatty acid
uptake in this tissue may not promote intracellular parasite
replication by enhancing lipid oxidation as described [24], but
instead, by producing a great deal of host cell lipid bodies, a
characteristic trait in T. cruzi infection [39]. Interestingly, cardiac
lipotoxicity results from elevated palmitoly-L-carnitine [40], which
we found elevated in hearts of T. cruzi infected mice. On the
contrary, propionyl-carnitine is considered a cardiac protector
[41] and we found it decreased in infected heart.
Phospholipids are essential components of the membrane lipid
bilayer. In comparison to control heart tissue, the phospholipid
catabolite glycerophosphorylcholine (GPC) was elevated following
infection. It may be indicative of a change in phospholipid
dynamics and were accompanied by strikingly higher levels of
multiple lysolipids such as 1-linoleoylglycerophosphoethanolamine
and 1-palmitoleoylglycerophosphocholine that may reflect en-
hanced hydrolysis of phospholipids or production of lipid
bodies. Additionally, the phospholipid precursors choline, choline
Figure 5. Branched chain amino acid metabolism. (A) Graphs
represent the ScaledImpData of different biochemicals of the branched
chain amino acid metabolism from heart tissue samples. (B) Same as in
A from plasma samples. Samples from control uninfected mice are in
white boxes, from mice sacrificed at 14 dpi in light gray boxes and from
mice sacrificed at 21 dpi in dark grey boxes. Statistically significant
differences respect to uninfected mouse samples are denoted, *p#0.05.
doi:10.1371/journal.pntd.0003337.g005
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phosphate, ethanolamine, and phosphoethanolamine also accu-
mulated in infected heart tissue and may be indicative of an
increased capacity for phospholipid synthesis. Differences in these
metabolites may reflect tissue remodeling during infection.
Noteworthy, heart tissue from T. cruzi infected mice was almost
depleted of adenine and had much lower levels of purine
nucleotides and metabolites such as adenosine, guanosine, inosine,
and hypoxanthine, compared to uninfected controls. Lower levels
of these metabolites may reflect a decrease in synthesis as
supported by lower levels of pentose phosphate pathway metab-
olism. But more likely, purine degradation may be enhanced as
evidenced by a strong accumulation of the downstream catabolic
products xanthosine, xanthine, urate, and allantoin in infected
hearts. Differences in the levels of these metabolites may also
reflect a change in redox homeostasis since the generation of
xanthine and urate are accompanied by the production of
hydrogen peroxide (H2O2). Thus, differences in purine metabo-
lism may contribute to altered redox homeostasis in cardiac tissue.
In addition, it has been described that the parasite scavenges
purines and pteridine for amastigote replication in HeLa cells [24].
Thus, the decreased levels of adenine observed in heart tissue may
reflect both phenomena: decreased synthesis and parasite utiliza-
tion.
Interestingly, xantine oxidase (XOS) the enzyme responsible for
reactive oxygen species (ROS) generation has been considered
responsible for cardiac dysfunction in T. cruzi infection [42].
Thus, allopurinol, a xanthine oxidase inhibitor, is being considered
for treating Chagasic patients [43]. Inhibition of ROS generation
ameliorates myocarditis during Chagas disease, although parasite
burden in the heart was not significantly decreased [44].
Interestingly, the effect of ROS inhibition seems to be related
with the levels of metabolites as substrates of immune-related
Figure 6. Nucleotide metabolism. (A) Graphs represent the ScaledImpData of different biochemicals of the nucleotide metabolism from heart
tissue samples. (B) Same as in A from plasma samples. Samples from control uninfected mice are in white boxes, from mice sacrificed at 14 dpi in
light gray boxes and from mice sacrificed at 21 dpi in dark grey boxes. Statistically significant differences respect to uninfected mouse samples are
denoted, *p#0.05.
doi:10.1371/journal.pntd.0003337.g006
Figure 7. Tryptophan, phenylalanine and tyrosine metabolism.
(A) Graphs represent the ScaledImpData of different biochemicals of the
tryptophan metabolism from heart tissue samples. (B) Same as in A
from plasma samples (C) A Graphs represent the ScaledImpData of
different biochemicals of the phenylalanine and tyrosine metabolism
from heart tissue samples. (D) Same as in C from plasma samples.
Samples from control uninfected mice are in white boxes, from mice
sacrificed at 14 dpi in light gray boxes and from mice sacrificed at
21 dpi in dark grey boxes. Statistically significant differences respect to
uninfected mouse samples are denoted, *p#0.05.
doi:10.1371/journal.pntd.0003337.g007
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enzymes and thus their imbalances can be targeted to combat
infectious diseases.
Besides, the fact that uric acid is so strongly elevated and
adenine so depleted may indicate that ROS production in the
heart should be very high (Figure 6A). ROS also increase the
ability of T. cruzi to replicate intracellularly [45]. Uric acid is
linked to several cardiovascular diseases [46,47,48], although there
is still discrepancy on whether it is really the cause or the effect of
the disease [49]. The increase in uric acid is also associated to
elevated fructose [50], also shown in our analysis. Uric acid is able
to activate inflammasome NLRP3, being a danger signal in many
pathological processes and in inflammation. Higher signaling
through NLRP3 has been recently related to adverse outcome in
other forms of cardiac dysfunction as idiopathic dilated cardio-
myopathy [51]. However, in apparent contrast, it has been
recently demonstrated a protective role of NLRP3 inflammasome
in the control of T.cruzi infection through caspase-1-dependente
IL-1R-independent nitric oxide (NO) production [52]. Thus, it
would be worth testing the role of NLRP3 in Chagas disease
cardiomyopathy and not only relative to infection.
In addition, Heme, a product involved in redox homeostasis,
was increased in infected heart, and is also able to increase T. cruzi
growth [53]. Increased heme levels are found in failing hearts [54]
associated to ROS production. In this regard, it is also worth
mentioning that allopurinol, that inhibits XOS, has been used
effectively against T. cruzi in mouse models [43,55] and also to
prevent cardiovascular dysfunction (CVD) [48].
Lysoglycerol-phosphocholines, that increased very significantly
in T. cruzi infected heart, may also contribute to immunosup-
pression associated to Chagas disease [56], since they inhibit T-cell
proliferation in response to activation and induce apoptosis [57].
Kynurenine is not usually found in heart tissue, and acts as an
endothelium-derived relaxing factor produced during inflamma-
tion [58]. It can also control dendritic cell immunogenicity [59].
Notably, this metabolite has been implicated in resistance to T.
cruzi infection [19,20]. Furthermore, the serum levels of IDO
enzymatic activity in Chagas disease symptomatic patients
decrease with therapeutic treatment [60]. Since, IDO activity is
often elevated in response to inflammatory cytokines such as
TNFa and IFNc, elevated in cardiac patients [12], these findings
may reflect immune cell activation in response to T. cruzi
infection.
p-Cresol sulfate and indoxyl sulfate are considered uremic
toxins [61]. Although they are generally associated to dialysis
disturbances they have an emerging role in cardiovascular disease
and mortality in renal patients. Serum p-Cresol sulfate predicts
cardiovascular disease and mortality in elderly hemodialysis
patients [62]. In patients with chronic renal failure p-cresol
sulphate accumulation in plasma is due to renal dysfunction and
cause endothelial dysfunction increasing the cardiovascular risk
[63]. We found it highly increased in heart tissue as well as serum
of infected mice. The levels of p-cresol sulphate can be also
predictive of clinical outcome. Our work, if confirmed in Chagas
disease patients, may suggest that p-cresol sulphate could be useful
a marker of T. cruzi infection and further studies are needed to
check if it also correlates with disease outcome.
Recently, a global metabolomic analysis in an experimental
hamster model of idiopathic dilated cardiomyopathy (DCM) has
been described [14]. By comparison with our data some specific
biomarkers, and by extension pathogenic mechanism(s), can be
inferred, that can help to distinguish among those clinically similar
but etiologically distinct dilated cardiomyopathies. In that study,
only 180 metabolites were detected and variations were found in
62 of them. Their results suggest that the glycolysis and the TCA
cycle energy pathways are attenuated in cardiac tissue during the
symptomatic phase. In contrast, hearts from T. cruzi infected mice
have increased glycolysis, despite having the TCA cycle decreased.
Similar to our results they observed increased oxidative stress in
the DCM. Thus, the rest of alterations we found can be considered
specific, so far, of cardiomyopathy associated to T. cruzi infection.
Among those, much higher lipid (and specially phospholipids)
accumulation in T. cruzi infected hearts as well as stronger
depletion of adenine and increase in allantoin and uric acid.
Previous studies on metabolic alterations caused by T. cruzi
infection were based only on host enzymatic expression in vitro
[24]. Thus our work greatly expands those results by detecting
their metabolites in vivo in a mouse model of infection. Our
findings suggest that T. cruzi infection disrupts multiple biochem-
ical pathways in heart tissue that may ultimately contribute to
cardiac failure. In particular, increased glycolysis and decreased
oxidative metabolism may predispose heart muscle to energetic
imbalances characteristic of heart failure [64]. Furthermore,
altered glucose utilization may limit the anabolic capacity of the
heart and therefore the ability to repair damaged tissue and to
detoxify free radicals. Consequently, evidence of altered redox
homeostasis, inflammation, and tissue remodeling were observed
in response to infection.
In summary, we have found many metabolic alterations in
experimental acute Chagas disease. Many of these suggest a
stressful condition in the heart such as: a) increased glycolysis, b)
respiratory chain impairment, c) lipid accumulation, d) ROS
production and uric acid formation. All of those could be related
with heart hypertrophy. Noteworthy, some of those metabolites
have much stronger variations than reported in other cardiac
pathologies. Probably more interestingly, we found elevated p-
cresol sulfate, which is associated to infections, and kynurenine
and allantoin in serum that, either individually or in combination,
may be specific biomarkers in this disease. Moreover, p-cresol
sulfate, kynurenine and allantoin presented very high positive
coefficients in the PCA analysis in plasma reinforcing its value as
possible biomarkers. Very importantly, in the evaluation of new
drugs against Chagas disease, a biomarker of cardiac function
recovery is urgently needed to assess the efficacy of new treatments
in the clinic-pathological symptoms and not only for determining
parasitological cure. Despite that our study spans only the acute
Chagas disease, taking into account that acute and chronic phases
share some similarities, the possibility that any of the candidate
biomarkers may apply to the chronic phase cannot be excluded.
Thus, future studies may benefit from examining metabolic
differences induced by acute versus chronic infection to determine
the long-term risk factors associated with T. cruzi infection, as well
as exploring the usefulness of the ones described here as
biomarkers of clinical improvement.
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Table S1 Summary of the significantly altered bio-
chemicals. 325 biochemical were identified in heart extracts and
306 in plasma extract. Following log transformation and
imputation with minimum observed values for each compound,
Welch’s two-sample t-test was used to identify biochemicals that
differed significantly between experimental groups. Biochemicals
that achieved statistical significance (p#0.05), as well as those
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levels of biochemicals are in red and decreased levels in green.
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(PCA). List of the calculated coefficients of heart tissue
biochemicals ordered from higher to lower. The higher positive
and negative coefficients are the ones that have more contribution
for the PCA analysis. Component 1 may have the greatest
contribution to separating the metabolic signature followed by
component 2. Plasma candidate biomarkers as p-cresol sulphate,
kynurenine and allantoin, which increase with the infection are
highlighted.
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Table S3 Contribution of the plasma individual bio-
chemicals to the Principal components analysis (PCA).
List of the calculated coefficients of heart tissue biochemicals
ordered from higher to lower. The higher positive and negative
coefficients are the ones that have more contribution for the PCA
analysis. Component 1 may have the greatest contribution to
separating the metabolic signature followed by component 2.
Plasma candidate biomarkers as p-cresol sulphate, kynurenine and
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Abstract
Inflammation plays an important role in the pathophysiology of Chagas disease, caused by
Trypanosoma cruzi. Prostanoids are regulators of homeostasis and inflammation and are
produced mainly by myeloid cells, being cyclooxygenases, COX-1 and COX-2, the key
enzymes in their biosynthesis from arachidonic acid (AA). Here, we have investigated the
expression of enzymes involved in AA metabolism during T. cruzi infection. Our results
show an increase in the expression of several of these enzymes in acute T. cruzi infected
heart. Interestingly, COX-2 was expressed by CD68+myeloid heart-infiltrating cells. In addi-
tion, infiltrating myeloid CD11b+Ly6G- cells purified from infected heart tissue express
COX-2 and produce prostaglandin E2 (PGE2) ex vivo. T. cruzi infections in COX-2 or PGE2-
dependent prostaglandin receptor EP-2 deficient mice indicate that both, COX-2 and EP-2
signaling contribute significantly to the heart leukocyte infiltration and to the release of che-
mokines and inflammatory cytokines in the heart of T. cruzi infected mice. In conclusion,
COX-2 plays a detrimental role in acute Chagas disease myocarditis and points to COX-2
as a potential target for immune intervention.
Author Summary
The role of prostanoids, products of the arachidonic acid pathway, during Trypanosoma
cruzi infection has been studied by inhibiting key enzymes in prostanoid synthesis as
cyclooxygenases (COX-1 and COX-2), with opposed results. Here we analyzed the expres-
sion of cyclooxygenases, prostanoid synthases and receptors in the heart of mice suscepti-
ble and non-susceptible to T. cruzi infection and found that they were highly increased
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respect to non-infected mice. We previously identified the presence of myeloid-derived
suppressor cells expressing arginase-1 (Arg-1). Further analysis showed that COX-2 was
expressed in Arg-1-myeloid cells in heart tissue, suggesting the existence of different mye-
loid populations involved in the leukocyte infiltration (COX-2+Arg-1-) and tissue repair
(COX-2-Arg-1+). Mice deficient in the expression of COX-2 and the prostaglandin PGE2
receptor EP-2 infected with T. cruzi showed a marked reduction in the cardiac inflamma-
tory infiltration in comparison with infected wild type mice, indicating an adverse effect of
COX-2 and PGE2 signaling through EP-2 receptor in the development of myocarditis dur-
ing acute T. cruzi infection, suggesting the possibility of immune intervention using COX
inhibitors.
Introduction
Chagas disease is a multisystemic disorder caused by Trypanosoma cruzi infection that affects
more than 8 million people worldwide, being endemic in Latin America. Due to the scarcity of
preventive and therapeutic tools and population at risk, it is considered as a neglected tropical
disease [1, 2]. More than 40,000 new infected people and 12,550 deaths per year are estimated.
The high rate of migration towards non-endemic countries has spread the boundaries of the
infection to other continents. Non-vectorial transmission is possible through oral ingestion,
blood transfusion, organ transplantation and during pregnancy. The risk of infection is related
to the country of origin of the migrants and the rate of prevalence in a given country [3].
Chagas disease is characterized by acute and chronic phases. Death occurs occasionally in
the acute phase (<5–10% of symptomatic cases) as a result of severe myocarditis, meningoen-
cephalitis, or both. The experimental model of infection in mice recapitulates many clinical fea-
tures observed in human infection, although different strains of mice and parasites produce
different disease outcomes [4].
Heart inflammation during the acute phase of T. cruzi experimental infection is initiated by
lymphoid and myeloid mononuclear cell infiltration [5]. We have isolated from infected hearts
an infiltrating monocytic CD11b+Ly6C+Ly6G- population expressing both classical (M1) and
alternatively (M2) activated macrophage markers that is able to suppress T cell proliferation ex
vivo, characteristics that define them as myeloid-derived suppressor cells (MDSCs) [6, 7].
Myeloid cells are thought to be the major source of prostanoids, end products of cell mem-
brane arachidonic acid (AA) catabolism, which include prostaglandins, prostacyclin and
thromboxanes [8]. Enzymes implicated in prostanoid production have been investigated for
many years [9]. All these lipid mediators have important roles in homeostasis and immune
response regulation [10]. Cyclooxygenases, COX-1 and COX-2, are principal enzymes in pros-
tanoid production. COX-1 expression is involved in homeostasis while COX-2 is induced by
several factors, including infection [9]. However, the specific role of COX-2 and downstream
enzymes in the context of infection varies depending on the infectious agent [11–13].
PGE2, a product of terminal PGE2 synthases (PGES) has pro-inflammatory properties [14]
but also immunosuppressive properties [15] by signaling through G-protein coupled PGE
receptors (EP), termed EP-1, EP-2, EP-3 and EP-4. PGE2 also decreases the ability of macro-
phages to phagocytize and kill microorganisms [16, 17], and is required for monocyte migra-
tion in response to chemokines [18, 19].
There are few studies about the role of prostanoids in human chagasic pathology [20, 21],
but it has been described that monocyte inflammatory mediators inhibit cellular proliferation
and enhance cytokine production in patients [22]. In rodent models of acute infection, the
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levels of PGF2α, TXB2, 6-oxo-PGF1α [23] and PGE2 [24] in plasma, were increased. Macro-
phages from infected rats show an increased number of lipid bodies, where COX-2 produces
PGE2 [25]. Recently, it has been shown that the absence of Phospholipase A2γ, an enzyme
implicated in AA release from membranes, decreases mice survival [26].
The role of COX in mice infected with T. cruzi has been studied using non-selective inhibi-
tors of COX-1 and COX-2, as well as COX-2-selective inhibitors (NSAIDs), with conflicting
results. Thus, it has been described that COX inhibitors cause an increase in mortality and par-
asitism [27] in T. cruzi infection, but contrarily, other reports claim that COX-2 inhibition
decreases the level of parasitism [28, 29]. In addition, both beneficial and adverse effects of
COX inhibitors have been reported, depending on the phase of T. cruzi infection and the mice
strain used [30]. Discrepancies between these studies could be explained by the different ability
of BALB/c and C57BL/6 mouse strains to produce PGE2 [31]; the presence of distinct levels of
cytokines in serum [32] or because of differences in cardiac cytokine expression profile [6].
Thus, in order to clarify the role of prostanoids in acute cardiac inflammation, we infected
susceptible and non-susceptible mice, as well as COX-2 and EP-2 deficient mice with T. cruzi
and analyzed cardiac inflammation, leukocyte infiltration and expression of cytokines, chemo-
kines and inflammatory mediators in the infected mice.
Results
Prostanoid-synthesizing enzymes in the heart tissue of T. cruzi infected
mice
We infected mice with the Y strain of T. cruzi. Immunopathology caused by this parasite strain
is characterized by cardiac inflammatory damage. As we previously reported [33], C57BL/6,
but not BALB/c, infected mice recovered from infection and survived (S1A Fig). Parasitemia
was detectable between 9 and 21 d.p.i. and was higher in BALB/c mice (S1B Fig). Hearts of
BALB/c infected mice showed more leukocyte infiltration and parasite nests than C57BL/6
mice (S1C Fig). We next studied the expression level of enzymes involved in the AA pathway
in the heart of both strains after infection (Fig 1A). COX-2 gene expression (Ptgs2), but not
COX-1 (Ptgs1), was increased in heart tissue during the acute phase of T. cruzi infection simi-
larly in both mouse strains. Ptges (microsomal prostaglandin E2 synthase, mPGES-1),Hpgds
(leucocyte type PGD synthase) and Tbxas1 (thromboxane synthase) mRNA expression levels
were also incremented. However, Ptgds (lipocalin-type prostaglandin D synthase) mRNA basal
level of expression in heart tissue did not change upon T. cruzi infection. These results indicate
that T. cruzi infection promoted the selective up-regulation of some of the enzymes involved in
prostanoid production in heart tissue, including COX-2 and mPGES-1.
Myeloid cells in inflamed cardiac tissue express COX-2
Since COX-2 plays a key role in the synthesis of PGs in inflammatory processes, we aimed to
identify the cells expressing this enzyme in the heart of T cruzi infected mice. Hearts from
C57BL/6 (Fig 1B) and BALB/c (Fig 1C) mice were immunostained for COX-2 and myeloid
and lymphoid markers, and imaged by confocal microscopy. Cells expressing COX-2 were
abundant in the infected hearts of both mice strains, showing a strong staining in the perinuc-
lear region of both myeloid CD68 positive and non-myeloid CD68 negative infiltrating cells.
Interestingly, there was no co-localization of COX-2 and Arg-1, a marker of M2 macrophages
and MDSCs (Fig 1D). Although COX-2 expression by activated lymphocytes has been previ-
ously described [34], CD4 staining was not detected in infiltrating COX-2+ cells in hearts of
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Fig 1. Expression of prostanoid synthases in T. cruzi infected cardiac tissue. (A) Expression of Ptgs1, Ptgs2, Ptges (mPGES1), Ptgds, Hpgds and
Tbxas1 in heart tissue of, either non-infected (0) or at different d.p.i. (7 to 28), BALB/c and C57BL/6 mice. Means ± SEM from three independent experiments
(n = 9) are shown. Statistical comparisons are indicated * p< 0.05, *** p< 0.001. (B) Heart tissue samples from C57BL/6 mice at 14 d.p.i. and (C) BALB/c
mice at 21 d.p.i., were stained with DAPI for nuclei (Blue) and specific antibodies for the macrophage marker CD68 (green) and the enzyme COX-2 (red). (D)
Heart tissue from BALB/c mice at 21 d.p.i. stained for COX-2 (red), CD68 (green) and Arg-1 (magenta). In the merge of B, C and D, red, yellow and white
arrows point to COX-2+, CD68+COX-2+ and CD68+Arg-1+ cells, respectively. Pictures are representative of several sections analyzed in 3 different mice from
three independent experiments; the scale bar is 20 μm.
doi:10.1371/journal.pntd.0004025.g001
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infected C57BL/6 (S2A Fig) nor BALB/c mice (S2C Fig). No staining was observed in negative
control sections incubated with secondary antibodies alone (S2B, S2D and S2E Fig).
We next isolated myeloid cells from hearts of T. cruzi infected C57BL/6 and BALB/c mice at
the times,14 and 21 d.p.i. respectively, when maximum Arg-1 and inducible nitric oxide
synthase (iNOS) expression is observed [7]. Using anti-Ly6G antibody labeled magnetic
microbeads we obtained the Ly6G+ population. CD11b+ cells were selected from the remaining
Ly6G- population, (Fig 2A). As previously described [7], the CD11b+Ly6G- cell population
expressed iNOS and Arg-1, and here we show that they also expressed COX-2 (Fig 2A). Inter-
estingly, COX-2 gene expression was much higher in CD11b+ cells obtained from infected car-
diac tissue than those from the blood (Fig 2B), pointing to infiltrating myeloid cells in inflamed
tissue as the source of COX-2.
CD11b+Ly6G- cells from infected cardiac tissue produce PGE2
In agreement with the increase in COX-2 expression, a significant increase in the production
of prostanoids as PGE2 and 6-oxo PGF1α in infected hearts was detected by mass spectrometry
analysis on total heart extracts (Fig 2C). Further ex vivo analysis on Ly6G+ and CD11b+Ly6G-
purified heart infiltrating myeloid cells cultured in the presence of radiolabeled AA, showed
that Ly6G+ cells did not produce any detectable prostanoid (Fig 2D). In contrast, CD11b+
Ly6G- cells produced high levels of PGE2 and low amounts of PGF2α (Fig 2E). These results
indicate that the CD11b+Ly6G- myeloid population is able to synthesize high levels of PGE2
from AA, while other cell types in heart tissue are likely producing PGE2 and 6-oxo PGF1α.
Cardiac inflammation is reduced in COX-2-/-mice
In order to study the role of COX-2 in the development of cardiac leukocyte infiltration, we
infected COX-2+/+ and COX-2-/- mice with the Y strain of the parasite. COX-2-/- mice showed
30% reduction in blood parasite number compared to COX-2+/+ mice at the peak of parasite-
mia (Fig 3A). However, COX-2 deficiency did not significantly affect cardiac parasite burden
compared to COX-2+/+ infected mice (Fig 3B). No mortality was observed neither in COX-2+/+
nor in COX-2-/- infected mice up to 42 d.p.i.
Inflammatory infiltrates were analyzed and quantified in T. cruzi infected hearts from
COX-2+/+ and COX-2-/- mice. Fig 3C shows the extent of leukocyte infiltration calculated from
several tissue sections as described in Methods. We observed significant less inflammatory
infiltration in infected COX-2-/- than in COX-2+/+ mice. Representative images corresponding
to the quantification of cell infiltration are shown in Fig 3D.
We next analyzed the cellular composition of the immune inflammatory infiltrate by deter-
mining gene expression of surface markers characteristic of various immune cell populations
by qRT-PCR and normalizing the data from infected animals respect to non-infected controls.
In agreement with histological findings, infection in COX-2-/- mice compared to COX-2+/+
mice, led to lower expression of the common leukocyte marker Ptprc (CD45) as well as of Cd4,
Cd8, Cd68, and Itgax (CD11c) as markers of T helper cells, cytotoxic T cells, macrophages and
dendritic cells, respectively (Fig 4A).
To characterize the immune response in hearts of COX-2-/- infected mice, gene expression
of chemokines and cytokines were analyzed. mRNA levels of chemokines (Ccl2, Ccl5 and
Cxcl9) and cytokines (Ifng, Tnf, Il4, Il6 and Il10) were significantly increased during T. cruzi
infection in hearts of both COX-2+/+ and COX-2-/- mice (Fig 4B and 4C). However, chemokine
expression presented different patterns in COX-2+/+ and COX-2-/- mice. Ccl2 and Ccl5 expres-
sion, but not Cxcl9, was significantly higher in COX-2+/+ mice than in COX-2-/- mice (Fig 4B).
Induction of pro-inflammatory cytokines Ifng, Tnf and Il6 was lower, whereas Il4 expression
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Fig 2. COX-2 expression and activity in heart and infiltrating myeloid cells during T. cruzi infection. (A) Purified Ly6G+, Ly6G-CD11b+and
Ly6G-CD11b- cells were obtained from infected C57BL/6 (14 d.p.i.) and BALB/c (21 d.p.i.) mice hearts, by magnetic cell separation. Arg-1, iNOS and COX-2
levels were analyzed byWestern blot. Protein levels of Actin are shown as loading control. A representative experiment of the two performed is shown. (B)
CD11b+ cells were obtained from pooled infected BALB/c mouse hearts or blood at 21 d.p.i (n = 15). Ptgs2 (COX-2) expression in blood and heart tissue was
determined by real time qRT-PCR. Mean ± SEM of two independent experiments is shown. (C) PGE2 and 6-oxo-PGF1α levels in total heart extracts of BALB/
c from non-infected (0 d.p.i.) and 21 d.p.i., were determined as described in Methods and represented as scaled imputed data (ScaledImpData) after
normalizing raw data values respect to median values of each day run (*p<0.05). Prostanoid production in purified Ly6G+ (D) and Ly6G- CD11b+ (E) cells
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was higher, in COX-2-/- compared to COX-2+/+mice (Fig 4C). The anti-inflammatory cytokine
Il10 showed lower expression in the COX-2-/- infected mice. There were no significant differ-
ences in Arg1 expression between COX-2+/+ or COX-2-/- mice (Fig 4D), but induction of Nos2
mRNA (iNOS) was significantly lower in COX-2-/- infected mice (Fig 4D). There was no
induction of Ptgs1 (COX-1) expression that could compensate for the COX-2-/- deficiency (Fig
4D). Ptges (mPGES-1) expression was increased upon infection, with lower levels in heart tis-
sue from COX-2-/- mice compared to COX-2+/+ mice (Fig 4D). Nevertheless, protein analysis
by western blot showed lower expression of both iNOS and Arg-1 in infected COX-2-/- respect
to COX-2+/+ mice (Fig 5). Analysis of TNF-α levels in plasma showed a similar increase in
both COX-2+/+ and COX-2-/- infected mice, indicating that the effect of COX-2 deficiency is
not systemic but specific of the heart (S3A Fig). Basal levels of gene expression did not signifi-
cantly change between COX-2+/+ and COX-2-/- mice (S4 Fig).
Cardiac inflammation is reduced in EP-2-/-mice
We found increased levels of PGE2 in heart tissue and cardiac infiltrating cells after T. cruzi
infection. Since the effector function of PGE2 produced by myeloid cells depends on its binding
to EP receptors, we studied gene expression of its 4 receptors, EP-1 (Ptger1), EP-2 (Ptger2), EP-
3 (Ptger3) and EP-4 (Ptger4), in hearts of mice during infection. The results show that in con-
trol infected mice the overall expression of EP receptors is higher than in non-infected hearts,
except for Ptger3 (Fig 6A). However, in C57BL/6 infected hearts Ptger2 expression showed the
highest increases suggesting a potential role of this receptor in T.cruzi infection. Thus, we used
mice deficient in the expression of the EP-2 (in the C57BL/6 background), which has been
involved in inflammation [35], and also in an autocrine loop of macrophage activation by
PGE2 [36], in order to study the role of this receptor during T. cruzi infection. The results show
that EP-2+/+ and EP-2-/- mice survived infection and no significant differences in parasitemia
or in heart parasite burden were observed between them (Fig 6B and 6C). These results suggest
that EP-2 signaling does not play an essential role in parasite elimination.
However, significant less heart inflammatory infiltrates were observed in infected EP-2-/-
in comparison with EP-2+/+ mice at 14 d.p.i. (Fig 6D). Representative images of cardiac tissue
and inflammatory infiltration are shown in Fig 6E. The expression of the common leukocyte
marker Ptprc (CD45) was lower in the heart of infected EP-2-/- mice respect to EP-2+/+,
whereas mRNA levels of cell markers as Cd4 (Th cells), Cd8 (Tc cells), and Itgax- (CD11c;
DCs), did not show significant differences. However, the expression of Cd68, a macrophage
marker, significantly increased in EP-2-/- respect to EP-2+/+ mice (Fig 7A). Regarding chemo-
kines, Ccl2 expression, but not Ccl5 and Cxcl9, was significantly reduced in the EP-2-/- com-
pared to EP-2+/+ infected mice (Fig 7B). Induction of pro-inflammatory cytokines Ifng and Il6,
the Th2 cytokine Il4 and the anti-inflammatory cytokine Il10, but not Tnf, was lower in EP-2-/-
compared with EP-2+/+ (Fig 7C). Similarly to COX-2-/-, no differences were observed in TNF-α
plasma levels in EP-2-/- as compared to EP-2+/+ infected mice (S3B Fig). Ptgs2 (COX-2) gene
expression was significantly lower in EP-2-/- infected mice (Fig 7D). There were no differences
between mouse strains in Nos2mRNA (iNOS) expression (Fig 7D), but Arg1mRNA expres-
sion was higher in EP-2-/- mice (Fig 7D). Western blot analysis showed a significant increase in
EP-2-/- respect to EP-2+/+ mice, in the protein levels of these enzymes involved in L-arginine
metabolism (Fig 8). Basal levels of gene expression did not significantly change between EP-2+/
+ and EP-2-/- mice (S5 Fig).
from BALB/c mice hearts at 21 d.p.i. was determined by incubation with labeled 25 μM [C14] AA and analysis by HPLC (black line and text). Prostanoid
standards (red line and text) were run in parallel as described in Methods. A representative experiment out of two performed is shown.
doi:10.1371/journal.pntd.0004025.g002
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Fig 3. Parasite burden and heart inflammation in T. cruzi infected COX-2+/+ and COX-2-/-mice. (A) The presence of parasites in the blood of COX-2+/+
or COX-2-/-mice at different d.p.i. was quantified by direct counting under optical microscopy. (B) DNA from heart tissue was isolated and qPCR using T. cruzi
DNA standard was performed to determine parasite burden in COX-2+/+ or COX-2-/- infected mice at 14 d.p.i. Means ± SEM from three independent
experiments are shown (n = 4). (C) Heart tissue sections of COX-2+/+ and COX-2-/-mice either non-infected (0 d.p.i.) or 14 d.p.i., were stained with Masson’s
Trichrome and inflammatory cell infiltration was quantified as described in Methods. (D) Representative pictures of heart tissue sections described in C.
Arrows indicate inflammatory infiltration. Scale bar is 100 μm. (ns = non-significant; *p<0.05; **p< 0.01; ***p<0.001).
doi:10.1371/journal.pntd.0004025.g003
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Fig 4. Gene expression of cell markers, chemokines, cytokines and inflammatory enzymes during T. cruzi infection in the heart of COX-2+/+ and
COX-2-/-mice.mRNA levels of the different genes analyzed was determined by qRT-PCR in heart tissue RNA samples isolated from non-infected (0 d.p.i.)
or 14 d.p.i. COX-2+/+ or COX-2-/-mice. Data are expressed as RQ calculated from CT values as described in Methods. Gene expression of lymphoid and
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Methods
Parasites and mice
BALB/c and C57BL/6 mice (6 to 8-week-old) were purchased from Harlan, Interfauna Iberica.
B6;129S7-Ptgs2tm1Jed/J (COX-2-/-) mice were purchased from The Jackson Laboratory. C57BL/
6 Ptger2tm1Sna (EP-2-/-) mice were a gift form Dr. Shu Narumiya, (Faculty of Medicine, Univer-
sity of Kyoto). Wild type B6/129S (COX-2+/+) and C57BL/6 (EP-2+/+) mice were obtained by
breeding heterozygote pairs.
myeloid cell markers as Ptprc, Cd4, Cd8a, Cd68 and Itgax (A), chemokines as Ccl2, Ccl5 andCxcl9 (B), cytokines as Ifng, Tnf, Il4, Il6 and Il10 (C) and
enzymes as Arg1, Nos2, Ptgs1 and Ptges (mPGES1) (D) is shown. Means ± SEM from one representative experiment (n = 3) out of four is shown (n = 5;
* p<0.05; **p<0.01; ***p<0.001).
doi:10.1371/journal.pntd.0004025.g004
Fig 5. iNOS and Arg-1 expression in T. cruzi infected cardiac tissue of COX-2+/+ and COX-2-/-mice. (A)
Western blot analysis of iNOS and Arg-1 protein in extracts from hearts of COX-2+/+ and COX-2-/- from non-
infected mice (0 d.p.i.) and at 14 d.p.i. Ponceau staining of the blot is shown as a loading control. Samples for
6 different infected mice are shown. (B) Quantification of iNOS and Arg-1 band areas relative to the Ponceau
staining from COX-2+/+ (dashed black bars) and COX-2-/- (dashed gray bars) is represented as means ± SEM
in arbitrary units. A representative experiment (n = 5) out of two is shown (**p<0.01).
doi:10.1371/journal.pntd.0004025.g005
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Fig 6. Parasite burden and heart inflammation in T. cruzi infected EP-2+/+ and EP-2-/-mice. (A) mRNA levels of EP receptors (Ptger1, Ptger2, Ptger3
and Ptger4) was determined by qRT-PCR in heart tissue RNA samples isolated from C57BL/6 mice non-infected (0 d.p.i.) and at 14 days post-infection
(n = 5). (B) The presence of the parasites in the blood of EP-2+/+ or EP-2-/-mice at different d.p.i. was quantified by direct counting under optical microscopy.
(C) DNA from heart tissue was isolated and qPCR using T. cruziDNA standard was performed to determine parasite burden in EP-2+/+ or EP-2-/- infected
mice at 14 d.p.i. Means ± SEM from a representative experiment (n = 4) from three independent experiments are shown (n = 4). (D) Heart tissue sections of
EP-2+/+ and EP-2-/- from non-infected mice (0 d.p.i.) and at 14 d.p.i., were stained with Masson’s Trichrome and inflammatory cell infiltration was quantified as
described in Methods. (***p<0.001). (E) Representative pictures of heart sections described in C. Arrows indicate inflammatory infiltration. Scale bar is
100 μm.
doi:10.1371/journal.pntd.0004025.g006
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Fig 7. Gene expression of cell markers, chemokines, cytokines and inflammatory enzymes during T. cruzi infection in the heart of EP-2+/+ and EP-
2-/-mice. Expression of the different genes was analyzed by qRT-PCR in RNA samples of heart tissue isolated from EP-2+/+ and EP-2-/- non-infected mice (0
d.p.i.) and at 14 d.p.i. Data are expressed as RQ calculated from CT values as described in Methods. Gene expression of lymphoid and myeloid cell markers
as Ptprc, Cd4, Cd8a, Cd68 and Itgax (A), chemokines as Ccl2, Ccl5 andCxcl9 (B), cytokines as Ifng, Tnf, Il4, Il6 and Il10 (C) and enzymes as Nos2, Ptgs2
and Arg1 (D) is shown. Means ± SEM from a representative experiment (n = 3) out of two is shown (n = 4;* p<0.05; **p<0.01; ***p<0.001).
doi:10.1371/journal.pntd.0004025.g007
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In vivo infections were performed with Y T. cruzi strain as described [6, 7]. Groups of 3–15
mice were infected with 2,000 trypomastigotes per mice by intraperitoneal injection. Groups of
3–6 non-infected mice were included in the experiments as a control. Survival was monitored
daily and parasitemia levels were checked every 2–3 days. Mice blood and tissues were collected
at 0 (non-infected), 14 and 21 days post-infection (d.p.i.), as indicated.
Ethics statement
This study was carried out in strict accordance with the European Commission legislation for the
protection of animals used for scientific purposes (Directives 86/609/EEC and 2010/63/EU).
Fig 8. iNOS and Arg-1 expression in T. cruzi infected cardiac tissue of EP-2+/+ and EP-2-/-mice. (A)
Western blot analysis of iNOS and Arg-1 protein in extracts from hearts of EP-2+/+ and EP-2-/- non-infected
mice (0 d.p.i.) and at 14 d.p.i. Ponceau staining of the blot is shown as a loading control. Extracts from 3
different infected mice were loaded. (B) Quantification of iNOS and Arg-1 band areas relative to the Ponceau
staining from EP-2+/+ (black bars) and EP-2-/- (gray bars) is represented as means ± SEM in arbitrary units. A
representative experiment out of two is shown (**p<0.01; ***p<0.001).
doi:10.1371/journal.pntd.0004025.g008
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Mice were maintained under pathogen-free conditions at the Centro de Biología Molecular
Severo Ochoa (CSIC-UAM) animal facility. The protocol for the treatment of the animals was
approved by the ‘‘Comité de Ética de Investigación de la Universidad Autónoma deMadrid”,
Spain (permits CEI-14-283 and CEI-47-899). Animals had unlimited access to food and water.
They were euthanized in a CO2 chamber and all efforts were made to minimize their suffering.
Quantitative PCR
Hearts were perfused with Phosphate buffered saline (PBS) solution containing 1UI/ml of
heparin, minced into small pieces with a sterile scalpel and DNA was isolated with High
PurePCR Template preparation Kit (Roche). For T. cruzi detection, we used the quantitative
PCR (qPCR) assay described by Piron et al. [37]. 100, 10, 1, 0.1 and 0.01 pg of DNA purified
from Y strain epimastigotes were used to generate the standard curve. qPCR reactions were
performed with 100 ng of genomic DNA and murine Tnf gene primers were used as DNA
loading control.
mRNA analysis by quantitative RT-PCR
For RNA extraction, heart tissue was perfused with PBS containing 1UI/ml of heparin, cut in
small pieces using a sterile scalpel blade, followed by mechanical disruption using a PT 1300 D
homogenizer (Kinematica Polytron, Fisher Scientific) in TRIzol reagent (Invitrogen) as indi-
cated by the manufacturer. Gene expression was analyzed by quantitative reverse transcription
PCR (qRT-PCR). Reverse transcription of total RNA was performed using the components of
the High Capacity cDNA Archive Kit (Applied Biosystems. Life Sciences) or the SuperScript
Enzyme (Invitrogen, Life Sciences). Amplification were performed using TaqMan MGB probes
(S1 Table) and the TaqMan Universal PCR Master Mix (Applied Biosystems) on an ABI
PRISM 7900 HT instrument (Applied Biosystems. Life Sciences). For cultured cells, samples
were treated as mentioned above except for the mechanical disruption. All samples were
assayed in triplicate. Quantification of gene expression by real-time PCR was calculated by
the comparative threshold cycle (CT) method as described in [38] (RQ = 2-ΔΔCT). All quantifi-
cations were normalized to the ribosomal 18S control to account for the variability in the
initial concentration of RNA and in the conversion efficiency of the reverse transcription
reaction.
Protein expression analysis
Protein extracts were prepared from heart tissue perfused with PBS containing 1UI/ml of hepa-
rin, cut in small pieces using a sterile scalpel blade followed by mechanical disruption in Triton
X-100 based protein lysis buffer. Protein concentration was determined by the bicinchoninic
acid method (BCA, Pierce) using Bovine Serum Albumin (BSA) for the standard curve. West-
ern blot analyses were performed as follows: 15 or 50 μg of cell or tissue extract were fraction-
ated on SDS polyacrylamide gel and transferred to a Nitrocellulose membrane Hybond-ECL
(Amersham Biosciences) and blocked in 5% fat free dry milk or 5% BSA in 0,1% Tween-20
Tris Buffered Saline. Membranes were incubated overnight with diluted primary antibodies (S2
Table) at 4–8°C. The membranes were incubated with horseradish peroxidase conjugated sec-
ondary antibodies (S2 Table) and detection was carried out with Supersignal detection reagent
(Pierce) followed by photographic film exposure. Fiji package software was used to quantify
band intensity normalizing band areas of the sample to their respective loading control.
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Histological studies
Cardiac tissues from mice were placed in 10% neutral buffered formalin for at least 4 hours at
room temperature followed by incubation in 70% ethanol overnight. Samples were then
embedded in paraffin (Tissue Embedding Station Leica EG1160), and 5 μm tissue sections
were prepared (Microtome Leica RM2155). Samples were deparaffinized and rehydrated using
a Tissue Processing Station Leica TP1020. Slides were stained with Masson´s Trichrome stain-
ing and mounted permanently in Eukitt´s quick hardening mounting medium (Biochemika,
Fluka analytical). The sections were microscopically analyzed in a Leica microscope (DMD
108, Leica microsystems Wetzlar GmbH, Germany) using the 20x magnification objective lens
and Lamp intensity 10 and f/Stop 12. Ventricular myocardium micrographs were taken avoid-
ing pericardium, endocardium, atria and big vessels. Nine pictures of different sections, sepa-
rated by at least 50 μm, per heart were taken. The degree of inflammatory-cell infiltration was
quantified using the Fiji package [39] and the plugin Trainable Weka Segmentation developed
by Ignacio Arganda Carreras (Versailles, France) [39] (Image J macro used for automated
image analysis is detailed in S1 File) and expressed as the percentage of the nuclei/tissue area
ratio.
Confocal immunofluorescence
Organs were removed from mice at different d.p.i., cut and fixed in a 4% paraformaldehyde
PBS buffered solution for 2h at room temperature, followed by incubation in a 30% sucrose
solution at 4°C overnight. Tissues were then embedded in Tissue-Tek OCT in Cryomolds
(Sakura) and frozen. 10 μm sections were cut using a cryostat Leica CM1900. Slides were fixed
in acetone for 10 min at room temperature and incubated 10 min with NH4Cl to reduce auto-
fluorescence. Then, slides were washed with PBS, permeabilized with 0,1% Triton X-100,
blocked and incubated over night at 4°C with primary antibodies (S2 Table) in blocking buffer
(PBS 0,1% Triton X-100, 5% BSA). The samples were washed with PBS and secondary antibod-
ies (S2 Table) were added in blocking buffer and incubated overnight at 4°C. Blocking of
unspecific secondary antibody binding was achieved by addition of 2% of normal serum of the
species in which the secondary antibody was raised. As a negative control, sections were treated
in the same manner, except that incubation with primary antibody was omitted. Nuclei were
stained using 1 μg/ml of DAPI (268298, Merck). Prolong Gold Antifade Reagent (Invitrogen)
was used to mount the slides that were kept at 4°C until observation. Stained slides were
observed with the confocal laser scanning microscope LSM710, coupled to an AxioimagerM2
microscope (Zeiss). The micrographs were processed using the software ZEN (Zeiss) or the Fiji
Package.
Isolation of Ly6G+ and CD11b+Ly6G- cells by magnetic sorting
BALB/c (n = 15) or C57BL/6 mice (n = 15) were infected i.p. with 2,000 trypomastigotes of the
Y strain. At 21 d.p.i. for BALB/c and 14 d.p.i. for C57BL/6, mice were euthanized in a CO2
chamber and hearts were aseptically removed, perfused with 10 ml PBS containing 1UI/ml of
heparin, and kept in cold Hank´s balanced saline solution (HBSS). Then, hearts were pooled in
a cell culture dish, washed thoroughly with HBSS and minced into small pieces with a sterile
surgery blade. Mouse hearts (maximum 4 per tube) were transferred into the gentleMACS C
tube containing 4,7 mL of HBSS. 300μL of Collagenase II solution (600 U/ml) and 10 μl DNase
I solution (60U/ml) were added. Then tissue was disrupted with GentleMACS Dissociator
(Miltenyi Biotec GMbH). To obtain cell suspensions, a 70 μm cell strainer (Falcon BD) was
used. After red blood cells lysis, the cells were magnetically sorted. For Ly6G+ cell sorting, anti
Ly-6G MicroBead kit was used with MACS LS columns and MACS Separators (Miltenyi Biotec
COX-2 Favors Myocarditis in Acute T. cruzi Infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004025 August 25, 2015 15 / 23
GmbH), following manufacturer instructions. Ly6G- fraction of the cell suspension was after-
wards processed for CD11b+ cell sorting using CD11b Microbeads kit.
Analysis of prostanoids
Prostanoid levels were determined in mouse tissue extracts from 0 (non-infected) and 21 d.p.i.
by Metabolon Inc., and expressed as ScaledImpData as previously described [40]. To determine
in vitro prostanoid production, heart infiltrating cells were magnetically sorted as described
above and incubated 30 minutes at 37°C in 500 μl of RPMI without Fetal bovine serum (FBS)
in the presence of 25 μM [14C] AA, PerkinElmer (Massachusetts, USA). 500 μl of 2% acetic
acid in cold methanol was added to extract and preserve AA derivatives. Samples were vortexed
and the air inside the tube was substituted by inert nitrogen gas. Samples were kept frozen at
-80°C until HPLC was performed. HPLC device was composed by a Beckman Solvent Module
126 with the column Ultraphere ODS (C-18, Beckman-Coulter) 5 μm diameter sphere particle,
4.5 mm and 25 cm column diameter and length respectively and a Beckman 171 Radioisotope
Detector. Scintillation liquid Ecoscint H was purchased from National Diagnostics. Prosta-
noids were resolved with the isocratic flow (1ml/min) of the mobile phase: Acetonitrile/water/
acetic acid 33:67:0.1 v/v/v. Standards were produced using [14C] Arachidonic Acid and differ-
ent cell types expressing the respective enzymes, and [14C] Arachidonic Acid incubated in
medium was used as input control as described [41].
Statistical analysis
For in vivo experiments, data are shown as means ± SEM. All the in vitro experiments were
performed at least three times. Significance was evaluated by Student’s t-test when two groups
were compared. ANOVA one way followed by Tukey post-test was used when groups of sam-
ples from an experiment had different time points. ANOVA two way followed by Bonferroni
post-test were used when the experiment included time and mice strain as variables. For sur-
vival analysis, we used Gehan-Breslow-Wilcoxon method. GraphPad Prism 5.00 software (La
Jolla, CA, USA) was used for statistical analysis.
Discussion
In order to clarify the role of prostanoids in the outcome of T. cruzi infection we first analyzed
the expression of prostanoid-synthesizing enzymes in cardiac tissue from T. cruzi susceptible
(BALB/c) and non-susceptible (C57BL/6) mice. Our results showed an increase of COX-2/
mPGES-1/PGE2 axis in heart tissue upon infection in both strains of mice, indicating that it
has no direct effect on susceptibility to infection. Confocal microscopy analysis showed the
presence of CD68+Arg-1+COX-2- cells and CD68+Arg-1-COX-2+, suggesting that there are at
least two subpopulations of monocytic infiltrating cells with mutually exclusive expression of
those enzymes. Thus, our results show that the myeloid population infiltrating the heart in T.
cruzi infection is more complex than previously described [7], and suggests a difference in the
function of these two myeloid populations. Macrophages can rapidly change their phenotype
and function in response to local microenvironmental signals, playing key roles in the initiation
and resolution of inflammation and tissue homeostasis [42] and could be involved in tissue
repair and fibrosis [43]. Thus, myeloid cardiac infiltration could inhibit parasite replication
and also facilitate the repair of damaged muscular tissue [44]. A suggestive hypothesis is that
COX-2 expressing macrophages could be linked to inflammation meanwhile Arg-1+macro-
phages could be involved in tissue repair.
Immunostaining of heart tissue sections showed the presence of myeloid and non-myeloid
cells positive for COX-2 in heart tissue sections of both BALB/c and C57BL/6 mice. However,
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after purification of myeloid cells from heart tissue, we found that only a particular subset
expressed COX-2, being the levels of COX-2 expression higher in C57BL/6 than BALB/c mice.
Likely, non-myeloid COX-2 positive cells are lost in the purification process, a fact that might
account for the apparent contrary results.
Interestingly, we demonstrated that PGE2 and 6-oxo-PGF1α (stable hydrolysis product of
PGI2) were elevated in infected heart tissue. Furthermore, monocytes (CD11b
+Ly6G-) isolated
from infected heart express COX-2, and are able to produce high levels of PGE2 ex vivo. The
differences in metabolites detected in total heart extracts versus purified myeloid cells are likely
due to their synthesis by other cell types and/or enrichment after cell purification. In agreement
with this, we have previously reported that T. cruzi infection induces COX-2 in cardiomyo-
cytes, leading to PGF2α and TXA2 production [45]. Although COX-2 expression can be
induced in CD4+ T cells upon activation [34], heart infiltrating CD4+ cells did not express
detectable levels of COX-2.
On the other hand, the increase of Tbxas1 and Hpgds gene expression observed upon T.
cruzi infection in both C57BL/6 and BALB/c mice suggests the production of their respective
TXA2 and PGD2 metabolites in infected cardiac tissue. Tbxas1 was elevated up to 28 d.p.i. and
its product, TXA2, besides its vascular functions [46], could have a pro-inflammatory role for
monocytes [47]. In contrast,Hpgds expression showed a gradual increase during the acute
phase, and its product, PGD2, could be involved in resolution of inflammation, as described in
other settings [48–50]. Resistant C57BL/6 mice showed significantly higher expression of
Hpgds at 21 d.p.i. and lower expression of Tbxas1 at 28 d.p.i. than the susceptible BALB/c mice,
suggesting that C57BL/6 may resolve inflammation earlier than BALB/c infected mice. How-
ever, TXA2 and PGD2 metabolites were not detected in purified Ly6G
+ nor in CD11b+Ly6G-
cells, suggesting that they could be produced by other infiltrating cell types or by infected cardi-
omyocytes [45].
Previous reports using COX-2 inhibitors in T. cruzi infection showed discordant results
[30]. Moreover, COX-2 inhibitors may interfere with the immune response [34], but more
importantly, many COX-2 inhibitors have effects independent of their ability to inhibit cyclo-
oxygenase activity [51–53]. For those reasons, we analyzed the contribution of COX-2 by using
a mouse model deficient for its expression. We found a small variation in parasitemia (30%
reduction at the peak of parasitemia) in COX-2-/- respect to the COX-2+/+ mice, which cannot
be taken as indicative of resistance. In addition, no changes were observed in cardiac parasite
burden, in spite that COX-2-/- mice expressed less iNOS than COX-2+/+ mice, considered to be
key for resistance in T. cruzi infection [54], indicating that heart parasite load is not affected by
the lack of COX-2 expression. Interestingly, we found that COX-2 was required for leukocyte
infiltration and inflammation in the heart upon T. cruzi infection, but it did not affect systemic
inflammation. However, COX-2-/- mice are resistant to death in sepsis, indicating that in this
case COX-2 has a systemic pro-inflammatory role [55]. An important role of endogenous
COX-2 derived PGs in migration of immune cells to infected tissues or lymphoid organs is
becoming evident [19]. Thus, the decrease in cardiac inflammation and in local production of
cytokines and chemokines observed in COX-2-/- infected mice, indicate a pro-inflammatory
role of prostanoids as PGE2 in acute myocarditis.
We have previously described that PGE2 induces COX-2 and mPGES-1 expression in an
autocrine loop required for full activation of macrophages [36]. Thus, the fact that COX-2-/-
mice showed a reduced PtgesmRNA expression (mPGES-1) suggest a blockade of the auto-
crine loop that may impair full activation of macrophages, resulting in the reduced cardiac
infiltration observed. In the same direction, lack of PGE2 signaling through EP-2 receptor in
EP-2-/- infected mice, resulted in reduced Ptgs (COX-2) mRNA expression that may also block
the autocrine loop, impairing macrophages to infiltrate the cardiac tissue. This is in agreement
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with the observed decrease in Ccl2mRNA expression in COX-2-/- and EP-2-/- infected mice
respect to wild type infected mice, since this chemokine is required for migration of monocytes
to the inflamed infected tissue [56]. Moreover, PGE2 also affects migration of myeloid cells
potentiating CCL2 activity [19]. Therefore, the reduction of cardiac infiltration in both animal
models suggest a detrimental pro-inflammatory role of COX-2 in the onset of cardiac
inflammation.
Strikingly, Arg-1 and iNOS expression, markers of MDSCs, was higher in hearts of infected
EP-2-/- mice than in those from COX-2-/- infected mice hearts, indicating that infiltrating cells
from EP-2-/- mice present a more marked MDSCs phenotype. In addition, the effect of EP-2
deficiency on cytokine and chemokine production in heart, was milder than the observed in
COX-2-/- infected mice. In the hearts of C57BL/6 mice, infection caused a greater significant
increase in the expression of Ptger2, which validates the use of EP-2-/- mice in the C57BL/6
background. But still Ptger1 and Ptger4 were significantly increased although in a minor extent.
Thus in EP-2-/- infected mice PGE2 can still signal through Ptger1 and Ptger4 causing this
milder effect in EP-2-/- mice in comparison to the observed in COX-2-/- infected hearts. In con-
trast, in COX-2-/- infected mice, mPGES1 synthase expression is substantially reduced and
PGH2 substrate for PGE2 production likely relies on constitutive COX-1 activity. Thus, the
decreased levels of PGE2 may affect signaling through all PGE2 receptors, having a broader
effect on leukocyte infiltration. The response to T. cruzi infection in mice deficient in other
enzymes and products of the AA pathway has been scarcely studied [26, 27]. Sharma et al.
described that deficiency of iPLA2-γ (Ca
++ independent PLA2 isoform-γ), which is involved in
AA membrane release, aggravated infection and decreased survival, while Mukherjee et al.
described that COX-1-/- mice showed higher parasitemia than wild type infected mice, but no
difference in survival was noted [27]. In our hands, interference within the AA pathway at a
different level, as COX-2 mediated production of prostanoids or PGE2/EP-2 signaling, results
in decreased inflammation in heart of T. cruzi infected mice, with low incidence in parasite
burden and survival. Altogether, these results point to an essential role of the AA pathway in
heart inflammation during T. cruzi infection.
In the other hand, related with the prostanoid pathway, 5-lipoxygenase (5-LO) has been
shown to play a detrimental role during T. cruzi infection by potentiating heart parasitism and
inflammation [57, 58] through the regulation of iNOS activity [59]. However, further studies
are needed to elucidate the crosstalk between LO and COX pathways during infection.”
Besides, we have previously showed that monocytic CD11b+Ly6G- heart infiltrating cells
(MDSCs), expressing iNOS and Arg-1 suppressed ex vivo T cell proliferation [7]. Since some of
these infiltrating cells also express COX-2 and produce PGE2 it is possible that COX-2-derived
PGs could contribute to immune suppression, a possibility that should be addressed in the
future.
In conclusion, during acute T. cruzi infection there is an increase in the expression of many
enzymes of the AA metabolism, including COX-2 and mPGES-1 that leads to an increase in
their metabolite PGE2, partially due to infiltrating myeloid cells in the heart. Besides, we have
identified a new myeloid infiltrating population characterized by the expression of COX-2.
Thus, so far there are at least three different myeloid populations infiltrating the T. cruzi
infected heart: granulocytes, monocytic MDSCs expressing iNOS and Arg-1 and monocytic
cells expressing COX-2. COX-2 activity likely increases PGE2 levels in heart tissue, which play
a pro-inflammatory role by signaling through EP-2. However, the phenotype of EP-2-/- is not
as strong as COX-2-/- infected mice probably due to PGE2 signaling through alternative EP
receptors. Our findings suggest that COX-2 plays a detrimental role in acute Chagas disease
myocarditis. Further research of the AA pathway is needed to completely understand its role
during T. cruzi infection for immune intervention approaches.
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Supporting Information
S1 Fig. Survival, parasite burden and inflammation of BALB/c and C57BL/6 mice infected
with T. cruzi. (A) Survival was checked every day during the infection in BALB/c and C57BL/6
mice (n = 5). (B) The presence of the parasites in the blood of BALB/c and C57BL/6 mice was
quantified by direct counting under optical microscopy. Means ± SEM of a representative
experiment (n = 4) from two independent experiments are shown. ( p< 0.05;  p< 0.01). (C)
Histology of cardiac tissue in non-infected (0 d.p.i.) or 21 d.p.i T. cruzi infected BALB/c and
C57BL/6 mice. Representative pictures of heart tissue sections of each group, processed for
Masson`s Trichrome histology staining, are shown. Black arrows point to the infiltrating leu-
kocytes and red arrows point to parasite nests. Scale bar is 100 μm.
(TIF)
S2 Fig. COX-2 and CD4 expression in T. cruzi infected mouse cardiac tissue. (A) Heart tis-
sue was isolated at 14 d.p.i. from infected C57BL/6 mice and sections were stained with DAPI
for nuclei (Blue), the lymphocyte marker CD4 (green) or COX-2 (red). A representative picture
of several sections analyzed in at least three different mice from two independent experiments
is shown. (B) Control sample from heart of C57BL/6 mice at 14 d.p.i. incubated with secondary
antibodies coupled to Alexa Fluor (AF) 488, and 647 in the absence of primary antibodies. (C)
Same as in A from heart of BALB/c mice at 21 d.p.i.. (D) Same as in B from heart of BALB/c
mice at 21 d.p.i. (E) Control samples from heart of BALB/c mice at 21 d.p.i. incubated with sec-
ondary antibodies coupled to Alexa Fluor (AF) 488, 555 and 647 in the absence of primary
antibodies. Scale bar is 20 μm.
(TIF)
S3 Fig. Serum levels of TNFα in COX-2+/+, COX-2-/-, EP-2+/+ and EP-2-/- mice during T.
cruzi infection. TNFα concentration in non-infected mice (0 d.p.i.) and at 14 d.p.i. in blood
serum of (A) COX-2+/+ and COX-2-/- and (B) EP-2+/+ and EP-2-/- mice. Representative
means ± SEM from two independent experiments are shown (n = 6) (ns = non-significant).
(TIF)
S4 Fig. Comparison of the gene expression of cell markers, chemokines, cytokines and
inflammatory enzymes basal levels in the heart of COX-2+/+ and COX-2-/- mice.mRNA lev-
els of the different genes analyzed was determined by qRT-PCR in heart tissue RNA samples
isolated from non-infected (0 d.p.i.) COX-2+/+ or COX-2-/- mice. Data are expressed as RQ cal-
culated from CT values as described in Methods. Gene expression of lymphoid and myeloid
cell markers as Ptprc, Cd4, Cd8a, Cd68 and Itgax (A), chemokines as Ccl2, Ccl5 and Cxcl9 (B),
cytokines as Ifng, Tnf, Il4, Il6 and Il10 (C) and enzymes as Arg1, Nos2, Ptgs1 and Ptges
(mPGES1) (D) is shown. Means ± SEM from one representative experiment (n = 3) out of four
is shown (n = 5;  p<0.05).
(TIF)
S5 Fig. Comparison of the gene expression of cell markers, chemokines, cytokines and
inflammatory enzymes basal levels in the heart of EP-2+/+ and EP-2-/- mice.mRNA levels
of the different genes analyzed was determined by qRT-PCR in heart tissue RNA samples
isolated from non-infected (0 d.p.i.) EP-2+/+ or EP-2-/-mice. Data are expressed as RQ calculated
from CT values as described in Methods. Gene expression of lymphoid and myeloid cell markers
as Ptprc, Cd4, Cd8a, Cd68 and Itgax (A), chemokines as Ccl2, Ccl5 and Cxcl9 (B), cytokines as
Ifng, Tnf, Il4, Il6 and Il10 (C) and enzymes asNos2, Ptgs2 and Arg1 (D) is shown. Means ± SEM
from one representative experiment (n = 3) out of four is shown (n = 5;  p<0.05).
(TIF)
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S1 Table. Taqman probes. List of the Taqman Probes from Applied Biosystems (A&B) used
in the mRNA analysis by quantitative RT-PCR, including reference of the manufacturer, gene
symbol and protein name.
(PDF)
S2 Table. Antibodies. List of antibodies from different providers used in confocal immunoflu-
orescence and western blot analysis including the reference from each provider, the application
and the dilution utilized.
(PDF)
S1 File. Image J macro used for automated image analysis. Plugin Trainable Weka Segmen-
tation developed by Ignacio Arganda Carreras (Versailles, France).
(PDF)
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a b  s  t  r a  c t
Chagas  disease  is caused  by  the  protozoan Trypanosoma  cruzi. This  is  an endemic disease  in the  Americas,
but  increased migration  to  Europe has  made it emerge  in countries  where  it was previously  unknown,
being  Spain  the  second  non endemic  country in number  of  patients.  T. cruzi  is  a parasite with  a wide
genetic  diversity,  which  has  been  grouped by  consensus  into  6  Discrete  Typing Units  (DTUs)  affecting
humans. Some authors  have  linked  these  DTUs  either  to  a  specific  epidemiological  context or to the
different  clinical  presentations.  Our  main objective  was to describe the  T.  cruzi DTUs  identified from  a
population  of chronically  infected  Latin American  migrants  attending  a reference  clinic  in Madrid.  149
patients meeting this  condition  were  selected  for  the study.  Molecular  characterization  was performed  by
an algorithm  that combines  PCR  of the intergenic  region  of the  mini  exon-gene,  the  24S and  18S regions
of rDNA and the  variable region  of the  satellite DNA.  A descriptive  analysis  was  performed  and associations
between geographical/clinical  data  and  the  different DTUs  were  tested.  DTUs  could  be  determined  in  105
out of 149 patients,  93.3% were  from  Bolivia,  67.7% were  women and  median  age was  35 years  (IQR
29–44).  The most common  DTU found  was TcV (58;  55.2%),  followed  by  TcIV  (17; 16.2%), TcII  (10; 9.5%)
and  TcI  (4; 3.8%). TcIII  and  TcVI were  not  identified  from  any  patient,  and  15.2% patients  presented  mixed
infections.  In  addition, we determined  DTUs  after  treatment  in a subset  of patients.  In  57%  patients  had
different  DTUs  before  and after treatment.  DTUs  distribution  from this  study  indicates  active transmission
of T.  cruzi is occurring  in  Bolivia,  in both  domestic  and sylvatic cycles. TcIV was confirmed as a cause of
chronic human  disease.  The  current  results  indicate  no correlation between DTU  and  any specific  clinical
presentation associated with  Chagas  disease,  nor  with  geographical origin.  Treatment with  benznidazole
does not always clear  T. cruzi’s genetic  material  from  blood,  and DTUs  detected  in the  same patient may
vary  over  time indicating that  polyparasitism  is  frequent.
© 2016  Elsevier B.V.  All  rights  reserved.
1. Introduction
Trypanosoma cruzi is  a protozoan parasite transmitted by many
species of triatomine vectors which can infect over 70 different gen-
era of mammalian hosts. Chagas disease is  the name given to the
human infection, which can produce cardiac and/or digestive dis-
orders in up to 30% of infected individuals. This disease is  endemic
∗ Corresponding author at: National Referral Centre for Tropical Diseases,
Infectious Diseases Department, Ramón y  Cajal University Hospital, IRICYS, Ctra
Colmenar, Km 9,100, 28034 Madrid, Spain.
E-mail address: rogelio.lopezvelez@salud.madrid.org (R. López-Vélez).
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in  Latin America, where up to 8–9 million people are thought to
be infected and between 25 to  90 million are at risk of acquiring
the disease according to the Pan American Health Organization
(2008).  Increased migration has made Chagas disease emerge in
areas where it was  previously not known, with Spain having the
largest number of imported cases after the United States (Schmunis
and Yadon, 2010).
T. cruzi presents great genetic diversity and is classified by con-
sensus into six Discrete Typing Units (DTUs) named TcI to TcVI
(Zingales, 2009).  The relevance of T. cruzi genetic diversity in Chagas
disease should be examined further but existing evidence supports
the importance of this diversity in terms of epiology and its associ-
ation with clinical presentation and outcomes.
http://dx.doi.org/10.1016/j.actatropica.2016.01.032
0001-706X/© 2016 Elsevier B.V. All  rights reserved.
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Different DTUs are associated with different biological cycles of
transmission and seem to have varying geographical distributions
(Zingales et al., 2012). TcI,  the most frequent and widely distributed
DTU, has been found from the South of the US to the North of Chile
and Argentina, and can be transmitted both in  sylvatic and domes-
tic cycles. TcIII and TcIV have been more frequently associated with
sylvatic cycles, and have been implicated as a  cause of acute out-
breaks in the Amazon basin (Marcili et al., 2009b; Monteiro et al.,
2012). TcIII has also been found in  armadillos (Yeo et al., 2005),
although it has been identified from domestic dogs as well (Cardinal
et al., 2008), and associated to  the terrestrial niche even in the
Chaco region (Llewellyn et al., 2009; Marcili et al., 2009a). While
TcIV seemed to have an arboreal ecotope (Cardinal et al., 2008) and
is the second most frequent DTU detected in Venezuela (Carrasco
et al., 2012). TcII, TcV and TcVI have been more often associated
with domestic cycles in the Southern Cone countries (Zingales et al.,
2012). However, the majority of these data have been obtained from
T. cruzi parasites cultured in  laboratory media, which may  alter the
composition of T. cruzi populations by eliminating or reducing some
near-clades of the parasite (Deane et al., 1984; Venegas et al., 2013).
Some authors have identified a differential tissue tropism
among these DTUs and linked some of them to specific clinical
presentations. For instance, TcI has been associated with cardiac
disease in Colombia, Argentina, Venezuela and Brazil (Burgos et al.,
2010; Miles et al., 1981; Ramírez et al., 2010); TcII, TcV and TcVI can
cause both cardiac and digestive disease, even causing megasyn-
dromes. In addition, T. cruzi’s genetic diversity seems to confer
different drug susceptibility both “in vitro” (Moraes et al., 2014;
Zingales et al., 2014), although this does not seem to  influence the
clinical outcome (Moreno et al., 2010), and “in vivo” (Teston et al.,
2013).
The aim of this study was to identify the T. cruzi near-clades
from a population of chronically infected Latin American migrant
patients, and to describe their association with geographical origin
and specific clinical manifestations. In  addition the persistence and
temporal variation of these DTUs after treatment were investigated.
2. Methods
2.1. Population and selection criteria
Participation in the study was offered to  Latin American
migrants attending the Tropical Medicine Referral Centre of the
Ramon y Cajal Hospital (Madrid, Spain) between January 2009 and
February 2011. Adult patients diagnosed with chronic T. cruzi infec-
tion who were willing to attend follow up visits and were able to
understand and sign informed consent were selected. Exclusion cri-
teria were: acute infection (discarded in  recently arrived subjects
by clinical findings and direct parasitological methods), age below
18 years and refusal to sign informed consent.
Diagnosis was established by two positive serological tests:
an in-house IFAT and an ELISA (ARCHITECT Chagas ELISA test.
BiosChile, Abbott lab. Wiesbaden, Germany). The in-house IFAT
was prepared with a  combination of cultured epimastigote anti-
gens (Mc, T  and Dm28), using a human IgG from bioMérieux® as
a marker. EDTA tubes were used for collection and transport and
samples were stored at −80 ◦C.
The study was approved by  the Ramón y Cajal Hospital Ethics
committee.
2.2. T. cruzi molecular detection and molecular characterization
Double blind molecular characterization was performed at the
CIMPAT laboratory in  Bogotá (Colombia) using an algorithm, as
previously reported (Ramírez et al., 2010).  The algorithm combines
PCR of the intergenic region of the mini exon-gene, the 24S  and
18S regions of rDNA and the variable region of the satellite DNA as
described. Molecular markers include the intergenic region of the
non-transcribed mini-exon gene using primers TCC (5′CCC CCCCCC
TCC CAG  GCC ACA CTG3′), TC1 (5′GTG TCC GCC ACC TCC TTCGGG
CC3′) and TC2 (5′CCT GCA GGC ACA CGT GTG TGT G 3′). All mini-
exon gene PCR assays were performed using two  primers instead
of a multiplex PCR assay to determine the presence of mixed infec-
tions. Thus, PCR reactions were set separately using TCC-TC1 and
TCC-TC2 primers. In order to  increase the number of genotyping
assays, in some cases PCRs were performed 3 times in triplicate.
We used segments containing the variable domain D7 of  the
rDNA 24S  subunit using D75 (5′GCAGATCTTGGTTGGCGTAG3′)
and D76 (5′GGTTCTCTGTTGCCCCTTTT3′),  and the A10 with
primers pr1 (5′CCGCTAAGCAGTTCTGTCCATA3′) and pr3
(5′GCTTTATTACCCCATGCCACAG3′) (Burgos et al., 2007). The
reference strains used to compare size of amplified fragments
were: TcI: Silvio X10, TcII: ESM, TcIII: Arma, TcIV: CanIII, TcV: Bug
and, TcVI: Cl Brener.
2.3. Statistical analysis
Qualitative variables were expressed as total number of obser-
vations and relative frequencies, and were analyzed with the 2
and Fisher exact tests. Quantitative variables were expressed as
medians and interquartile ranges (IQR), or mean and standard devi-
ations if they were normal. Unpaired Student’s t-test or Wilcoxon
test were used for associations of quantitative data. Associations
were tested between demographic characteristics and clinical data,
and the different DTUs among those patients in whom a  DTU could
be determined. Age, gender, geographical origin, serological titres
and presence of specific visceral involvement during a  three year
follow-up period were analyzed. Additionally, DTU determination
was repeated after treatment in 19 cases.
2.4. Description of visceral involvement
Every patient had a  12-lead electrocardiogram (ECG) and
echocardiogram performed at baseline. Other examinations (car-
diac Holter, cardiac MRI, oesophageal manometry or barium
enema) were requested if clinical symptoms were present or
according to the results found in the baseline examinations. Car-
diac involvement was considered to be present when at least
one of the following was found: left or right bundle branch
block, left anterior fascicular block, left posterior fascicular block,
any degree of atrioventricular block, sinus bradycardia, primary
ST-T changes, abnormal q waves, atrial fibrillation, ventricular
arrhythmias, reduced global left ventricular function or evidence
of regional wall motion abnormality. Digestive involvement was
diagnosed when at least one of the following was  present: loss
of peristaltic activity of the esophagus, synchronic waves and fail-
ure or incomplete aperture of the lower esophageal sphincter with
ingestion, low amplitude waves; decreased bowel haustrae or a
dilated, atonic colon.
3. Results
3.1. Overall demographic data and geographical distribution
One hundred and forty-nine consecutive patients were selected
for the study, 101 (67.7%) were women and median age was 35
years (IQR 29–44). Median time  living in Spain was 5 years (IQR
3–5). DTUs could be determined in 105 patients (70.4%), 70 were
women (66.6%) and median age was 36 years (IQR 29–45). Overall,
the most common DTU found was TcV (58; 55.2%), followed by
TcIV (17; 16.2%), TcII (10; 9.5%) and TcI (4;  3.8%). Additionally, 16
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Fig. 1. Distribution of Discrete Tying Units according to patients’ geographical origin in Bolivia.
Table 1
Baseline characteristics of patients in whom DTU was determined.
DTU Number of patients (%)  Mean Age (SD) Female n(%) ELISA Mean (SD) IFAT Mean (SD) Visceral involvement N (%)
TcI 4(3.8%) 37.2(8.73) 2(50%) 2.14(.17) 130(60) 4(100%)
TcII  10(9.5%) 37.3(12.78) 6(60%) 2.33(.21) 195.55(70.5) 3(30%)
TcIV  17(16.2%) 35.5(9.27) 8(47%) 2.39(.29) 176.47(76.2) 7(41.1%)
TcV  58(55.2%) 36.8(9.16) 43(74.14%) 2.34(.29) 181.42(63.8) 15(25.8%)
TcI  + TcIV 4(3.8%) 35.7(6.29) 4(100%) 2.36(.27) 160(113.1) 1(25%)
TcI  + TcV 7(6.6%) 38.7(10.32) 4(57.14%) 2.22(.29) 194.28(90.7) 3(42.8%)
TcIV  + TcV 5(4.7%) 37(12.28) 3(60%) 2.5(0) 224(87.6) 1(20%)
Total  105(100%) 36.8(9.44) 70(66.66%) 2.34(.28) 181.9(71.1) 34(32.3%)
DTU: Discrete Typing Unit. SD:  standard deviation. ELISA: enzyme-linked immunosorbent assay. IFAT:  immuno fluorescent antibody test.
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(15.2%) patients presented mixed infections, namely with TcI +  TcV
(7; 6.6%), TcIV + TcV (5; 4.7%) or  TcI +  TcIV (4; 3.8%). No TcIII  or  TcVI
were found in our samples.
Most of the patients who had their DTU determined came from
Bolivia (98; 93.3%), one came from Paraguay and another came from
Ecuador. No geographical origin was reported in  5 patients. The
distribution of DTUs according to geographical origin in Bolivia is
shown in Fig. 1. The geographical origin is the one reported by the
patients as either their place of birth or the place where they spent
most of their lives before coming to Spain (at least five years of resi-
dency were considered). When DTU types were analyzed according
to geographical origin, no statistically significant differences were
observed (p = 0.266).
3.2. Clinical signs and visceral involvement
Among the 105 patients whose DTU could be  determined,
53 (50.5%) referred symptoms suggestive of Chagas disease. The
tests performed confirmed visceral involvement in  34 (32.3%): 28
had cardiac involvement [16 (10.73%) had ECG abnormalities, 17
(16.3%) had cardiac ultrasound abnormalities, no Holter or cardiac
MRI  abnormalities were described]; 5  had digestive involvement [3
out of 56 (5.3%) had oesophageal disease detected by  manometry,
and 2 out of 17 (11.7%) had an abnormal barium enema] and 1 had
both cardiac and digestive involvement. Some patients presented
more than one abnormality. Despite this, no association was  found
between a particular DTU and the presence of symptoms or visceral
involvement (p = 0.998 and p =  0.101, respectively), or between DTU
and the type of visceral involvement (cardiac or  digestive). DTU dis-
tribution and associated demographic and clinical characteristics
are listed in Table 1.
3.3. Serum titration and correlation with molecular
characterization of T. cruzi infection
The mean ELISA titres were 2.34 (SD 0.28), while mean IFAT
titres were 181.9 (SD 71.1). No statistically significant correlation
was found between the IFAT or ELISA titres and DTUs (p  =  0.641 and
p = 0.941, respectively). These serum titres remained stable during
a three year follow up  period both in  treated and untreated patients.
DTU distribution and associated ELISA and IFAT titres are  listed in
Table 1.
3.4. Molecular characterization of T. cruzi before and after
treatment
A subset of 19 patients had a second DTU determination per-
formed once they had completed treatment (the median time
until the second determination was 3 months). Details on specific
DTU determined before and after therapy are listed in  Table 2.
Patients were treated with standard anti-parasitic therapy with
benznidazole 5 mg/kg for 60 days, although one patient (patient
11) presented an adverse reaction and therapy was  changed to
nifurtimox 10 mg/kg for 90 days.
For one patient, no DTU could  be detected before treatment
(patient 15) and in another 4 (patients 16, 17, 18, 19) no DTU could
be detected after treatment. In  the remaining 14 (77.7%) a  DTU was
determined before and after treatment. In 4 out of these 14 cases
(28.6%) the DTU found after the treatment was the same as the one
found previously. There were 2 cases of mixed infections, where
one of the DTUs remained after treatment while the other appar-
ently cleared from peripheral blood. The other 8 (57%) patients had
different DTUs before and after treatment.
Table 2
Discrete Typing Units  variability before and after treatment.
Patient number DTU Before treatmenta DTU After treatment
1 V  I
2  V  II
3  V  II
4  V  III
5  V  IV
6  I +  IV IV
7  V  IV
8  IV V
9  V  V
10 V  V
11  I +  V V
12  V  V
13  V  V
14  IV V
15  ND IV
16  V  ND
17  IV ND
18  V  ND
19  V  ND
DTU: Discrete Typing Unit. ND: not  detected.
a Benznidazole 5 mg/kg for 60 days, or nifurtimox 10 mg/kg for 90 days in patient
11.
4.  Discussion
Advances in the field of T.  cruzi genetic diversity include a
recent consensus to standardize the diverse results found in  dif-
ferent settings (Zingales, 2009). However, different algorithms and
characterization techniques are in  use and their development is
ongoing, which add complexity to the interpretation of  findings.
In addition, fluctuant parasitemia and suspected differential tissue
tropisms make it difficult to  establish clear associations between
DTU type and clinical manifestations.
To the authorsı´ knowledge this is  the largest study perform-
ing DTU characterization in human patients outside endemic areas
(where re-infection does not occur). In addition, visceral involve-
ment was fully described. A limitation of this study is  that the
mode of infection could not be fully determined. Nevertheless, most
patients probably acquired the infection through vectorial trans-
mission, and secondary through congenital transmission.
Our group published a  previous study presenting epidemiologi-
cal data on T.  cruzi’s DTUs obtained from 33 patients (Perez-Molina
et al., 2014). The current study presents the results of other larger
set of patients for whom this determination was made and our cur-
rent sample size allowed us to  test statistical associations between
DTU type and visceral involvement. In the current study, a mean of
4 years follow-up has passed, allowing for a broader clinical evalu-
ation including early visceral involvement. In addition, this follow
up period allowed us to  take a second sample for DTU identification
in patients who had fulfilled complete treatment.
T. cruzi’s DNA was characterized in 105 out of 149 patients, a
high sensitivity not reached in  previous studies, probably because
PCRs were performed 3 times in  triplicate. This was done in  purpose
to increase the detection rate of DNA in  samples. In addition, the
youngest the patient the commonest it is  to have a  detectable para-
sitemia, and mean age in our population was  35 years old. The most
common DTUs detected in  our samples were, in order of frequency,
TcV, TcIV, TcII and TcI,  as well as many mixed infections. DTU dis-
tribution and the presence of mixed infections confirms previous
findings from our group among Bolivian patients (Perez-Molina
et al., 2014). In this work, our bigger sample size and a  regular fol-
low up with exhaustive clinical examination allowed us to detect
any visceral involvement and to relate it to  the DTUs identified. No
correlation was  observed between these DTUs and the specific geo-
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graphical origin of the patients, nor  the presence of specific visceral
involvement.
In this study, TcV was confirmed to be the main cause of human
infection and disease among Bolivians, what is  concordant with
previous works from Brenière et al. where this DTU was  named
clonet 39 (Breniere et al., 1998, 1989). However, we have detected
a number of Bolivian patients with TcII and TcIV, indicating more
heterogeneity than previously reported in Bolivia. This might be
because the probes used for DNA characterization in  previous stud-
ies among humans excluded TcIII and TcIV DTUs as these were
considered to  be sylvatic, (del Puerto et al., 2010) or had a  very
small sample size (Barnabé et al., 2011). TcIV had been previously
associated with acute oral outbreaks in  tropical areas (Monteiro
et al., 2012; Ramirez et al., 2013), and has been described as the sec-
ond most common DTU in  human samples from Venezuela and the
fourth most frequent in human samples from Colombia (Carrasco
et al., 2012; Ramírez et al., 2010). The current results confirm that
this DTU is also an important cause of chronic Chagas disease with
visceral involvement (5 had cardiac involvement and 2 had diges-
tive involvement) in Bolivian patients as for Colombians (Ramírez
et al., 2010), and therefore should be considered as a preferent
strain to be tested in  future drug development, according to recent
expert claims on  other DTUs (Zingales et al., 2014). TcII, which has
been rarely reported in  Bolivia, was found in less than 10% of our
patients as expected, while it has been reported as a  the more
common DTU in Venezuela and Colombia (Carrasco et al., 2012;
Ramírez et al., 2010; Ramirez et al., 2013). TcI has previously been
reported as a major cause of infection in  Bolivia and our data con-
firm TcI as a cause of chronic human infection, although it is less
frequent. Nevertheless, it is  worth noting that all 4 patients who
were infected with TcI had visceral involvement. TcIII was  not  found
in our sample population, although beings mainly transmitted in
sylvatic cycles of T. cruzi (Brenière et al., 2012; Zingales et al., 2012),
has been also found in  domestic Triatoma infestans from Bolivia
(Perez et al., 2012). TcVI has rarely been found outside the Gran
Chaco region. Our findings are concordant with DTUs found in vec-
tors and reservoirs in the same areas, except for the absence of TcIII
in our samples.
Another important finding was the high proportion of mixed
infections (up to  15.2% of the baseline determinations), what was
similar to the one found in  a  previous work by our group (Perez-
Molina et al., 2014) and concordant with other authors’ findings
in  Latin America (Cura et al., 2012). A  previous study in the Boli-
vian Gran Chaco region found mixed infections in up to 13% of
the T. infestans vectors examined (Perez et al., 2013). Mixed infec-
tions have also been detected in other vectors and reservoirs in  the
American region (Noireau et al., 2009; Ramirez et al., 2012).
Since most of our  patients were Bolivian (93.3%), the DTU dis-
tribution and the presence of mixed infections observed in  this
study could be representative of T.  cruzi’s epidemiology only in this
endemic area. The lack of correlation between DTU and specific
geographical origin might be due to the fact that  patients reported
the place where they lived mainly before migrating. Cities known
to receive internal migration are  overrepresented in  our sample,
and probably do not reflect the areas where the infection was most
likely acquired considering that most infections are due to vectorial
transmission. In addition, congenital transmission is  also frequent
in Bolivia, allowing the spread of any DTU to urban areas.
Although some authors have identified differential tissue
tropism for different DTUs (Burgos et al., 2010; del Puerto et al.,
2010; Ramírez et al., 2010) we found no correlation between DTU
and specific visceral involvement, in  accordance with other pub-
lished studies (Poveda et al., 2014; Zafra et al., 2011). This might be
because the number of certain DTUs detected in samples was too
low to achieve statistical significance.
Treatment with Benznidazole 5 mg/kg for 60 days did not clear
T. cruzi genetic material from blood samples, and this has also been
reported by other authors (Murcia et al., 2010), although the signif-
icance of this finding with respect to parasite clearance is  unclear.
The presence of T. cruzi’s genetic material in blood suggests either
failure to treatment or maybe the presence of DNA  fragments able
to hybridize. DTU I, II, III,  IV and V were all detected after treat-
ment, while only TcIII was not identified prior  to treatment. Some
authors have shown, by means of a  qualitative PCR assay that T.
cruzi’s genetic material can appear in blood  up to  420 days after
correct treatment (Murcia et al., 2010), what in a clinical setting
translates failure to treatment. In  our work we  detected parasite
DNA in  14 out of 19 patients who  had received treatment, we also
identified different T. cruzi’s near clades before and after treatment.
Up to 22.9% (24/105) of patients had polyparasitism: 16  mixed
infections were detected before treatment was administered and
another 8 patients out of 14 who  had a  second DTU  determination
after treatment presented a  DTU that was  different from the pre-
vious one. As  mentioned above, a  different DTU was found after
treatment in 8 cases. Cryptic mixed infections and heterogeneous
drug response might be responsible for this finding. T. cruzi is
believed to  present intermittent parasitemia in the host, a  recent
study showed that diverse DTUs can be detected from a  single indi-
vidual at a different time point in  the absence of treatment (Sanchez
et al., 2013); In addition, strains and clones tested in  vitro have
shown differential response to nitrohetercyclic compounds as the
ones used in  our clinical practice (Moraes et al., 2014). Therefore,
mixed infections in Chagas diseases is  a  natural phenomenon and
could be  more frequent than expected (Perez et al., 2014). Assum-
ing that mixed infections are the natural process, the correlation of
DTUs with visceral involvement would be confusing. Anyway, this
phenomenon has to be confirmed and its implications in clinical
management clarified.
In  conclusion, the DTU distribution found in  this study may  be
indicative of where active transmission of T. cruzi,  in both domestic
and sylvatic cycles, is occurring in  Bolivia. TcIV was confirmed as
a cause of chronic human disease. Some experts believe research
efforts should be focused on developing new drugs only against
those DTUs known to cause human disease (Zingales et al., 2014),
but our results indicate any DTU may  be transmitted to humans and
cause visceral involvement. The current results appear to indicate
there is no significant correlation between DTU and any specific
clinical presentation associated with Chagas disease. In order to
identify temporal changes before disease appears, field studies fol-
lowing patients in the indeterminate stage of the disease should be
performed, but this way  of procedure is difficult as once an infected
patient is  detected the antiparasitic treatment follows and the nat-
ural course of the disease is  broken. Treatment with benznidazole
does not always clear T.  cruzi’s genetic material from blood as this
may be detected up to three months after completing treatment,
what suggests either failure to treatment or maybe the presence
of DNA fragments able to hybridize. Finally, DTUs detected in the
same patient may  vary over time indicating that polyparasitism is
frequent.
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